{"cells":[{"cell_type":"markdown","source":["## Get Started with Spark NLP for Healthcare"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"4decee04-7491-41e4-94f4-8b592e29f89b"}}},{"cell_type":"markdown","source":["## Getting the keys and installation\n\n1. In order to get trial keys for Spark NLP for Healthcare\n, fill the form at https://www.johnsnowlabs.com/spark-nlp-try-free/ and you will get your keys to your email in a few minutes.\n\n2. On a new cluster or existing one\n\n  - add the following to the `Advanced Options -> Spark` tab, in `Spark.Config` box:\n\n    ```bash\n    spark.local.dir /var\n    spark.kryoserializer.buffer.max 1000M\n    spark.serializer org.apache.spark.serializer.KryoSerializer\n    ```\n  - add the following to the `Advanced Options -> Spark` tab, in `Environment Variables` box:\n\n    ```bash\n    AWS_ACCESS_KEY_ID=xxx\n    AWS_SECRET_ACCESS_KEY=yyy\n    SPARK_NLP_LICENSE=zzz\n    ```\n\n3. Download the followings with AWS CLI to your local computer\n\n    `$ aws s3 cp --region us-east-2 s3://pypi.johnsnowlabs.com/$jsl_secret/spark-nlp-jsl-$jsl_version.jar spark-nlp-jsl-$jsl_version.jar`\n\n    `$ aws s3 cp --region us-east-2 s3://pypi.johnsnowlabs.com/$jsl_secret/spark-nlp-jsl/spark_nlp_jsl-$jsl_version-py3-none-any.whl spark_nlp_jsl-$jsl_version-py3-none-any.whl` \n\n4. In `Libraries` tab inside your cluster:\n\n - Install New -> PyPI -> `spark-nlp==$public_version` -> Install\n - Install New -> Maven -> Coordinates -> `com.johnsnowlabs.nlp:spark-nlp_2.12:$public_version` -> Install\n\n - add following jars for the Healthcare library that you downloaded above:\n        - Install New -> Python Whl -> upload `spark_nlp_jsl-$jsl_version-py3-none-any.whl`\n\n        - Install New -> Jar -> upload `spark-nlp-jsl-$jsl_version.jar`\n\n5. Now you can attach your notebook to the cluster and use Spark NLP!\n\nFor more information, see \n\n  https://nlp.johnsnowlabs.com/docs/en/install#databricks-support\n\n  https://nlp.johnsnowlabs.com/docs/en/licensed_install#install-spark-nlp-for-healthcare-on-databricks\n  \nThe follwing notebook is prepared and tested on **r2.2xlarge at 8.0 (includes Apache Spark 3.1.1, Scala 2.12)** on Databricks\n\nIn order to get more detailed examples, please check this repository : https://github.com/JohnSnowLabs/spark-nlp-workshop/tree/master/tutorials/Certification_Trainings/Healthcare/databricks_notebooks"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"cfc64c02-f8d2-4c7a-9fd0-431cdfdd88dd"}}},{"cell_type":"markdown","source":["Let's import the libraries which we will use in the following cells."],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"6c393ed9-47c2-440b-aeca-6d20f2a3e065"}}},{"cell_type":"code","source":["import os\nimport json\nimport string\nimport numpy as np\nimport pandas as pd\n\nimport sparknlp\nimport sparknlp_jsl\nfrom sparknlp.base import *\nfrom sparknlp.util import *\nfrom sparknlp.annotator import *\nfrom sparknlp_jsl.base import *\nfrom sparknlp_jsl.annotator import *\nfrom sparknlp.pretrained import ResourceDownloader\n\nfrom pyspark.sql import functions as F\nfrom pyspark.ml import Pipeline, PipelineModel\nfrom sparknlp.training import CoNLL\n\npd.set_option('max_colwidth', 100)\npd.set_option('display.max_columns', 100)  \npd.set_option('display.expand_frame_repr', False)\n\nprint('sparknlp.version : ',sparknlp.version())\nprint('sparknlp_jsl.version : ',sparknlp_jsl.version())\n\nspark\n"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"65e4642d-6133-46f1-a02e-1fabfd5f969f"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">sparknlp.version :  3.1.0\nsparknlp_jsl.version :  3.1.0\nOut[1]: </div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">sparknlp.version :  3.1.0\nsparknlp_jsl.version :  3.1.0\nOut[1]: </div>"]}},{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"\n            <div>\n                <p><b>SparkSession - hive</b></p>\n                \n        <div>\n            <p><b>SparkContext</b></p>\n\n            <p><a href=\"/?o=3418543878422327#setting/sparkui/0418-135725-tort451/driver-8253718905438865556\">Spark UI</a></p>\n\n            <dl>\n              <dt>Version</dt>\n                <dd><code>v3.1.1</code></dd>\n              <dt>Master</dt>\n                <dd><code>spark://10.164.252.205:7077</code></dd>\n              <dt>AppName</dt>\n                <dd><code>Databricks Shell</code></dd>\n            </dl>\n        </div>\n        \n            </div>\n        ","textData":null,"removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"htmlSandbox","arguments":{}}},"output_type":"display_data","data":{"text/html":["\n            <div>\n                <p><b>SparkSession - hive</b></p>\n                \n        <div>\n            <p><b>SparkContext</b></p>\n\n            <p><a href=\"/?o=3418543878422327#setting/sparkui/0418-135725-tort451/driver-8253718905438865556\">Spark UI</a></p>\n\n            <dl>\n              <dt>Version</dt>\n                <dd><code>v3.1.1</code></dd>\n              <dt>Master</dt>\n                <dd><code>spark://10.164.252.205:7077</code></dd>\n              <dt>AppName</dt>\n                <dd><code>Databricks Shell</code></dd>\n            </dl>\n        </div>\n        \n            </div>\n        "]}}],"execution_count":0},{"cell_type":"markdown","source":["**Read Dataset**\n\nWe will download a sample file and create a spark dataframe."],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"0174ce86-9b1b-4e4e-ba8f-1068c3ba21f4"}}},{"cell_type":"code","source":["! wget -q https://s3.amazonaws.com/auxdata.johnsnowlabs.com/public/resources/en/pubmed/pubmed_sample_text_small.csv"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"7334d46e-1f94-4f79-b7f0-314b5f4cbdb9"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\"></div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\"></div>"]}}],"execution_count":0},{"cell_type":"code","source":["pubMedDF = spark.read.option(\"header\", \"true\").csv(\"dbfs:/pubmed_sample_text_small.csv\")\n                \npubMedDF.show(truncate=100)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"e43d12f0-44e7-4001-93dc-7efdce22e401"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">+----------------------------------------------------------------------------------------------------+\n|                                                                                                text|\n+----------------------------------------------------------------------------------------------------+\n|The human KCNJ9 (Kir 3.3, GIRK3) is a member of the G-protein-activated inwardly rectifying potas...|\n|BACKGROUND: At present, it is one of the most important issues for the treatment of breast cancer...|\n|OBJECTIVE: To investigate the relationship between preoperative atrialfibrillation and early and ...|\n|Combined EEG/fMRI recording has been used to localize the generators of EEGevents and to identify...|\n|Kohlschutter syndrome is a rare neurodegenerative disorder presenting withintractable seizures, d...|\n|Statistical analysis of neuroimages is commonly approached with intergroupcomparisons made by rep...|\n|The synthetic DOX-LNA conjugate was characterized by proton nuclear magneticresonance and mass sp...|\n|Our objective was to compare three different methods of blood pressuremeasurement through the res...|\n|We conducted a phase II study to assess the efficacy and tolerability ofirinotecan and cisplatin ...|\n|&#34;&#34;&#34;Monomeric sarcosine oxidase (MSOX) is a flavoenzyme that catalyzes the oxidative demethylation...|\n|We presented the tachinid fly Exorista japonica with moving host models: afreeze-dried larva of t...|\n|The literature dealing with the water conducting properties of sapwood xylem intrees is inconsist...|\n|A novel approach to synthesize chitosan-O-isopropyl-5&#39;-O-d4T monophosphateconjugate was developed...|\n|An HPLC-ESI-MS-MS method has been developed for the quantitative determination offour diterpenoid...|\n|The localizing and lateralizing values of eye and head ictal deviations duringfrontal lobe seizur...|\n|OBJECTIVE: To evaluate the effectiveness and acceptability of expectantmanagement of induced and ...|\n|For the construction of new combinatorial libraries, a lead compound was created by replacing the...|\n|We report the results of a screen for genetic association with urinary arsenicmetabolite levels i...|\n|Intraparenchymal pericatheter cyst is rarely reported. Obstruction in theventriculoperitoneal shu...|\n|It is known that patients with Klinefelter&#39;s syndrome are inclined to developconcomitant malignan...|\n+----------------------------------------------------------------------------------------------------+\nonly showing top 20 rows\n\n</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">+----------------------------------------------------------------------------------------------------+\n                                                                                                text|\n+----------------------------------------------------------------------------------------------------+\nThe human KCNJ9 (Kir 3.3, GIRK3) is a member of the G-protein-activated inwardly rectifying potas...|\nBACKGROUND: At present, it is one of the most important issues for the treatment of breast cancer...|\nOBJECTIVE: To investigate the relationship between preoperative atrialfibrillation and early and ...|\nCombined EEG/fMRI recording has been used to localize the generators of EEGevents and to identify...|\nKohlschutter syndrome is a rare neurodegenerative disorder presenting withintractable seizures, d...|\nStatistical analysis of neuroimages is commonly approached with intergroupcomparisons made by rep...|\nThe synthetic DOX-LNA conjugate was characterized by proton nuclear magneticresonance and mass sp...|\nOur objective was to compare three different methods of blood pressuremeasurement through the res...|\nWe conducted a phase II study to assess the efficacy and tolerability ofirinotecan and cisplatin ...|\n&#34;&#34;&#34;Monomeric sarcosine oxidase (MSOX) is a flavoenzyme that catalyzes the oxidative demethylation...|\nWe presented the tachinid fly Exorista japonica with moving host models: afreeze-dried larva of t...|\nThe literature dealing with the water conducting properties of sapwood xylem intrees is inconsist...|\nA novel approach to synthesize chitosan-O-isopropyl-5&#39;-O-d4T monophosphateconjugate was developed...|\nAn HPLC-ESI-MS-MS method has been developed for the quantitative determination offour diterpenoid...|\nThe localizing and lateralizing values of eye and head ictal deviations duringfrontal lobe seizur...|\nOBJECTIVE: To evaluate the effectiveness and acceptability of expectantmanagement of induced and ...|\nFor the construction of new combinatorial libraries, a lead compound was created by replacing the...|\nWe report the results of a screen for genetic association with urinary arsenicmetabolite levels i...|\nIntraparenchymal pericatheter cyst is rarely reported. Obstruction in theventriculoperitoneal shu...|\nIt is known that patients with Klinefelter&#39;s syndrome are inclined to developconcomitant malignan...|\n+----------------------------------------------------------------------------------------------------+\nonly showing top 20 rows\n\n</div>"]}}],"execution_count":0},{"cell_type":"markdown","source":["## 1. Clinical NER Pipeline\nWe will extract clinical entities from text by using `ner_clinical_large` model."],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"7a92a940-a2dd-43b6-81f5-d57782a5ff32"}}},{"cell_type":"code","source":["# Annotator that transforms a text column from dataframe into an Annotation ready for NLP\ndocumentAssembler = DocumentAssembler()\\\n        .setInputCol(\"text\")\\\n        .setOutputCol(\"document\")\n\n# Sentence Detector annotator, processes various sentences per line\n\n#sentenceDetector = SentenceDetector()\\\n        #.setInputCols([\"document\"])\\\n        #.setOutputCol(\"sentence\")\nsentenceDetector = SentenceDetectorDLModel.pretrained(\"sentence_detector_dl_healthcare\",\"en\",\"clinical/models\")\\\n        .setInputCols([\"document\"])\\\n        .setOutputCol(\"sentence\")\n \n# Tokenizer splits words in a relevant format for NLP\ntokenizer = Tokenizer()\\\n        .setInputCols([\"sentence\"])\\\n        .setOutputCol(\"token\")\n\n# Clinical word embeddings trained on PubMED dataset\nword_embeddings = WordEmbeddingsModel.pretrained(\"embeddings_clinical\",\"en\",\"clinical/models\")\\\n        .setInputCols([\"sentence\",\"token\"])\\\n        .setOutputCol(\"embeddings\")\n\npos_tagger = PerceptronModel.pretrained(\"pos_clinical\", \"en\", \"clinical/models\") \\\n        .setInputCols([\"sentence\", \"token\"])\\\n        .setOutputCol(\"pos_tags\")\n\n# NER model trained on i2b2 (sampled from MIMIC) dataset\nclinical_ner = MedicalNerModel.pretrained(\"ner_clinical_large\",\"en\",\"clinical/models\")\\\n        .setInputCols([\"sentence\",\"token\",\"embeddings\"])\\\n        .setOutputCol(\"ner\")\n\nner_converter = NerConverter()\\\n        .setInputCols([\"sentence\",\"token\",\"ner\"])\\\n        .setOutputCol(\"ner_chunk\")\n\nnerPipeline = Pipeline(stages=[\n        documentAssembler,\n        sentenceDetector,\n        tokenizer,\n        word_embeddings,\n        pos_tagger,\n        clinical_ner,\n        ner_converter])\n\n\nempty_data = spark.createDataFrame([[\"\"]]).toDF(\"text\")\n\nner_model = nerPipeline.fit(empty_data)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"a8b241d9-88b2-45aa-b091-a4b037f46b10"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">sentence_detector_dl_healthcare download started this may take some time.\nApproximate size to download 363.9 KB\n\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[OK!]\nembeddings_clinical download started this may take some time.\nApproximate size to download 1.6 GB\n\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[OK!]\npos_clinical download started this may take some time.\nApproximate size to download 1.5 MB\n\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[OK!]\nner_clinical_large download started this may take some time.\nApproximate size to download 13.9 MB\n\r[ | ]\r[ / ]\r[ — ]\r[OK!]\n</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">sentence_detector_dl_healthcare download started this may take some time.\nApproximate size to download 363.9 KB\n\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[OK!]\nembeddings_clinical download started this may take some time.\nApproximate size to download 1.6 GB\n\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[OK!]\npos_clinical download started this may take some time.\nApproximate size to download 1.5 MB\n\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[OK!]\nner_clinical_large download started this may take some time.\nApproximate size to download 13.9 MB\n\r[ | ]\r[ / ]\r[ — ]\r[OK!]\n</div>"]}}],"execution_count":0},{"cell_type":"code","source":["ner_model.stages"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"a5eee89a-6d6c-48b9-97ed-ce37fe6d11c4"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">Out[6]: [DocumentAssembler_2eb43949d513,\n SentenceDetectorDLModel_d2546f0acfe2,\n REGEX_TOKENIZER_adf041b5e4f3,\n WORD_EMBEDDINGS_MODEL_9004b1d00302,\n POS_6f55785005bf,\n MedicalNerModel_1a8637089929,\n NerConverter_30ad7a702efd]</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">Out[6]: [DocumentAssembler_2eb43949d513,\n SentenceDetectorDLModel_d2546f0acfe2,\n REGEX_TOKENIZER_adf041b5e4f3,\n WORD_EMBEDDINGS_MODEL_9004b1d00302,\n POS_6f55785005bf,\n MedicalNerModel_1a8637089929,\n NerConverter_30ad7a702efd]</div>"]}}],"execution_count":0},{"cell_type":"code","source":["clinical_ner.getClasses()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"2648633c-04a0-475a-b581-9effd1133623"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">Out[7]: [&#39;O&#39;,\n &#39;B-TREATMENT&#39;,\n &#39;I-TREATMENT&#39;,\n &#39;B-PROBLEM&#39;,\n &#39;I-PROBLEM&#39;,\n &#39;B-TEST&#39;,\n &#39;I-TEST&#39;]</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">Out[7]: [&#39;O&#39;,\n &#39;B-TREATMENT&#39;,\n &#39;I-TREATMENT&#39;,\n &#39;B-PROBLEM&#39;,\n &#39;I-PROBLEM&#39;,\n &#39;B-TEST&#39;,\n &#39;I-TEST&#39;]</div>"]}}],"execution_count":0},{"cell_type":"code","source":["result = ner_model.transform(pubMedDF.limit(100))"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"587a68da-1aa6-4a85-b7ea-e95bec4cf903"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\"></div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\"></div>"]}}],"execution_count":0},{"cell_type":"code","source":["result.show()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"8f0defec-05fc-4d89-8f5f-29fe99945df8"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">+--------------------+--------------------+--------------------+--------------------+--------------------+--------------------+--------------------+--------------------+\n|                text|            document|            sentence|               token|          embeddings|            pos_tags|                 ner|           ner_chunk|\n+--------------------+--------------------+--------------------+--------------------+--------------------+--------------------+--------------------+--------------------+\n|The human KCNJ9 (...|[{document, 0, 95...|[{document, 0, 12...|[{token, 0, 2, Th...|[{word_embeddings...|[{pos, 0, 2, DD, ...|[{named_entity, 0...|[{chunk, 48, 106,...|\n|BACKGROUND: At pr...|[{document, 0, 14...|[{document, 0, 19...|[{token, 0, 9, BA...|[{word_embeddings...|[{pos, 0, 9, NN, ...|[{named_entity, 0...|[{chunk, 67, 79, ...|\n|OBJECTIVE: To inv...|[{document, 0, 15...|[{document, 0, 14...|[{token, 0, 8, OB...|[{word_embeddings...|[{pos, 0, 8, NN, ...|[{named_entity, 0...|[{chunk, 130, 144...|\n|Combined EEG/fMRI...|[{document, 0, 16...|[{document, 0, 29...|[{token, 0, 7, Co...|[{word_embeddings...|[{pos, 0, 7, VVNJ...|[{named_entity, 0...|[{chunk, 0, 26, C...|\n|Kohlschutter synd...|[{document, 0, 25...|[{document, 0, 20...|[{token, 0, 11, K...|[{word_embeddings...|[{pos, 0, 11, NN,...|[{named_entity, 0...|[{chunk, 0, 20, K...|\n|Statistical analy...|[{document, 0, 10...|[{document, 0, 22...|[{token, 0, 10, S...|[{word_embeddings...|[{pos, 0, 10, JJ,...|[{named_entity, 0...|[{chunk, 0, 34, S...|\n|The synthetic DOX...|[{document, 0, 57...|[{document, 0, 10...|[{token, 0, 2, Th...|[{word_embeddings...|[{pos, 0, 2, DD, ...|[{named_entity, 0...|[{chunk, 0, 30, T...|\n|Our objective was...|[{document, 0, 24...|[{document, 0, 19...|[{token, 0, 2, Ou...|[{word_embeddings...|[{pos, 0, 2, PNG,...|[{named_entity, 0...|[{chunk, 56, 80, ...|\n|We conducted a ph...|[{document, 0, 14...|[{document, 0, 24...|[{token, 0, 1, We...|[{word_embeddings...|[{pos, 0, 1, PN, ...|[{named_entity, 0...|[{chunk, 13, 28, ...|\n|&#34;&#34;&#34;Monomeric sarc...|[{document, 0, 14...|[{document, 0, 14...|[{token, 0, 2, &#34;&#34;...|[{word_embeddings...|[{pos, 0, 2, NN, ...|[{named_entity, 0...|[{chunk, 3, 36, M...|\n|We presented the ...|[{document, 0, 12...|[{document, 0, 34...|[{token, 0, 1, We...|[{word_embeddings...|[{pos, 0, 1, PN, ...|[{named_entity, 0...|[{chunk, 13, 46, ...|\n|The literature de...|[{document, 0, 16...|[{document, 0, 13...|[{token, 0, 2, Th...|[{word_embeddings...|[{pos, 0, 2, DD, ...|[{named_entity, 0...|[{chunk, 154, 166...|\n|A novel approach ...|[{document, 0, 64...|[{document, 0, 97...|[{token, 0, 0, A,...|[{word_embeddings...|[{pos, 0, 0, DD, ...|[{named_entity, 0...|[{chunk, 99, 124,...|\n|An HPLC-ESI-MS-MS...|[{document, 0, 90...|[{document, 0, 24...|[{token, 0, 1, An...|[{word_embeddings...|[{pos, 0, 1, DD, ...|[{named_entity, 0...|[{chunk, 0, 23, A...|\n|The localizing an...|[{document, 0, 72...|[{document, 0, 12...|[{token, 0, 2, Th...|[{word_embeddings...|[{pos, 0, 2, DD, ...|[{named_entity, 0...|[{chunk, 50, 70, ...|\n|OBJECTIVE: To eva...|[{document, 0, 13...|[{document, 0, 14...|[{token, 0, 8, OB...|[{word_embeddings...|[{pos, 0, 8, NN, ...|[{named_entity, 0...|[{chunk, 97, 143,...|\n|For the construct...|[{document, 0, 32...|[{document, 0, 20...|[{token, 0, 2, Fo...|[{word_embeddings...|[{pos, 0, 2, II, ...|[{named_entity, 0...|[{chunk, 24, 50, ...|\n|We report the res...|[{document, 0, 13...|[{document, 0, 31...|[{token, 0, 1, We...|[{word_embeddings...|[{pos, 0, 1, PN, ...|[{named_entity, 0...|[{chunk, 25, 32, ...|\n|Intraparenchymal ...|[{document, 0, 10...|[{document, 0, 53...|[{token, 0, 15, I...|[{word_embeddings...|[{pos, 0, 15, JJ,...|[{named_entity, 0...|[{chunk, 0, 33, I...|\n|It is known that ...|[{document, 0, 34...|[{document, 0, 14...|[{token, 0, 1, It...|[{word_embeddings...|[{pos, 0, 1, PN, ...|[{named_entity, 0...|[{chunk, 31, 52, ...|\n+--------------------+--------------------+--------------------+--------------------+--------------------+--------------------+--------------------+--------------------+\nonly showing top 20 rows\n\n</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">+--------------------+--------------------+--------------------+--------------------+--------------------+--------------------+--------------------+--------------------+\n                text|            document|            sentence|               token|          embeddings|            pos_tags|                 ner|           ner_chunk|\n+--------------------+--------------------+--------------------+--------------------+--------------------+--------------------+--------------------+--------------------+\nThe human KCNJ9 (...|[{document, 0, 95...|[{document, 0, 12...|[{token, 0, 2, Th...|[{word_embeddings...|[{pos, 0, 2, DD, ...|[{named_entity, 0...|[{chunk, 48, 106,...|\nBACKGROUND: At pr...|[{document, 0, 14...|[{document, 0, 19...|[{token, 0, 9, BA...|[{word_embeddings...|[{pos, 0, 9, NN, ...|[{named_entity, 0...|[{chunk, 67, 79, ...|\nOBJECTIVE: To inv...|[{document, 0, 15...|[{document, 0, 14...|[{token, 0, 8, OB...|[{word_embeddings...|[{pos, 0, 8, NN, ...|[{named_entity, 0...|[{chunk, 130, 144...|\nCombined EEG/fMRI...|[{document, 0, 16...|[{document, 0, 29...|[{token, 0, 7, Co...|[{word_embeddings...|[{pos, 0, 7, VVNJ...|[{named_entity, 0...|[{chunk, 0, 26, C...|\nKohlschutter synd...|[{document, 0, 25...|[{document, 0, 20...|[{token, 0, 11, K...|[{word_embeddings...|[{pos, 0, 11, NN,...|[{named_entity, 0...|[{chunk, 0, 20, K...|\nStatistical analy...|[{document, 0, 10...|[{document, 0, 22...|[{token, 0, 10, S...|[{word_embeddings...|[{pos, 0, 10, JJ,...|[{named_entity, 0...|[{chunk, 0, 34, S...|\nThe synthetic DOX...|[{document, 0, 57...|[{document, 0, 10...|[{token, 0, 2, Th...|[{word_embeddings...|[{pos, 0, 2, DD, ...|[{named_entity, 0...|[{chunk, 0, 30, T...|\nOur objective was...|[{document, 0, 24...|[{document, 0, 19...|[{token, 0, 2, Ou...|[{word_embeddings...|[{pos, 0, 2, PNG,...|[{named_entity, 0...|[{chunk, 56, 80, ...|\nWe conducted a ph...|[{document, 0, 14...|[{document, 0, 24...|[{token, 0, 1, We...|[{word_embeddings...|[{pos, 0, 1, PN, ...|[{named_entity, 0...|[{chunk, 13, 28, ...|\n&#34;&#34;&#34;Monomeric sarc...|[{document, 0, 14...|[{document, 0, 14...|[{token, 0, 2, &#34;&#34;...|[{word_embeddings...|[{pos, 0, 2, NN, ...|[{named_entity, 0...|[{chunk, 3, 36, M...|\nWe presented the ...|[{document, 0, 12...|[{document, 0, 34...|[{token, 0, 1, We...|[{word_embeddings...|[{pos, 0, 1, PN, ...|[{named_entity, 0...|[{chunk, 13, 46, ...|\nThe literature de...|[{document, 0, 16...|[{document, 0, 13...|[{token, 0, 2, Th...|[{word_embeddings...|[{pos, 0, 2, DD, ...|[{named_entity, 0...|[{chunk, 154, 166...|\nA novel approach ...|[{document, 0, 64...|[{document, 0, 97...|[{token, 0, 0, A,...|[{word_embeddings...|[{pos, 0, 0, DD, ...|[{named_entity, 0...|[{chunk, 99, 124,...|\nAn HPLC-ESI-MS-MS...|[{document, 0, 90...|[{document, 0, 24...|[{token, 0, 1, An...|[{word_embeddings...|[{pos, 0, 1, DD, ...|[{named_entity, 0...|[{chunk, 0, 23, A...|\nThe localizing an...|[{document, 0, 72...|[{document, 0, 12...|[{token, 0, 2, Th...|[{word_embeddings...|[{pos, 0, 2, DD, ...|[{named_entity, 0...|[{chunk, 50, 70, ...|\nOBJECTIVE: To eva...|[{document, 0, 13...|[{document, 0, 14...|[{token, 0, 8, OB...|[{word_embeddings...|[{pos, 0, 8, NN, ...|[{named_entity, 0...|[{chunk, 97, 143,...|\nFor the construct...|[{document, 0, 32...|[{document, 0, 20...|[{token, 0, 2, Fo...|[{word_embeddings...|[{pos, 0, 2, II, ...|[{named_entity, 0...|[{chunk, 24, 50, ...|\nWe report the res...|[{document, 0, 13...|[{document, 0, 31...|[{token, 0, 1, We...|[{word_embeddings...|[{pos, 0, 1, PN, ...|[{named_entity, 0...|[{chunk, 25, 32, ...|\nIntraparenchymal ...|[{document, 0, 10...|[{document, 0, 53...|[{token, 0, 15, I...|[{word_embeddings...|[{pos, 0, 15, JJ,...|[{named_entity, 0...|[{chunk, 0, 33, I...|\nIt is known that ...|[{document, 0, 34...|[{document, 0, 14...|[{token, 0, 1, It...|[{word_embeddings...|[{pos, 0, 1, PN, ...|[{named_entity, 0...|[{chunk, 31, 52, ...|\n+--------------------+--------------------+--------------------+--------------------+--------------------+--------------------+--------------------+--------------------+\nonly showing top 20 rows\n\n</div>"]}}],"execution_count":0},{"cell_type":"code","source":["result.select(\"sentence.result\").show(truncate=100)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"8fdca092-5e99-47f8-8ed9-262643442d67"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">+----------------------------------------------------------------------------------------------------+\n|                                                                                              result|\n+----------------------------------------------------------------------------------------------------+\n|[The human KCNJ9 (Kir 3.3, GIRK3) is a member of the G-protein-activated inwardly rectifying pota...|\n|[BACKGROUND: At present, it is one of the most important issues for the treatment of breast cance...|\n|[OBJECTIVE: To investigate the relationship between preoperative atrialfibrillation and early and...|\n|[Combined EEG/fMRI recording has been used to localize the generators of EEGevents and to identif...|\n|[Kohlschutter syndrome is a rare neurodegenerative disorder presenting withintractable seizures, ...|\n|[Statistical analysis of neuroimages is commonly approached with intergroupcomparisons made by re...|\n|[The synthetic DOX-LNA conjugate was characterized by proton nuclear magneticresonance and mass s...|\n|[Our objective was to compare three different methods of blood pressuremeasurement through the re...|\n|[We conducted a phase II study to assess the efficacy and tolerability ofirinotecan and cisplatin...|\n|[&#34;&#34;&#34;Monomeric sarcosine oxidase (MSOX) is a flavoenzyme that catalyzes the oxidative demethylatio...|\n|[We presented the tachinid fly Exorista japonica with moving host models: afreeze-dried larva of ...|\n|[The literature dealing with the water conducting properties of sapwood xylem intrees is inconsis...|\n|[A novel approach to synthesize chitosan-O-isopropyl-5&#39;-O-d4T monophosphateconjugate was develope...|\n|[An HPLC-ESI-MS-MS method has been developed for the quantitative determination offour diterpenoi...|\n|[The localizing and lateralizing values of eye and head ictal deviations duringfrontal lobe seizu...|\n|[OBJECTIVE: To evaluate the effectiveness and acceptability of expectantmanagement of induced and...|\n|[For the construction of new combinatorial libraries, a lead compound was created by replacing th...|\n|[We report the results of a screen for genetic association with urinary arsenicmetabolite levels ...|\n|[Intraparenchymal pericatheter cyst is rarely reported., Obstruction in theventriculoperitoneal s...|\n|[It is known that patients with Klinefelter&#39;s syndrome are inclined to developconcomitant maligna...|\n+----------------------------------------------------------------------------------------------------+\nonly showing top 20 rows\n\n</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">+----------------------------------------------------------------------------------------------------+\n                                                                                              result|\n+----------------------------------------------------------------------------------------------------+\n[The human KCNJ9 (Kir 3.3, GIRK3) is a member of the G-protein-activated inwardly rectifying pota...|\n[BACKGROUND: At present, it is one of the most important issues for the treatment of breast cance...|\n[OBJECTIVE: To investigate the relationship between preoperative atrialfibrillation and early and...|\n[Combined EEG/fMRI recording has been used to localize the generators of EEGevents and to identif...|\n[Kohlschutter syndrome is a rare neurodegenerative disorder presenting withintractable seizures, ...|\n[Statistical analysis of neuroimages is commonly approached with intergroupcomparisons made by re...|\n[The synthetic DOX-LNA conjugate was characterized by proton nuclear magneticresonance and mass s...|\n[Our objective was to compare three different methods of blood pressuremeasurement through the re...|\n[We conducted a phase II study to assess the efficacy and tolerability ofirinotecan and cisplatin...|\n[&#34;&#34;&#34;Monomeric sarcosine oxidase (MSOX) is a flavoenzyme that catalyzes the oxidative demethylatio...|\n[We presented the tachinid fly Exorista japonica with moving host models: afreeze-dried larva of ...|\n[The literature dealing with the water conducting properties of sapwood xylem intrees is inconsis...|\n[A novel approach to synthesize chitosan-O-isopropyl-5&#39;-O-d4T monophosphateconjugate was develope...|\n[An HPLC-ESI-MS-MS method has been developed for the quantitative determination offour diterpenoi...|\n[The localizing and lateralizing values of eye and head ictal deviations duringfrontal lobe seizu...|\n[OBJECTIVE: To evaluate the effectiveness and acceptability of expectantmanagement of induced and...|\n[For the construction of new combinatorial libraries, a lead compound was created by replacing th...|\n[We report the results of a screen for genetic association with urinary arsenicmetabolite levels ...|\n[Intraparenchymal pericatheter cyst is rarely reported., Obstruction in theventriculoperitoneal s...|\n[It is known that patients with Klinefelter&#39;s syndrome are inclined to developconcomitant maligna...|\n+----------------------------------------------------------------------------------------------------+\nonly showing top 20 rows\n\n</div>"]}}],"execution_count":0},{"cell_type":"code","source":["from pyspark.sql import functions as F\n\nresult_df = result.select(F.explode(F.arrays_zip(\"token.result\",\"ner.result\")).alias(\"cols\"))\\\n                  .select(F.expr(\"cols['0']\").alias(\"token\"),\n                          F.expr(\"cols['1']\").alias(\"ner_label\"))\n\nresult_df.show(50, truncate=100)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"e5ddd5a9-7797-4e80-8445-5b92776942c7"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">+-------------------+-----------+\n|              token|  ner_label|\n+-------------------+-----------+\n|                The|          O|\n|              human|          O|\n|              KCNJ9|          O|\n|                  (|          O|\n|                Kir|          O|\n|                3.3|          O|\n|                  ,|          O|\n|              GIRK3|          O|\n|                  )|          O|\n|                 is|          O|\n|                  a|          O|\n|             member|          O|\n|                 of|          O|\n|                the|B-TREATMENT|\n|G-protein-activated|I-TREATMENT|\n|           inwardly|I-TREATMENT|\n|         rectifying|I-TREATMENT|\n|          potassium|I-TREATMENT|\n|                  (|I-TREATMENT|\n|               GIRK|I-TREATMENT|\n|                  )|          O|\n|            channel|          O|\n|             family|          O|\n|                  .|          O|\n|               Here|          O|\n|                 we|          O|\n|           describe|          O|\n|                the|B-TREATMENT|\n|genomicorganization|I-TREATMENT|\n|                 of|          O|\n|                the|          O|\n|              KCNJ9|          O|\n|              locus|          O|\n|                 on|          O|\n|         chromosome|          O|\n|            1q21-23|          O|\n|                 as|          O|\n|                  a|  B-PROBLEM|\n|          candidate|  I-PROBLEM|\n|               gene|  I-PROBLEM|\n|            forType|  I-PROBLEM|\n|                 II|  I-PROBLEM|\n|           diabetes|  I-PROBLEM|\n|           mellitus|  I-PROBLEM|\n|                 in|          O|\n|                the|          O|\n|               Pima|          O|\n|             Indian|          O|\n|         population|          O|\n|                  .|          O|\n+-------------------+-----------+\nonly showing top 50 rows\n\n</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">+-------------------+-----------+\n              token|  ner_label|\n+-------------------+-----------+\n                The|          O|\n              human|          O|\n              KCNJ9|          O|\n                  (|          O|\n                Kir|          O|\n                3.3|          O|\n                  ,|          O|\n              GIRK3|          O|\n                  )|          O|\n                 is|          O|\n                  a|          O|\n             member|          O|\n                 of|          O|\n                the|B-TREATMENT|\nG-protein-activated|I-TREATMENT|\n           inwardly|I-TREATMENT|\n         rectifying|I-TREATMENT|\n          potassium|I-TREATMENT|\n                  (|I-TREATMENT|\n               GIRK|I-TREATMENT|\n                  )|          O|\n            channel|          O|\n             family|          O|\n                  .|          O|\n               Here|          O|\n                 we|          O|\n           describe|          O|\n                the|B-TREATMENT|\ngenomicorganization|I-TREATMENT|\n                 of|          O|\n                the|          O|\n              KCNJ9|          O|\n              locus|          O|\n                 on|          O|\n         chromosome|          O|\n            1q21-23|          O|\n                 as|          O|\n                  a|  B-PROBLEM|\n          candidate|  I-PROBLEM|\n               gene|  I-PROBLEM|\n            forType|  I-PROBLEM|\n                 II|  I-PROBLEM|\n           diabetes|  I-PROBLEM|\n           mellitus|  I-PROBLEM|\n                 in|          O|\n                the|          O|\n               Pima|          O|\n             Indian|          O|\n         population|          O|\n                  .|          O|\n+-------------------+-----------+\nonly showing top 50 rows\n\n</div>"]}}],"execution_count":0},{"cell_type":"markdown","source":["Lets count the ner_labels."],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"cd9b758e-f80d-437b-9bc4-b4f8baf4d2e5"}}},{"cell_type":"code","source":["result_df.select(\"token\", \"ner_label\").groupBy('ner_label').count().orderBy('count', ascending=False).show(truncate=False)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"e611b234-51bc-4d08-b09a-4ff16195bd6a"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">+-----------+-----+\n|ner_label  |count|\n+-----------+-----+\n|O          |13906|\n|I-PROBLEM  |1586 |\n|B-PROBLEM  |913  |\n|I-TREATMENT|736  |\n|I-TEST     |627  |\n|B-TREATMENT|614  |\n|B-TEST     |529  |\n+-----------+-----+\n\n</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">+-----------+-----+\nner_label  |count|\n+-----------+-----+\nO          |13906|\nI-PROBLEM  |1586 |\nB-PROBLEM  |913  |\nI-TREATMENT|736  |\nI-TEST     |627  |\nB-TREATMENT|614  |\nB-TEST     |529  |\n+-----------+-----+\n\n</div>"]}}],"execution_count":0},{"cell_type":"code","source":["result.select(F.explode(F.arrays_zip('ner_chunk.result', 'ner_chunk.begin', 'ner_chunk.end', 'ner_chunk.metadata')).alias(\"cols\")) \\\n      .select(F.expr(\"cols['3']['sentence']\").alias(\"sentence_id\"),\n              F.expr(\"cols['0']\").alias(\"chunk\"),\n              F.expr(\"cols['1']\").alias(\"begin\"),\n              F.expr(\"cols['2']\").alias(\"end\"),\n              F.expr(\"cols['3']['entity']\").alias(\"ner_label\")).show(truncate=False)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"8af41c08-e8cf-43ee-98e1-44b7fc4d72c4"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">+-----------+-----------------------------------------------------------+-----+---+---------+\n|sentence_id|chunk                                                      |begin|end|ner_label|\n+-----------+-----------------------------------------------------------+-----+---+---------+\n|0          |the G-protein-activated inwardly rectifying potassium (GIRK|48   |106|TREATMENT|\n|1          |the genomicorganization                                    |142  |164|TREATMENT|\n|1          |a candidate gene forType II diabetes mellitus              |210  |254|PROBLEM  |\n|2          |byapproximately                                            |380  |394|TREATMENT|\n|3          |single nucleotide polymorphisms                            |464  |494|TREATMENT|\n|3          |aVal366Ala substitution                                    |532  |554|PROBLEM  |\n|3          |an 8 base-pair                                             |561  |574|PROBLEM  |\n|3          |insertion/deletion                                         |581  |598|PROBLEM  |\n|4          |Ourexpression studies                                      |601  |621|TEST     |\n|4          |the transcript in various humantissues                     |648  |685|PROBLEM  |\n|4          |fat andskeletal muscle                                     |749  |770|PROBLEM  |\n|5          |furtherstudies                                             |830  |843|PROBLEM  |\n|5          |the KCNJ9 protein                                          |864  |880|TREATMENT|\n|5          |evaluation                                                 |892  |901|TEST     |\n|5          |Type II diabetes                                           |940  |955|PROBLEM  |\n|0          |the treatment                                              |67   |79 |TREATMENT|\n|0          |breast cancer                                              |84   |96 |PROBLEM  |\n|0          |the standard therapy                                       |109  |128|TREATMENT|\n|0          |anthracyclines                                             |167  |180|TREATMENT|\n|0          |taxanes                                                    |186  |192|TREATMENT|\n+-----------+-----------------------------------------------------------+-----+---+---------+\nonly showing top 20 rows\n\n</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">+-----------+-----------------------------------------------------------+-----+---+---------+\nsentence_id|chunk                                                      |begin|end|ner_label|\n+-----------+-----------------------------------------------------------+-----+---+---------+\n0          |the G-protein-activated inwardly rectifying potassium (GIRK|48   |106|TREATMENT|\n1          |the genomicorganization                                    |142  |164|TREATMENT|\n1          |a candidate gene forType II diabetes mellitus              |210  |254|PROBLEM  |\n2          |byapproximately                                            |380  |394|TREATMENT|\n3          |single nucleotide polymorphisms                            |464  |494|TREATMENT|\n3          |aVal366Ala substitution                                    |532  |554|PROBLEM  |\n3          |an 8 base-pair                                             |561  |574|PROBLEM  |\n3          |insertion/deletion                                         |581  |598|PROBLEM  |\n4          |Ourexpression studies                                      |601  |621|TEST     |\n4          |the transcript in various humantissues                     |648  |685|PROBLEM  |\n4          |fat andskeletal muscle                                     |749  |770|PROBLEM  |\n5          |furtherstudies                                             |830  |843|PROBLEM  |\n5          |the KCNJ9 protein                                          |864  |880|TREATMENT|\n5          |evaluation                                                 |892  |901|TEST     |\n5          |Type II diabetes                                           |940  |955|PROBLEM  |\n0          |the treatment                                              |67   |79 |TREATMENT|\n0          |breast cancer                                              |84   |96 |PROBLEM  |\n0          |the standard therapy                                       |109  |128|TREATMENT|\n0          |anthracyclines                                             |167  |180|TREATMENT|\n0          |taxanes                                                    |186  |192|TREATMENT|\n+-----------+-----------------------------------------------------------+-----+---+---------+\nonly showing top 20 rows\n\n</div>"]}}],"execution_count":0},{"cell_type":"markdown","source":["**We can also filter NER results to get specific entities by using `setWhiteList()` parameter. In this example we will get only `PROBLEM` entities.**"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"137169dd-12ee-42a3-a558-5d74377bce6d"}}},{"cell_type":"code","source":["ner_converter_filter = NerConverter()\\\n        .setInputCols([\"sentence\",\"token\",\"ner\"])\\\n        .setOutputCol(\"ner_chunk\")\\\n        .setWhiteList([\"PROBLEM\"])\n\nnerFilteredPipeline = Pipeline(stages=[\n        documentAssembler,\n        sentenceDetector,\n        tokenizer,\n        word_embeddings,\n        clinical_ner,\n        ner_converter_filter])\n\n\nempty_data = spark.createDataFrame([[\"\"]]).toDF(\"text\")\n\nner_filtered_model = nerFilteredPipeline.fit(empty_data)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"cfaf91a4-95ef-40ea-aa45-359b72e22fef"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\"></div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\"></div>"]}}],"execution_count":0},{"cell_type":"code","source":["filtered_result = ner_filtered_model.transform(pubMedDF.limit(100))"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"9dfa9da8-aadd-4a5d-9dd8-0e18f26ca78e"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\"></div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\"></div>"]}}],"execution_count":0},{"cell_type":"code","source":["filtered_result.select(F.explode(F.arrays_zip('ner_chunk.result', 'ner_chunk.begin', 'ner_chunk.end', 'ner_chunk.metadata')).alias(\"cols\")) \\\n               .select(F.expr(\"cols['3']['sentence']\").alias(\"sentence_id\"),\n                       F.expr(\"cols['0']\").alias(\"chunk\"),\n                       F.expr(\"cols['1']\").alias(\"begin\"),\n                       F.expr(\"cols['2']\").alias(\"end\"),\n                       F.expr(\"cols['3']['entity']\").alias(\"ner_label\")).show(truncate=False)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"bb537f59-53db-4c08-8c76-3386401b3a97"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">+-----------+---------------------------------------------+-----+----+---------+\n|sentence_id|chunk                                        |begin|end |ner_label|\n+-----------+---------------------------------------------+-----+----+---------+\n|1          |a candidate gene forType II diabetes mellitus|210  |254 |PROBLEM  |\n|3          |aVal366Ala substitution                      |532  |554 |PROBLEM  |\n|3          |an 8 base-pair                               |561  |574 |PROBLEM  |\n|3          |insertion/deletion                           |581  |598 |PROBLEM  |\n|4          |the transcript in various humantissues       |648  |685 |PROBLEM  |\n|4          |fat andskeletal muscle                       |749  |770 |PROBLEM  |\n|5          |furtherstudies                               |830  |843 |PROBLEM  |\n|5          |Type II diabetes                             |940  |955 |PROBLEM  |\n|0          |breast cancer                                |84   |96  |PROBLEM  |\n|7          |change                                       |866  |871 |PROBLEM  |\n|10         |Themajor toxicity                            |1110 |1126|PROBLEM  |\n|10         |myelosuppression                             |1132 |1147|PROBLEM  |\n|3          |atrial fibrillation                          |398  |416 |PROBLEM  |\n|4          |late death                                   |475  |484 |PROBLEM  |\n|4          |cardiovascular-related re-hospitalization    |490  |530 |PROBLEM  |\n|6          |preoperative atrial fibrillation             |655  |686 |PROBLEM  |\n|7          |stroke                                       |793  |798 |PROBLEM  |\n|7          |renal failure                                |805  |817 |PROBLEM  |\n|7          |atrial fibrillationand mortality             |918  |949 |PROBLEM  |\n|8          |preoperative atrial fibrillationwas          |1055 |1089|PROBLEM  |\n+-----------+---------------------------------------------+-----+----+---------+\nonly showing top 20 rows\n\n</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">+-----------+---------------------------------------------+-----+----+---------+\nsentence_id|chunk                                        |begin|end |ner_label|\n+-----------+---------------------------------------------+-----+----+---------+\n1          |a candidate gene forType II diabetes mellitus|210  |254 |PROBLEM  |\n3          |aVal366Ala substitution                      |532  |554 |PROBLEM  |\n3          |an 8 base-pair                               |561  |574 |PROBLEM  |\n3          |insertion/deletion                           |581  |598 |PROBLEM  |\n4          |the transcript in various humantissues       |648  |685 |PROBLEM  |\n4          |fat andskeletal muscle                       |749  |770 |PROBLEM  |\n5          |furtherstudies                               |830  |843 |PROBLEM  |\n5          |Type II diabetes                             |940  |955 |PROBLEM  |\n0          |breast cancer                                |84   |96  |PROBLEM  |\n7          |change                                       |866  |871 |PROBLEM  |\n10         |Themajor toxicity                            |1110 |1126|PROBLEM  |\n10         |myelosuppression                             |1132 |1147|PROBLEM  |\n3          |atrial fibrillation                          |398  |416 |PROBLEM  |\n4          |late death                                   |475  |484 |PROBLEM  |\n4          |cardiovascular-related re-hospitalization    |490  |530 |PROBLEM  |\n6          |preoperative atrial fibrillation             |655  |686 |PROBLEM  |\n7          |stroke                                       |793  |798 |PROBLEM  |\n7          |renal failure                                |805  |817 |PROBLEM  |\n7          |atrial fibrillationand mortality             |918  |949 |PROBLEM  |\n8          |preoperative atrial fibrillationwas          |1055 |1089|PROBLEM  |\n+-----------+---------------------------------------------+-----+----+---------+\nonly showing top 20 rows\n\n</div>"]}}],"execution_count":0},{"cell_type":"markdown","source":["**As you can see, we got only `PROBLEM` entities from the text.**"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"0c269599-bf8e-487b-9c87-796a65586d00"}}},{"cell_type":"markdown","source":["### NER Visualization\n\nWe have sparknlp_display library for visualization. This library works with LightPipeline results."],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"fd3d2439-d310-4ecd-80fd-658cabcb869d"}}},{"cell_type":"code","source":["sample_text = [pubMedDF.limit(3).collect()[i][0] for i in range(3)]"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"7f9368cc-b9c3-4703-9f64-2ed1b8c69a80"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\"></div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\"></div>"]}}],"execution_count":0},{"cell_type":"code","source":["sample_text[1]"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"7b64c449-022f-407e-94a4-ba3a5e7fd0b3"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">Out[16]: &#39;BACKGROUND: At present, it is one of the most important issues for the treatment of breast cancer to develop the standard therapy for patients previously treated with anthracyclines and taxanes. With the objective of determining the usefulnessof vinorelbine monotherapy in patients with advanced or recurrent breast cancerafter standard therapy, we evaluated the efficacy and safety of vinorelbine inpatients previously treated with anthracyclines and taxanes. METHODS: Vinorelbinewas administered at a dose level of 25 mg/m(2) intravenously on days 1 and 8 of a3 week cycle. Patients were given three or more cycles in the absence of tumorprogression. A maximum of nine cycles were administered. RESULTS: The responserate in 50 evaluable patients was 20.0% (10 out of 50; 95% confidence interval,10.0-33.7%). Responders plus those who had minor response (MR) or no change (NC) accounted for 58.0% [10 partial responses (PRs) + one MR + 18 NCs out of 50]. TheKaplan-Meier estimate (50% point) of time to progression (TTP) was 115.0 days.The response rate in the visceral organs was 17.3% (nine PRs out of 52). Themajor toxicity was myelosuppression, which was reversible and did not requirediscontinuation of treatment. CONCLUSION: The results of this study show thatvinorelbine monotherapy is useful in patients with advanced or recurrent breastcancer previously exposed to both anthracyclines and taxanes.&#39;</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">Out[16]: &#39;BACKGROUND: At present, it is one of the most important issues for the treatment of breast cancer to develop the standard therapy for patients previously treated with anthracyclines and taxanes. With the objective of determining the usefulnessof vinorelbine monotherapy in patients with advanced or recurrent breast cancerafter standard therapy, we evaluated the efficacy and safety of vinorelbine inpatients previously treated with anthracyclines and taxanes. METHODS: Vinorelbinewas administered at a dose level of 25 mg/m(2) intravenously on days 1 and 8 of a3 week cycle. Patients were given three or more cycles in the absence of tumorprogression. A maximum of nine cycles were administered. RESULTS: The responserate in 50 evaluable patients was 20.0% (10 out of 50; 95% confidence interval,10.0-33.7%). Responders plus those who had minor response (MR) or no change (NC) accounted for 58.0% [10 partial responses (PRs) + one MR + 18 NCs out of 50]. TheKaplan-Meier estimate (50% point) of time to progression (TTP) was 115.0 days.The response rate in the visceral organs was 17.3% (nine PRs out of 52). Themajor toxicity was myelosuppression, which was reversible and did not requirediscontinuation of treatment. CONCLUSION: The results of this study show thatvinorelbine monotherapy is useful in patients with advanced or recurrent breastcancer previously exposed to both anthracyclines and taxanes.&#39;</div>"]}}],"execution_count":0},{"cell_type":"code","source":["ner_lp = LightPipeline(ner_model)\nlight_result = ner_lp.fullAnnotate(sample_text[1])"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"9f47605f-cc54-4a5a-8901-1693c9c8d71a"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\"></div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\"></div>"]}}],"execution_count":0},{"cell_type":"code","source":["from sparknlp_display import NerVisualizer\n\nvisualiser = NerVisualizer()\n\nvis = visualiser.display(light_result[0], label_col='ner_chunk', document_col='document', return_html=True)\n\n# Change color of an entity label\n#visualiser.set_label_colors({'PROBLEM':'#008080', 'TEST':'#800080', 'TREATMENT':'#808080'})\n#visualiser.display(light_result[0], label_col='ner_chunk')\n\n# Set label filter\n# vis = visualiser.display(light_result, label_col='ner_chunk', document_col='document',\n                   #labels=['PROBLEM','TEST','TREATMENT])\n  \ndisplayHTML(vis)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"41778236-d460-4e3a-8425-5b43f02c2a0d"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"\n<style>\n    @import url('https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;500;600;700&display=swap');\n    @import url('https://fonts.googleapis.com/css2?family=Vistol Regular:wght@300;400;500;600;700&display=swap');\n    \n    .spark-nlp-display-scroll-entities {\n        border: 1px solid #E7EDF0;\n        border-radius: 3px;\n        text-align: justify;\n        \n    }\n    .spark-nlp-display-scroll-entities span {  \n        font-size: 14px;\n        line-height: 24px;\n        color: #536B76;\n        font-family: 'Montserrat', sans-serif !important;\n    }\n    \n    .spark-nlp-display-entity-wrapper{\n    \n        display: inline-grid;\n        text-align: center;\n        border-radius: 4px;\n        margin: 0 2px 5px 2px;\n        padding: 1px\n    }\n    .spark-nlp-display-entity-name{\n        font-size: 14px;\n        line-height: 24px;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        background: #f1f2f3;\n        border-width: medium;\n        text-align: center;\n        \n        font-weight: 400;\n        \n        border-radius: 5px;\n        padding: 2px 5px;\n        display: block;\n        margin: 3px 2px;\n    \n    }\n    .spark-nlp-display-entity-type{\n        font-size: 14px;\n        line-height: 24px;\n        color: #ffffff;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        text-transform: uppercase;\n        \n        font-weight: 500;\n\n        display: block;\n        padding: 3px 5px;\n    }\n    \n    .spark-nlp-display-entity-resolution{\n        font-size: 14px;\n        line-height: 24px;\n        color: #ffffff;\n        font-family: 'Vistol Regular', sans-serif !important;\n        \n        text-transform: uppercase;\n        \n        font-weight: 500;\n\n        display: block;\n        padding: 3px 5px;\n    }\n    \n    .spark-nlp-display-others{\n        font-size: 14px;\n        line-height: 24px;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        font-weight: 400;\n    }\n\n</style>\n <span class=\"spark-nlp-display-others\" style=\"background-color: white\">BACKGROUND: At present, it is one of the most important issues for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">the treatment </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080\"><span class=\"spark-nlp-display-entity-name\">breast cancer </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> to develop </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">the standard therapy </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> for patients previously treated with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">anthracyclines </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">taxanes </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. With the objective of determining </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">the usefulnessof vinorelbine monotherapy </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in patients with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">advanced or recurrent breast cancerafter standard therapy </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, we evaluated the efficacy and safety of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">vinorelbine </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> inpatients previously treated with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">anthracyclines </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">taxanes </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. METHODS: </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">Vinorelbinewas </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> administered at a dose level of 25 mg/m(2) intravenously on days 1 and 8 of a3 week cycle. Patients were given three or more cycles in the absence of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">tumorprogression </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. A maximum of nine cycles were administered. RESULTS: The responserate in 50 evaluable patients was 20.0% (10 out of 50; 95% confidence interval,10.0-33.7%). Responders plus those who had minor response (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">MR) </span><span class=\"spark-nlp-display-entity-type\">TEST</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> or no </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080\"><span class=\"spark-nlp-display-entity-name\">change </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">NC) </span><span class=\"spark-nlp-display-entity-type\">TEST</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> accounted for 58.0% [10 </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">partial responses </span><span class=\"spark-nlp-display-entity-type\">TEST</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">PRs </span><span class=\"spark-nlp-display-entity-type\">TEST</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) + one </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">MR </span><span class=\"spark-nlp-display-entity-type\">TEST</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> + 18 </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">NCs out </span><span class=\"spark-nlp-display-entity-type\">TEST</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of 50]. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">TheKaplan-Meier estimate </span><span class=\"spark-nlp-display-entity-type\">TEST</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (50% point) of time to progression (TTP) was 115.0 days.</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">The response rate in the visceral organs </span><span class=\"spark-nlp-display-entity-type\">TEST</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was 17.3% (nine PRs out of 52). </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080\"><span class=\"spark-nlp-display-entity-name\">Themajor toxicity </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080\"><span class=\"spark-nlp-display-entity-name\">myelosuppression </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, which was reversible and did not </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">requirediscontinuation </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">treatment </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. CONCLUSION: The results of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">this study </span><span class=\"spark-nlp-display-entity-type\">TEST</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> show </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">thatvinorelbine monotherapy </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> is useful in patients with advanced or </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">recurrent breastcancer </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> previously exposed to both </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">anthracyclines </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">taxanes </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">.</span></div>","textData":null,"removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"htmlSandbox","arguments":{}}},"output_type":"display_data","data":{"text/html":["\n<style>\n    @import url('https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;500;600;700&display=swap');\n    @import url('https://fonts.googleapis.com/css2?family=Vistol Regular:wght@300;400;500;600;700&display=swap');\n    \n    .spark-nlp-display-scroll-entities {\n        border: 1px solid #E7EDF0;\n        border-radius: 3px;\n        text-align: justify;\n        \n    }\n    .spark-nlp-display-scroll-entities span {  \n        font-size: 14px;\n        line-height: 24px;\n        color: #536B76;\n        font-family: 'Montserrat', sans-serif !important;\n    }\n    \n    .spark-nlp-display-entity-wrapper{\n    \n        display: inline-grid;\n        text-align: center;\n        border-radius: 4px;\n        margin: 0 2px 5px 2px;\n        padding: 1px\n    }\n    .spark-nlp-display-entity-name{\n        font-size: 14px;\n        line-height: 24px;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        background: #f1f2f3;\n        border-width: medium;\n        text-align: center;\n        \n        font-weight: 400;\n        \n        border-radius: 5px;\n        padding: 2px 5px;\n        display: block;\n        margin: 3px 2px;\n    \n    }\n    .spark-nlp-display-entity-type{\n        font-size: 14px;\n        line-height: 24px;\n        color: #ffffff;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        text-transform: uppercase;\n        \n        font-weight: 500;\n\n        display: block;\n        padding: 3px 5px;\n    }\n    \n    .spark-nlp-display-entity-resolution{\n        font-size: 14px;\n        line-height: 24px;\n        color: #ffffff;\n        font-family: 'Vistol Regular', sans-serif !important;\n        \n        text-transform: uppercase;\n        \n        font-weight: 500;\n\n        display: block;\n        padding: 3px 5px;\n    }\n    \n    .spark-nlp-display-others{\n        font-size: 14px;\n        line-height: 24px;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        font-weight: 400;\n    }\n\n</style>\n <span class=\"spark-nlp-display-others\" style=\"background-color: white\">BACKGROUND: At present, it is one of the most important issues for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">the treatment </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080\"><span class=\"spark-nlp-display-entity-name\">breast cancer </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> to develop </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">the standard therapy </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> for patients previously treated with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">anthracyclines </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">taxanes </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. With the objective of determining </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">the usefulnessof vinorelbine monotherapy </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in patients with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">advanced or recurrent breast cancerafter standard therapy </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, we evaluated the efficacy and safety of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">vinorelbine </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> inpatients previously treated with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">anthracyclines </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">taxanes </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. METHODS: </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">Vinorelbinewas </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> administered at a dose level of 25 mg/m(2) intravenously on days 1 and 8 of a3 week cycle. Patients were given three or more cycles in the absence of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">tumorprogression </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. A maximum of nine cycles were administered. RESULTS: The responserate in 50 evaluable patients was 20.0% (10 out of 50; 95% confidence interval,10.0-33.7%). Responders plus those who had minor response (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">MR) </span><span class=\"spark-nlp-display-entity-type\">TEST</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> or no </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080\"><span class=\"spark-nlp-display-entity-name\">change </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">NC) </span><span class=\"spark-nlp-display-entity-type\">TEST</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> accounted for 58.0% [10 </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">partial responses </span><span class=\"spark-nlp-display-entity-type\">TEST</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">PRs </span><span class=\"spark-nlp-display-entity-type\">TEST</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) + one </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">MR </span><span class=\"spark-nlp-display-entity-type\">TEST</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> + 18 </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">NCs out </span><span class=\"spark-nlp-display-entity-type\">TEST</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of 50]. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">TheKaplan-Meier estimate </span><span class=\"spark-nlp-display-entity-type\">TEST</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (50% point) of time to progression (TTP) was 115.0 days.</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">The response rate in the visceral organs </span><span class=\"spark-nlp-display-entity-type\">TEST</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was 17.3% (nine PRs out of 52). </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080\"><span class=\"spark-nlp-display-entity-name\">Themajor toxicity </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080\"><span class=\"spark-nlp-display-entity-name\">myelosuppression </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, which was reversible and did not </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">requirediscontinuation </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">treatment </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. CONCLUSION: The results of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">this study </span><span class=\"spark-nlp-display-entity-type\">TEST</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> show </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">thatvinorelbine monotherapy </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> is useful in patients with advanced or </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">recurrent breastcancer </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> previously exposed to both </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">anthracyclines </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8b6673\"><span class=\"spark-nlp-display-entity-name\">taxanes </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">.</span></div>"]}}],"execution_count":0},{"cell_type":"markdown","source":["**There are many NER models for different purposes in Spark NLP. Lets show what if we use `jsl_ner_wip_clinical` model that has about 80 different NER label.**"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"c9f7973c-ea56-4696-880b-b87881f63e87"}}},{"cell_type":"code","source":["jsl_ner = MedicalNerModel.pretrained(\"jsl_ner_wip_clinical\",\"en\",\"clinical/models\")\\\n        .setInputCols([\"sentence\",\"token\",\"embeddings\"])\\\n        .setOutputCol(\"ner\")\n\njslPipeline = Pipeline(stages=[\n        documentAssembler,\n        sentenceDetector,\n        tokenizer,\n        word_embeddings,\n        pos_tagger,\n        jsl_ner,\n        ner_converter])\n\n\nempty_data = spark.createDataFrame([[\"\"]]).toDF(\"text\")\n\njsl_model = jslPipeline.fit(empty_data)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"a56c478a-df79-40a7-a47c-6b56a74514d8"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">jsl_ner_wip_clinical download started this may take some time.\nApproximate size to download 14.5 MB\n\r[ | ]\r[OK!]\n</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">jsl_ner_wip_clinical download started this may take some time.\nApproximate size to download 14.5 MB\n\r[ | ]\r[OK!]\n</div>"]}}],"execution_count":0},{"cell_type":"code","source":["jsl_lp = LightPipeline(jsl_model)\njsl_light_result = jsl_lp.fullAnnotate(sample_text[1])"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"50364834-442d-4a98-9407-68731d973e47"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\"></div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\"></div>"]}}],"execution_count":0},{"cell_type":"code","source":["from sparknlp_display import NerVisualizer\n\nvisualiser = NerVisualizer()\n\nvis = visualiser.display(jsl_light_result[0], label_col='ner_chunk', document_col='document', return_html=True)\n\ndisplayHTML(vis)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"daff7974-6b96-42f2-afa1-b40f10dd7cda"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"\n<style>\n    @import url('https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;500;600;700&display=swap');\n    @import url('https://fonts.googleapis.com/css2?family=Vistol Regular:wght@300;400;500;600;700&display=swap');\n    \n    .spark-nlp-display-scroll-entities {\n        border: 1px solid #E7EDF0;\n        border-radius: 3px;\n        text-align: justify;\n        \n    }\n    .spark-nlp-display-scroll-entities span {  \n        font-size: 14px;\n        line-height: 24px;\n        color: #536B76;\n        font-family: 'Montserrat', sans-serif !important;\n    }\n    \n    .spark-nlp-display-entity-wrapper{\n    \n        display: inline-grid;\n        text-align: center;\n        border-radius: 4px;\n        margin: 0 2px 5px 2px;\n        padding: 1px\n    }\n    .spark-nlp-display-entity-name{\n        font-size: 14px;\n        line-height: 24px;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        background: #f1f2f3;\n        border-width: medium;\n        text-align: center;\n        \n        font-weight: 400;\n        \n        border-radius: 5px;\n        padding: 2px 5px;\n        display: block;\n        margin: 3px 2px;\n    \n    }\n    .spark-nlp-display-entity-type{\n        font-size: 14px;\n        line-height: 24px;\n        color: #ffffff;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        text-transform: uppercase;\n        \n        font-weight: 500;\n\n        display: block;\n        padding: 3px 5px;\n    }\n    \n    .spark-nlp-display-entity-resolution{\n        font-size: 14px;\n        line-height: 24px;\n        color: #ffffff;\n        font-family: 'Vistol Regular', sans-serif !important;\n        \n        text-transform: uppercase;\n        \n        font-weight: 500;\n\n        display: block;\n        padding: 3px 5px;\n    }\n    \n    .spark-nlp-display-others{\n        font-size: 14px;\n        line-height: 24px;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        font-weight: 400;\n    }\n\n</style>\n <span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #18AB0B\"><span class=\"spark-nlp-display-entity-name\">BACKGROUND: </span><span class=\"spark-nlp-display-entity-type\">Section_Header</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> At present, it is one of the most important issues for the treatment of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #12562A\"><span class=\"spark-nlp-display-entity-name\">breast cancer </span><span class=\"spark-nlp-display-entity-type\">Oncological</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> to develop the standard therapy for patients previously treated with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #11B580\"><span class=\"spark-nlp-display-entity-name\">anthracyclines </span><span class=\"spark-nlp-display-entity-type\">Drug_Ingredient</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #11B580\"><span class=\"spark-nlp-display-entity-name\">taxanes </span><span class=\"spark-nlp-display-entity-type\">Drug_Ingredient</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. With the objective of determining the usefulnessof </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #11B580\"><span class=\"spark-nlp-display-entity-name\">vinorelbine monotherapy </span><span class=\"spark-nlp-display-entity-type\">Drug_Ingredient</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in patients with advanced or </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B475D\"><span class=\"spark-nlp-display-entity-name\">recurrent </span><span class=\"spark-nlp-display-entity-type\">Modifier</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #51155C\"><span class=\"spark-nlp-display-entity-name\">breast cancerafter standard therapy </span><span class=\"spark-nlp-display-entity-type\">Procedure</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, we evaluated the efficacy and safety of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #11B580\"><span class=\"spark-nlp-display-entity-name\">vinorelbine </span><span class=\"spark-nlp-display-entity-type\">Drug_Ingredient</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> inpatients previously treated with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #11B580\"><span class=\"spark-nlp-display-entity-name\">anthracyclines </span><span class=\"spark-nlp-display-entity-type\">Drug_Ingredient</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #11B580\"><span class=\"spark-nlp-display-entity-name\">taxanes </span><span class=\"spark-nlp-display-entity-type\">Drug_Ingredient</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #18AB0B\"><span class=\"spark-nlp-display-entity-name\">METHODS: </span><span class=\"spark-nlp-display-entity-type\">Section_Header</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> Vinorelbinewas administered at a dose level of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2EBA7E\"><span class=\"spark-nlp-display-entity-name\">25 </span><span class=\"spark-nlp-display-entity-type\">Strength</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> mg/m(2) </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #25659C\"><span class=\"spark-nlp-display-entity-name\">intravenously </span><span class=\"spark-nlp-display-entity-type\">Route</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #BA7DC1\"><span class=\"spark-nlp-display-entity-name\">on days 1 and 8 of a3 week cycle </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. Patients were given </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #BA7DC1\"><span class=\"spark-nlp-display-entity-name\">three or more cycles </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in the absence of tumorprogression. A maximum of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #868874\"><span class=\"spark-nlp-display-entity-name\">nine cycles </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> were administered. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #18AB0B\"><span class=\"spark-nlp-display-entity-name\">RESULTS: </span><span class=\"spark-nlp-display-entity-type\">Section_Header</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> The responserate in 50 evaluable patients was 20.0% (10 out of 50; 95% confidence interval,10.0-33.7%). Responders plus those who had </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #69161C\"><span class=\"spark-nlp-display-entity-name\">minor response </span><span class=\"spark-nlp-display-entity-type\">Test_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">MR </span><span class=\"spark-nlp-display-entity-type\">Test</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) or </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #69161C\"><span class=\"spark-nlp-display-entity-name\">no change </span><span class=\"spark-nlp-display-entity-type\">Test_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">NC </span><span class=\"spark-nlp-display-entity-type\">Test</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) accounted for 58.0% [10 </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">partial responses </span><span class=\"spark-nlp-display-entity-type\">Test</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">PRs </span><span class=\"spark-nlp-display-entity-type\">Test</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) + one </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">MR </span><span class=\"spark-nlp-display-entity-type\">Test</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #69161C\"><span class=\"spark-nlp-display-entity-name\">+ 18 NCs out of 50] </span><span class=\"spark-nlp-display-entity-type\">Test_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. TheKaplan-Meier estimate (50% point) of time to progression (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8BA41F\"><span class=\"spark-nlp-display-entity-name\">TTP </span><span class=\"spark-nlp-display-entity-type\">Disease_Syndrome_Disorder</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) was </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #1E59AA\"><span class=\"spark-nlp-display-entity-name\">115.0 days </span><span class=\"spark-nlp-display-entity-type\">Duration</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">.The response rate in the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #690581\"><span class=\"spark-nlp-display-entity-name\">visceral organs </span><span class=\"spark-nlp-display-entity-type\">Internal_organ_or_component</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #69161C\"><span class=\"spark-nlp-display-entity-name\">17.3% </span><span class=\"spark-nlp-display-entity-type\">Test_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (nine PRs out of 52). </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8BA41F\"><span class=\"spark-nlp-display-entity-name\">Themajor toxicity </span><span class=\"spark-nlp-display-entity-type\">Disease_Syndrome_Disorder</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3334C5\"><span class=\"spark-nlp-display-entity-name\">myelosuppression </span><span class=\"spark-nlp-display-entity-type\">Symptom</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, which was </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B475D\"><span class=\"spark-nlp-display-entity-name\">reversible </span><span class=\"spark-nlp-display-entity-type\">Modifier</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and did not requirediscontinuation of treatment. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #18AB0B\"><span class=\"spark-nlp-display-entity-name\">CONCLUSION: </span><span class=\"spark-nlp-display-entity-type\">Section_Header</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> The results of this study show </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #11B580\"><span class=\"spark-nlp-display-entity-name\">thatvinorelbine monotherapy </span><span class=\"spark-nlp-display-entity-type\">Drug_Ingredient</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> is useful in patients with advanced or </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B475D\"><span class=\"spark-nlp-display-entity-name\">recurrent </span><span class=\"spark-nlp-display-entity-type\">Modifier</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3334C5\"><span class=\"spark-nlp-display-entity-name\">breastcancer </span><span class=\"spark-nlp-display-entity-type\">Symptom</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> previously exposed to both </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #11B580\"><span class=\"spark-nlp-display-entity-name\">anthracyclines </span><span class=\"spark-nlp-display-entity-type\">Drug_Ingredient</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #11B580\"><span class=\"spark-nlp-display-entity-name\">taxanes </span><span class=\"spark-nlp-display-entity-type\">Drug_Ingredient</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">.</span></div>","textData":null,"removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"htmlSandbox","arguments":{}}},"output_type":"display_data","data":{"text/html":["\n<style>\n    @import url('https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;500;600;700&display=swap');\n    @import url('https://fonts.googleapis.com/css2?family=Vistol Regular:wght@300;400;500;600;700&display=swap');\n    \n    .spark-nlp-display-scroll-entities {\n        border: 1px solid #E7EDF0;\n        border-radius: 3px;\n        text-align: justify;\n        \n    }\n    .spark-nlp-display-scroll-entities span {  \n        font-size: 14px;\n        line-height: 24px;\n        color: #536B76;\n        font-family: 'Montserrat', sans-serif !important;\n    }\n    \n    .spark-nlp-display-entity-wrapper{\n    \n        display: inline-grid;\n        text-align: center;\n        border-radius: 4px;\n        margin: 0 2px 5px 2px;\n        padding: 1px\n    }\n    .spark-nlp-display-entity-name{\n        font-size: 14px;\n        line-height: 24px;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        background: #f1f2f3;\n        border-width: medium;\n        text-align: center;\n        \n        font-weight: 400;\n        \n        border-radius: 5px;\n        padding: 2px 5px;\n        display: block;\n        margin: 3px 2px;\n    \n    }\n    .spark-nlp-display-entity-type{\n        font-size: 14px;\n        line-height: 24px;\n        color: #ffffff;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        text-transform: uppercase;\n        \n        font-weight: 500;\n\n        display: block;\n        padding: 3px 5px;\n    }\n    \n    .spark-nlp-display-entity-resolution{\n        font-size: 14px;\n        line-height: 24px;\n        color: #ffffff;\n        font-family: 'Vistol Regular', sans-serif !important;\n        \n        text-transform: uppercase;\n        \n        font-weight: 500;\n\n        display: block;\n        padding: 3px 5px;\n    }\n    \n    .spark-nlp-display-others{\n        font-size: 14px;\n        line-height: 24px;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        font-weight: 400;\n    }\n\n</style>\n <span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #18AB0B\"><span class=\"spark-nlp-display-entity-name\">BACKGROUND: </span><span class=\"spark-nlp-display-entity-type\">Section_Header</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> At present, it is one of the most important issues for the treatment of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #12562A\"><span class=\"spark-nlp-display-entity-name\">breast cancer </span><span class=\"spark-nlp-display-entity-type\">Oncological</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> to develop the standard therapy for patients previously treated with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #11B580\"><span class=\"spark-nlp-display-entity-name\">anthracyclines </span><span class=\"spark-nlp-display-entity-type\">Drug_Ingredient</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #11B580\"><span class=\"spark-nlp-display-entity-name\">taxanes </span><span class=\"spark-nlp-display-entity-type\">Drug_Ingredient</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. With the objective of determining the usefulnessof </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #11B580\"><span class=\"spark-nlp-display-entity-name\">vinorelbine monotherapy </span><span class=\"spark-nlp-display-entity-type\">Drug_Ingredient</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in patients with advanced or </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B475D\"><span class=\"spark-nlp-display-entity-name\">recurrent </span><span class=\"spark-nlp-display-entity-type\">Modifier</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #51155C\"><span class=\"spark-nlp-display-entity-name\">breast cancerafter standard therapy </span><span class=\"spark-nlp-display-entity-type\">Procedure</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, we evaluated the efficacy and safety of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #11B580\"><span class=\"spark-nlp-display-entity-name\">vinorelbine </span><span class=\"spark-nlp-display-entity-type\">Drug_Ingredient</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> inpatients previously treated with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #11B580\"><span class=\"spark-nlp-display-entity-name\">anthracyclines </span><span class=\"spark-nlp-display-entity-type\">Drug_Ingredient</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #11B580\"><span class=\"spark-nlp-display-entity-name\">taxanes </span><span class=\"spark-nlp-display-entity-type\">Drug_Ingredient</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #18AB0B\"><span class=\"spark-nlp-display-entity-name\">METHODS: </span><span class=\"spark-nlp-display-entity-type\">Section_Header</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> Vinorelbinewas administered at a dose level of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #2EBA7E\"><span class=\"spark-nlp-display-entity-name\">25 </span><span class=\"spark-nlp-display-entity-type\">Strength</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> mg/m(2) </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #25659C\"><span class=\"spark-nlp-display-entity-name\">intravenously </span><span class=\"spark-nlp-display-entity-type\">Route</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #BA7DC1\"><span class=\"spark-nlp-display-entity-name\">on days 1 and 8 of a3 week cycle </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. Patients were given </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #BA7DC1\"><span class=\"spark-nlp-display-entity-name\">three or more cycles </span><span class=\"spark-nlp-display-entity-type\">Frequency</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in the absence of tumorprogression. A maximum of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #868874\"><span class=\"spark-nlp-display-entity-name\">nine cycles </span><span class=\"spark-nlp-display-entity-type\">Dosage</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> were administered. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #18AB0B\"><span class=\"spark-nlp-display-entity-name\">RESULTS: </span><span class=\"spark-nlp-display-entity-type\">Section_Header</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> The responserate in 50 evaluable patients was 20.0% (10 out of 50; 95% confidence interval,10.0-33.7%). Responders plus those who had </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #69161C\"><span class=\"spark-nlp-display-entity-name\">minor response </span><span class=\"spark-nlp-display-entity-type\">Test_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">MR </span><span class=\"spark-nlp-display-entity-type\">Test</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) or </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #69161C\"><span class=\"spark-nlp-display-entity-name\">no change </span><span class=\"spark-nlp-display-entity-type\">Test_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">NC </span><span class=\"spark-nlp-display-entity-type\">Test</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) accounted for 58.0% [10 </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">partial responses </span><span class=\"spark-nlp-display-entity-type\">Test</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">PRs </span><span class=\"spark-nlp-display-entity-type\">Test</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) + one </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5fe\"><span class=\"spark-nlp-display-entity-name\">MR </span><span class=\"spark-nlp-display-entity-type\">Test</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #69161C\"><span class=\"spark-nlp-display-entity-name\">+ 18 NCs out of 50] </span><span class=\"spark-nlp-display-entity-type\">Test_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. TheKaplan-Meier estimate (50% point) of time to progression (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8BA41F\"><span class=\"spark-nlp-display-entity-name\">TTP </span><span class=\"spark-nlp-display-entity-type\">Disease_Syndrome_Disorder</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) was </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #1E59AA\"><span class=\"spark-nlp-display-entity-name\">115.0 days </span><span class=\"spark-nlp-display-entity-type\">Duration</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">.The response rate in the </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #690581\"><span class=\"spark-nlp-display-entity-name\">visceral organs </span><span class=\"spark-nlp-display-entity-type\">Internal_organ_or_component</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #69161C\"><span class=\"spark-nlp-display-entity-name\">17.3% </span><span class=\"spark-nlp-display-entity-type\">Test_Result</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (nine PRs out of 52). </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8BA41F\"><span class=\"spark-nlp-display-entity-name\">Themajor toxicity </span><span class=\"spark-nlp-display-entity-type\">Disease_Syndrome_Disorder</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3334C5\"><span class=\"spark-nlp-display-entity-name\">myelosuppression </span><span class=\"spark-nlp-display-entity-type\">Symptom</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, which was </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B475D\"><span class=\"spark-nlp-display-entity-name\">reversible </span><span class=\"spark-nlp-display-entity-type\">Modifier</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and did not requirediscontinuation of treatment. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #18AB0B\"><span class=\"spark-nlp-display-entity-name\">CONCLUSION: </span><span class=\"spark-nlp-display-entity-type\">Section_Header</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> The results of this study show </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #11B580\"><span class=\"spark-nlp-display-entity-name\">thatvinorelbine monotherapy </span><span class=\"spark-nlp-display-entity-type\">Drug_Ingredient</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> is useful in patients with advanced or </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B475D\"><span class=\"spark-nlp-display-entity-name\">recurrent </span><span class=\"spark-nlp-display-entity-type\">Modifier</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3334C5\"><span class=\"spark-nlp-display-entity-name\">breastcancer </span><span class=\"spark-nlp-display-entity-type\">Symptom</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> previously exposed to both </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #11B580\"><span class=\"spark-nlp-display-entity-name\">anthracyclines </span><span class=\"spark-nlp-display-entity-type\">Drug_Ingredient</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #11B580\"><span class=\"spark-nlp-display-entity-name\">taxanes </span><span class=\"spark-nlp-display-entity-type\">Drug_Ingredient</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">.</span></div>"]}}],"execution_count":0},{"cell_type":"markdown","source":["**If you want to go over more about NER, you can check this comprehensive notebook :**\n\nhttps://github.com/JohnSnowLabs/spark-nlp-workshop/blob/master/tutorials/Certification_Trainings/Healthcare/databricks_notebooks/1.Clinical_Named_Entity_Recognition_Model_v3.0.ipynb"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"35eb9508-9756-46d7-ad8e-38c47ba9dc02"}}},{"cell_type":"markdown","source":["## 2. Clinical Assertion\n\nNow we will check the assertion status of the clinical entities. We will use `ner_clinical_large` model for NER detection, and `assertion_dl` model for checking the assertion status of detected entities. While doing that, we will use the same pipeline that we created fot detecting NER."],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"ebc4b105-20b3-4189-a240-0b645f164f05"}}},{"cell_type":"code","source":["# Assertion model trained on i2b2 (sampled from MIMIC) dataset\n# coming from sparknlp_jsl.annotator !!\nclinical_assertion = AssertionDLModel.pretrained(\"assertion_dl\", \"en\", \"clinical/models\") \\\n    .setInputCols([\"sentence\", \"ner_chunk\", \"embeddings\"]) \\\n    .setOutputCol(\"assertion\")\n    \nassertionPipeline = Pipeline(stages=[\n    nerPipeline,\n    clinical_assertion\n    ])\n\nempty_data = spark.createDataFrame([[\"\"]]).toDF(\"text\")\n\nassertion_model = assertionPipeline.fit(empty_data)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"90b553d4-e8c2-4463-a82f-c7364b8f31bc"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">assertion_dl download started this may take some time.\nApproximate size to download 1.3 MB\n\r[ | ]\r[ / ]\r[OK!]\n</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">assertion_dl download started this may take some time.\nApproximate size to download 1.3 MB\n\r[ | ]\r[ / ]\r[OK!]\n</div>"]}}],"execution_count":0},{"cell_type":"markdown","source":["**This time we will use LightPipeline while implementing.**"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"b31e3f69-b98f-4f5a-ad9e-7715d5467776"}}},{"cell_type":"code","source":["sample_text[0]"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"dc5ab018-f78c-484f-8c20-486be3c942d9"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">Out[26]: &#39;The human KCNJ9 (Kir 3.3, GIRK3) is a member of the G-protein-activated inwardly rectifying potassium (GIRK) channel family. Here we describe the genomicorganization of the KCNJ9 locus on chromosome 1q21-23 as a candidate gene forType II diabetes mellitus in the Pima Indian population. The gene spansapproximately 7.6 kb and contains one noncoding and two coding exons separated byapproximately 2.2 and approximately 2.6 kb introns, respectively. We identified14 single nucleotide polymorphisms (SNPs), including one that predicts aVal366Ala substitution, and an 8 base-pair (bp) insertion/deletion. Ourexpression studies revealed the presence of the transcript in various humantissues including pancreas, and two major insulin-responsive tissues: fat andskeletal muscle. The characterization of the KCNJ9 gene should facilitate furtherstudies on the function of the KCNJ9 protein and allow evaluation of thepotential role of the locus in Type II diabetes.&#39;</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">Out[26]: &#39;The human KCNJ9 (Kir 3.3, GIRK3) is a member of the G-protein-activated inwardly rectifying potassium (GIRK) channel family. Here we describe the genomicorganization of the KCNJ9 locus on chromosome 1q21-23 as a candidate gene forType II diabetes mellitus in the Pima Indian population. The gene spansapproximately 7.6 kb and contains one noncoding and two coding exons separated byapproximately 2.2 and approximately 2.6 kb introns, respectively. We identified14 single nucleotide polymorphisms (SNPs), including one that predicts aVal366Ala substitution, and an 8 base-pair (bp) insertion/deletion. Ourexpression studies revealed the presence of the transcript in various humantissues including pancreas, and two major insulin-responsive tissues: fat andskeletal muscle. The characterization of the KCNJ9 gene should facilitate furtherstudies on the function of the KCNJ9 protein and allow evaluation of thepotential role of the locus in Type II diabetes.&#39;</div>"]}}],"execution_count":0},{"cell_type":"code","source":["assertion_light = LightPipeline(assertion_model)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"955a8ac0-da53-42c2-919b-e93941182a34"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\"></div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\"></div>"]}}],"execution_count":0},{"cell_type":"markdown","source":["**We can use `annotate` method to get faster results for short sentences.**"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"ebf959c4-40e8-4d98-aa15-85508b43e548"}}},{"cell_type":"code","source":["assertion_anno_res = assertion_light.annotate(sample_text[0])"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"c2669d54-d46e-41d3-bd2f-256471e0e985"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\"></div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\"></div>"]}}],"execution_count":0},{"cell_type":"code","source":["assertion_anno_res.keys()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"5d1e1565-3c95-4d9d-a056-12a8fe1fb380"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">Out[29]: dict_keys([&#39;document&#39;, &#39;ner_chunk&#39;, &#39;assertion&#39;, &#39;token&#39;, &#39;ner&#39;, &#39;embeddings&#39;, &#39;pos_tags&#39;, &#39;sentence&#39;])</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">Out[29]: dict_keys([&#39;document&#39;, &#39;ner_chunk&#39;, &#39;assertion&#39;, &#39;token&#39;, &#39;ner&#39;, &#39;embeddings&#39;, &#39;pos_tags&#39;, &#39;sentence&#39;])</div>"]}}],"execution_count":0},{"cell_type":"markdown","source":["**Lets create a pandas dataframe to see our results obviously.**"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"4725bcd9-f3d9-46d7-a766-4cb9c747ba76"}}},{"cell_type":"code","source":["pd.DataFrame(list(zip(assertion_anno_res[\"ner_chunk\"], assertion_anno_res[\"assertion\"])), columns=[\"ner_chunk\", \"assertion\"])"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"c18e9391-a13b-4ee4-af74-8a9b6b315499"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">Out[30]: </div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">Out[30]: </div>"]}},{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>ner_chunk</th>\n      <th>assertion</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>the G-protein-activated inwardly rectifying potassium (GIRK</td>\n      <td>conditional</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>the genomicorganization</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>a candidate gene forType II diabetes mellitus</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>byapproximately</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>single nucleotide polymorphisms</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>5</th>\n      <td>aVal366Ala substitution</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>6</th>\n      <td>an 8 base-pair</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>7</th>\n      <td>insertion/deletion</td>\n      <td>absent</td>\n    </tr>\n    <tr>\n      <th>8</th>\n      <td>Ourexpression studies</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>9</th>\n      <td>the transcript in various humantissues</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>10</th>\n      <td>fat andskeletal muscle</td>\n      <td>possible</td>\n    </tr>\n    <tr>\n      <th>11</th>\n      <td>furtherstudies</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>12</th>\n      <td>the KCNJ9 protein</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>13</th>\n      <td>evaluation</td>\n      <td>possible</td>\n    </tr>\n    <tr>\n      <th>14</th>\n      <td>Type II diabetes</td>\n      <td>present</td>\n    </tr>\n  </tbody>\n</table>\n</div>","textData":null,"removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"htmlSandbox","arguments":{}}},"output_type":"display_data","data":{"text/html":["<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>ner_chunk</th>\n      <th>assertion</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>the G-protein-activated inwardly rectifying potassium (GIRK</td>\n      <td>conditional</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>the genomicorganization</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>a candidate gene forType II diabetes mellitus</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>byapproximately</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>single nucleotide polymorphisms</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>5</th>\n      <td>aVal366Ala substitution</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>6</th>\n      <td>an 8 base-pair</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>7</th>\n      <td>insertion/deletion</td>\n      <td>absent</td>\n    </tr>\n    <tr>\n      <th>8</th>\n      <td>Ourexpression studies</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>9</th>\n      <td>the transcript in various humantissues</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>10</th>\n      <td>fat andskeletal muscle</td>\n      <td>possible</td>\n    </tr>\n    <tr>\n      <th>11</th>\n      <td>furtherstudies</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>12</th>\n      <td>the KCNJ9 protein</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>13</th>\n      <td>evaluation</td>\n      <td>possible</td>\n    </tr>\n    <tr>\n      <th>14</th>\n      <td>Type II diabetes</td>\n      <td>present</td>\n    </tr>\n  </tbody>\n</table>\n</div>"]}}],"execution_count":0},{"cell_type":"markdown","source":["**This time we will use `fullAnnotate` method on our text to get metadata results.**"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"b38c9964-efb3-47b0-88de-ce3ce7e3d2ae"}}},{"cell_type":"code","source":["assertion_result = assertion_light.fullAnnotate(sample_text[0])[0]"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"56a98af9-278c-4fc4-91f3-5f1cddbdab48"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\"></div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\"></div>"]}}],"execution_count":0},{"cell_type":"code","source":["assertion_result.keys()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"5f79d2d4-74b5-4076-9c7e-7908c2e83c25"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">Out[32]: dict_keys([&#39;document&#39;, &#39;ner_chunk&#39;, &#39;assertion&#39;, &#39;token&#39;, &#39;ner&#39;, &#39;embeddings&#39;, &#39;pos_tags&#39;, &#39;sentence&#39;])</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">Out[32]: dict_keys([&#39;document&#39;, &#39;ner_chunk&#39;, &#39;assertion&#39;, &#39;token&#39;, &#39;ner&#39;, &#39;embeddings&#39;, &#39;pos_tags&#39;, &#39;sentence&#39;])</div>"]}}],"execution_count":0},{"cell_type":"code","source":["chunks=[]\nentities=[]\nstatus=[]\n\nfor n,m in zip(assertion_result['ner_chunk'],assertion_result['assertion']):\n\n    chunks.append(n.result)\n    entities.append(n.metadata['entity']) \n    status.append(m.result)\n\ndf = pd.DataFrame({'chunks':chunks, 'entities':entities, 'assertion':status})"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"02eb3069-10eb-4c66-a0dd-feeaa64abe4e"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\"></div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\"></div>"]}}],"execution_count":0},{"cell_type":"code","source":["df"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"c3058392-62e4-47a3-b7cc-cee31916f56c"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">Out[34]: </div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">Out[34]: </div>"]}},{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>chunks</th>\n      <th>entities</th>\n      <th>assertion</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>the G-protein-activated inwardly rectifying potassium (GIRK</td>\n      <td>TREATMENT</td>\n      <td>conditional</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>the genomicorganization</td>\n      <td>TREATMENT</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>a candidate gene forType II diabetes mellitus</td>\n      <td>PROBLEM</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>byapproximately</td>\n      <td>TREATMENT</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>single nucleotide polymorphisms</td>\n      <td>TREATMENT</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>5</th>\n      <td>aVal366Ala substitution</td>\n      <td>PROBLEM</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>6</th>\n      <td>an 8 base-pair</td>\n      <td>PROBLEM</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>7</th>\n      <td>insertion/deletion</td>\n      <td>PROBLEM</td>\n      <td>absent</td>\n    </tr>\n    <tr>\n      <th>8</th>\n      <td>Ourexpression studies</td>\n      <td>TEST</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>9</th>\n      <td>the transcript in various humantissues</td>\n      <td>PROBLEM</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>10</th>\n      <td>fat andskeletal muscle</td>\n      <td>PROBLEM</td>\n      <td>possible</td>\n    </tr>\n    <tr>\n      <th>11</th>\n      <td>furtherstudies</td>\n      <td>PROBLEM</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>12</th>\n      <td>the KCNJ9 protein</td>\n      <td>TREATMENT</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>13</th>\n      <td>evaluation</td>\n      <td>TEST</td>\n      <td>possible</td>\n    </tr>\n    <tr>\n      <th>14</th>\n      <td>Type II diabetes</td>\n      <td>PROBLEM</td>\n      <td>present</td>\n    </tr>\n  </tbody>\n</table>\n</div>","textData":null,"removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"htmlSandbox","arguments":{}}},"output_type":"display_data","data":{"text/html":["<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>chunks</th>\n      <th>entities</th>\n      <th>assertion</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>the G-protein-activated inwardly rectifying potassium (GIRK</td>\n      <td>TREATMENT</td>\n      <td>conditional</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>the genomicorganization</td>\n      <td>TREATMENT</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>a candidate gene forType II diabetes mellitus</td>\n      <td>PROBLEM</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>byapproximately</td>\n      <td>TREATMENT</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>single nucleotide polymorphisms</td>\n      <td>TREATMENT</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>5</th>\n      <td>aVal366Ala substitution</td>\n      <td>PROBLEM</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>6</th>\n      <td>an 8 base-pair</td>\n      <td>PROBLEM</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>7</th>\n      <td>insertion/deletion</td>\n      <td>PROBLEM</td>\n      <td>absent</td>\n    </tr>\n    <tr>\n      <th>8</th>\n      <td>Ourexpression studies</td>\n      <td>TEST</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>9</th>\n      <td>the transcript in various humantissues</td>\n      <td>PROBLEM</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>10</th>\n      <td>fat andskeletal muscle</td>\n      <td>PROBLEM</td>\n      <td>possible</td>\n    </tr>\n    <tr>\n      <th>11</th>\n      <td>furtherstudies</td>\n      <td>PROBLEM</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>12</th>\n      <td>the KCNJ9 protein</td>\n      <td>TREATMENT</td>\n      <td>present</td>\n    </tr>\n    <tr>\n      <th>13</th>\n      <td>evaluation</td>\n      <td>TEST</td>\n      <td>possible</td>\n    </tr>\n    <tr>\n      <th>14</th>\n      <td>Type II diabetes</td>\n      <td>PROBLEM</td>\n      <td>present</td>\n    </tr>\n  </tbody>\n</table>\n</div>"]}}],"execution_count":0},{"cell_type":"markdown","source":["**Also we can filter assertion results by using `AssertionFilterer` annotator. We will use the same pipeline that we vreated before to get the assertions. We will try to get only `present` assertions.**"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"8a0b83e8-6cc2-4a34-b90c-866cecb22528"}}},{"cell_type":"code","source":["assertion_filterer = AssertionFilterer()\\\n      .setInputCols(\"sentence\",\"ner_chunk\",\"assertion\")\\\n      .setOutputCol(\"assertion_filtered\")\\\n      .setWhiteList([\"present\"])\n\nassertionFilteredPipeline = Pipeline(stages=[\n    assertionPipeline,\n    assertion_filterer\n    ])\n\nempty_data = spark.createDataFrame([[\"\"]]).toDF(\"text\")\n\nassertion_filtered_model = assertionFilteredPipeline.fit(empty_data)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"67ccb653-d5e8-48dd-aed1-a160c1e91069"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\"></div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\"></div>"]}}],"execution_count":0},{"cell_type":"code","source":["assertion_filtered_light = LightPipeline(assertion_filtered_model)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"2d0ef4a8-8103-43a6-be93-d74d427c915a"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\"></div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\"></div>"]}}],"execution_count":0},{"cell_type":"code","source":["assertion_filtered_result = assertion_filtered_light.fullAnnotate(sample_text[0])[0]"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"8cc99adc-6f60-4a95-bb7d-6a3d9e21f24e"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\"></div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\"></div>"]}}],"execution_count":0},{"cell_type":"code","source":["assertion_filtered_result.keys()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"30f2d50f-0b12-456d-9e10-b46932668afa"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">Out[38]: dict_keys([&#39;assertion_filtered&#39;, &#39;document&#39;, &#39;ner_chunk&#39;, &#39;assertion&#39;, &#39;token&#39;, &#39;ner&#39;, &#39;embeddings&#39;, &#39;pos_tags&#39;, &#39;sentence&#39;])</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">Out[38]: dict_keys([&#39;assertion_filtered&#39;, &#39;document&#39;, &#39;ner_chunk&#39;, &#39;assertion&#39;, &#39;token&#39;, &#39;ner&#39;, &#39;embeddings&#39;, &#39;pos_tags&#39;, &#39;sentence&#39;])</div>"]}}],"execution_count":0},{"cell_type":"code","source":["assertion_filtered_result[\"assertion_filtered\"]"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"911d9564-9b6d-43cb-bbfa-8228519b0219"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">Out[39]: [Annotation(chunk, 142, 164, the genomicorganization, {&#39;entity&#39;: &#39;TREATMENT&#39;, &#39;sentence&#39;: &#39;1&#39;, &#39;chunk&#39;: &#39;1&#39;, &#39;confidence&#39;: &#39;0.5477&#39;}),\n Annotation(chunk, 210, 254, a candidate gene forType II diabetes mellitus, {&#39;entity&#39;: &#39;PROBLEM&#39;, &#39;sentence&#39;: &#39;1&#39;, &#39;chunk&#39;: &#39;2&#39;, &#39;confidence&#39;: &#39;0.6645857&#39;}),\n Annotation(chunk, 380, 394, byapproximately, {&#39;entity&#39;: &#39;TREATMENT&#39;, &#39;sentence&#39;: &#39;2&#39;, &#39;chunk&#39;: &#39;3&#39;, &#39;confidence&#39;: &#39;0.7681&#39;}),\n Annotation(chunk, 464, 494, single nucleotide polymorphisms, {&#39;entity&#39;: &#39;TREATMENT&#39;, &#39;sentence&#39;: &#39;3&#39;, &#39;chunk&#39;: &#39;4&#39;, &#39;confidence&#39;: &#39;0.6379667&#39;}),\n Annotation(chunk, 532, 554, aVal366Ala substitution, {&#39;entity&#39;: &#39;PROBLEM&#39;, &#39;sentence&#39;: &#39;3&#39;, &#39;chunk&#39;: &#39;5&#39;, &#39;confidence&#39;: &#39;0.5322&#39;}),\n Annotation(chunk, 561, 574, an 8 base-pair, {&#39;entity&#39;: &#39;PROBLEM&#39;, &#39;sentence&#39;: &#39;3&#39;, &#39;chunk&#39;: &#39;6&#39;, &#39;confidence&#39;: &#39;0.606&#39;}),\n Annotation(chunk, 601, 621, Ourexpression studies, {&#39;entity&#39;: &#39;TEST&#39;, &#39;sentence&#39;: &#39;4&#39;, &#39;chunk&#39;: &#39;8&#39;, &#39;confidence&#39;: &#39;0.89975&#39;}),\n Annotation(chunk, 648, 685, the transcript in various humantissues, {&#39;entity&#39;: &#39;PROBLEM&#39;, &#39;sentence&#39;: &#39;4&#39;, &#39;chunk&#39;: &#39;9&#39;, &#39;confidence&#39;: &#39;0.64259994&#39;}),\n Annotation(chunk, 830, 843, furtherstudies, {&#39;entity&#39;: &#39;PROBLEM&#39;, &#39;sentence&#39;: &#39;5&#39;, &#39;chunk&#39;: &#39;11&#39;, &#39;confidence&#39;: &#39;0.8787&#39;}),\n Annotation(chunk, 864, 880, the KCNJ9 protein, {&#39;entity&#39;: &#39;TREATMENT&#39;, &#39;sentence&#39;: &#39;5&#39;, &#39;chunk&#39;: &#39;12&#39;, &#39;confidence&#39;: &#39;0.35633335&#39;}),\n Annotation(chunk, 940, 955, Type II diabetes, {&#39;entity&#39;: &#39;PROBLEM&#39;, &#39;sentence&#39;: &#39;5&#39;, &#39;chunk&#39;: &#39;14&#39;, &#39;confidence&#39;: &#39;0.67420006&#39;})]</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">Out[39]: [Annotation(chunk, 142, 164, the genomicorganization, {&#39;entity&#39;: &#39;TREATMENT&#39;, &#39;sentence&#39;: &#39;1&#39;, &#39;chunk&#39;: &#39;1&#39;, &#39;confidence&#39;: &#39;0.5477&#39;}),\n Annotation(chunk, 210, 254, a candidate gene forType II diabetes mellitus, {&#39;entity&#39;: &#39;PROBLEM&#39;, &#39;sentence&#39;: &#39;1&#39;, &#39;chunk&#39;: &#39;2&#39;, &#39;confidence&#39;: &#39;0.6645857&#39;}),\n Annotation(chunk, 380, 394, byapproximately, {&#39;entity&#39;: &#39;TREATMENT&#39;, &#39;sentence&#39;: &#39;2&#39;, &#39;chunk&#39;: &#39;3&#39;, &#39;confidence&#39;: &#39;0.7681&#39;}),\n Annotation(chunk, 464, 494, single nucleotide polymorphisms, {&#39;entity&#39;: &#39;TREATMENT&#39;, &#39;sentence&#39;: &#39;3&#39;, &#39;chunk&#39;: &#39;4&#39;, &#39;confidence&#39;: &#39;0.6379667&#39;}),\n Annotation(chunk, 532, 554, aVal366Ala substitution, {&#39;entity&#39;: &#39;PROBLEM&#39;, &#39;sentence&#39;: &#39;3&#39;, &#39;chunk&#39;: &#39;5&#39;, &#39;confidence&#39;: &#39;0.5322&#39;}),\n Annotation(chunk, 561, 574, an 8 base-pair, {&#39;entity&#39;: &#39;PROBLEM&#39;, &#39;sentence&#39;: &#39;3&#39;, &#39;chunk&#39;: &#39;6&#39;, &#39;confidence&#39;: &#39;0.606&#39;}),\n Annotation(chunk, 601, 621, Ourexpression studies, {&#39;entity&#39;: &#39;TEST&#39;, &#39;sentence&#39;: &#39;4&#39;, &#39;chunk&#39;: &#39;8&#39;, &#39;confidence&#39;: &#39;0.89975&#39;}),\n Annotation(chunk, 648, 685, the transcript in various humantissues, {&#39;entity&#39;: &#39;PROBLEM&#39;, &#39;sentence&#39;: &#39;4&#39;, &#39;chunk&#39;: &#39;9&#39;, &#39;confidence&#39;: &#39;0.64259994&#39;}),\n Annotation(chunk, 830, 843, furtherstudies, {&#39;entity&#39;: &#39;PROBLEM&#39;, &#39;sentence&#39;: &#39;5&#39;, &#39;chunk&#39;: &#39;11&#39;, &#39;confidence&#39;: &#39;0.8787&#39;}),\n Annotation(chunk, 864, 880, the KCNJ9 protein, {&#39;entity&#39;: &#39;TREATMENT&#39;, &#39;sentence&#39;: &#39;5&#39;, &#39;chunk&#39;: &#39;12&#39;, &#39;confidence&#39;: &#39;0.35633335&#39;}),\n Annotation(chunk, 940, 955, Type II diabetes, {&#39;entity&#39;: &#39;PROBLEM&#39;, &#39;sentence&#39;: &#39;5&#39;, &#39;chunk&#39;: &#39;14&#39;, &#39;confidence&#39;: &#39;0.67420006&#39;})]</div>"]}}],"execution_count":0},{"cell_type":"markdown","source":["Here is the `present` entities."],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"caaff294-35f6-402f-892c-ca5360185bf4"}}},{"cell_type":"code","source":["chunks=[]\nentities=[]\n\n\nfor n in assertion_filtered_result['assertion_filtered']:\n\n    chunks.append(n.result)\n    entities.append(n.metadata['entity']) \n\n\nfiltered_df = pd.DataFrame({'chunks':chunks, 'entities':entities})\n\nfiltered_df"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"397339c9-1b1e-4d66-a8c5-d7d5dfaa936b"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">Out[40]: </div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">Out[40]: </div>"]}},{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>chunks</th>\n      <th>entities</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>the genomicorganization</td>\n      <td>TREATMENT</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>a candidate gene forType II diabetes mellitus</td>\n      <td>PROBLEM</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>byapproximately</td>\n      <td>TREATMENT</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>single nucleotide polymorphisms</td>\n      <td>TREATMENT</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>aVal366Ala substitution</td>\n      <td>PROBLEM</td>\n    </tr>\n    <tr>\n      <th>5</th>\n      <td>an 8 base-pair</td>\n      <td>PROBLEM</td>\n    </tr>\n    <tr>\n      <th>6</th>\n      <td>Ourexpression studies</td>\n      <td>TEST</td>\n    </tr>\n    <tr>\n      <th>7</th>\n      <td>the transcript in various humantissues</td>\n      <td>PROBLEM</td>\n    </tr>\n    <tr>\n      <th>8</th>\n      <td>furtherstudies</td>\n      <td>PROBLEM</td>\n    </tr>\n    <tr>\n      <th>9</th>\n      <td>the KCNJ9 protein</td>\n      <td>TREATMENT</td>\n    </tr>\n    <tr>\n      <th>10</th>\n      <td>Type II diabetes</td>\n      <td>PROBLEM</td>\n    </tr>\n  </tbody>\n</table>\n</div>","textData":null,"removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"htmlSandbox","arguments":{}}},"output_type":"display_data","data":{"text/html":["<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>chunks</th>\n      <th>entities</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>the genomicorganization</td>\n      <td>TREATMENT</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>a candidate gene forType II diabetes mellitus</td>\n      <td>PROBLEM</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>byapproximately</td>\n      <td>TREATMENT</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>single nucleotide polymorphisms</td>\n      <td>TREATMENT</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>aVal366Ala substitution</td>\n      <td>PROBLEM</td>\n    </tr>\n    <tr>\n      <th>5</th>\n      <td>an 8 base-pair</td>\n      <td>PROBLEM</td>\n    </tr>\n    <tr>\n      <th>6</th>\n      <td>Ourexpression studies</td>\n      <td>TEST</td>\n    </tr>\n    <tr>\n      <th>7</th>\n      <td>the transcript in various humantissues</td>\n      <td>PROBLEM</td>\n    </tr>\n    <tr>\n      <th>8</th>\n      <td>furtherstudies</td>\n      <td>PROBLEM</td>\n    </tr>\n    <tr>\n      <th>9</th>\n      <td>the KCNJ9 protein</td>\n      <td>TREATMENT</td>\n    </tr>\n    <tr>\n      <th>10</th>\n      <td>Type II diabetes</td>\n      <td>PROBLEM</td>\n    </tr>\n  </tbody>\n</table>\n</div>"]}}],"execution_count":0},{"cell_type":"markdown","source":["### Assertion Visualization\n\nWe can visualize the assertion status of detected entities by using `AssertionVisualizer` module of `sparknlp_display` library."],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"55fe5fb1-e22c-4a4b-9bda-ce7d305c78cb"}}},{"cell_type":"code","source":["from sparknlp_display import AssertionVisualizer\n\nassertion_vis = AssertionVisualizer()\n\n## To set custom label colors:\nassertion_vis.set_label_colors({'TREATMENT':'#008080', 'PROBLEM':'#800080'}) #set label colors by specifying hex codes\n\nvis = assertion_vis.display(assertion_result, \n                            label_col = 'ner_chunk', \n                            assertion_col = 'assertion',\n                            document_col = 'document' ,\n                            return_html=True\n                      )\n\ndisplayHTML(vis)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"84348f59-37d3-4657-bed4-c09336cfd71f"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"\n<style>\n    @import url('https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;500;600;700&display=swap');\n    @import url('https://fonts.googleapis.com/css2?family=Vistol Regular:wght@300;400;500;600;700&display=swap');\n    \n    .spark-nlp-display-scroll-entities {\n        border: 1px solid #E7EDF0;\n        border-radius: 3px;\n        text-align: justify;\n        \n    }\n    .spark-nlp-display-scroll-entities span {  \n        font-size: 14px;\n        line-height: 24px;\n        color: #536B76;\n        font-family: 'Montserrat', sans-serif !important;\n    }\n    \n    .spark-nlp-display-entity-wrapper{\n    \n        display: inline-grid;\n        text-align: center;\n        border-radius: 4px;\n        margin: 0 2px 5px 2px;\n        padding: 1px\n    }\n    .spark-nlp-display-entity-name{\n        font-size: 14px;\n        line-height: 24px;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        background: #f1f2f3;\n        border-width: medium;\n        text-align: center;\n        \n        font-weight: 400;\n        \n        border-radius: 5px;\n        padding: 2px 5px;\n        display: block;\n        margin: 3px 2px;\n    \n    }\n    .spark-nlp-display-entity-type{\n        font-size: 14px;\n        line-height: 24px;\n        color: #ffffff;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        text-transform: uppercase;\n        \n        font-weight: 500;\n\n        display: block;\n        padding: 3px 5px;\n    }\n    \n    .spark-nlp-display-entity-resolution{\n        font-size: 14px;\n        line-height: 24px;\n        color: #ffffff;\n        font-family: 'Vistol Regular', sans-serif !important;\n        \n        text-transform: uppercase;\n        \n        font-weight: 500;\n\n        display: block;\n        padding: 3px 5px;\n    }\n    \n    .spark-nlp-display-others{\n        font-size: 14px;\n        line-height: 24px;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        font-weight: 400;\n    }\n\n</style>\n <span class=\"spark-nlp-display-others\" style=\"background-color: white\">The human KCNJ9 (Kir 3.3, GIRK3) is a member of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #008080B3\"><span class=\"spark-nlp-display-entity-name\">the G-protein-activated inwardly rectifying potassium (GIRK </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #008080FF\">conditional </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) channel family. Here we describe </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #008080B3\"><span class=\"spark-nlp-display-entity-name\">the genomicorganization </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #008080FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of the KCNJ9 locus on chromosome 1q21-23 as </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">a candidate gene forType II diabetes mellitus </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in the Pima Indian population. The gene spansapproximately 7.6 kb and contains one noncoding and two coding exons separated </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #008080B3\"><span class=\"spark-nlp-display-entity-name\">byapproximately </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #008080FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> 2.2 and approximately 2.6 kb introns, respectively. We identified14 </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #008080B3\"><span class=\"spark-nlp-display-entity-name\">single nucleotide polymorphisms </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #008080FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (SNPs), including one that predicts </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">aVal366Ala substitution </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">an 8 base-pair </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (bp) </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">insertion/deletion </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">absent </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">Ourexpression studies </span><span class=\"spark-nlp-display-entity-type\">TEST</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> revealed the presence of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">the transcript in various humantissues </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> including pancreas, and two major insulin-responsive tissues: </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">fat andskeletal muscle </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">possible </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. The characterization of the KCNJ9 gene should facilitate </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">furtherstudies </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> on the function of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #008080B3\"><span class=\"spark-nlp-display-entity-name\">the KCNJ9 protein </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #008080FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and allow </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">evaluation </span><span class=\"spark-nlp-display-entity-type\">TEST</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">possible </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of thepotential role of the locus in </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">Type II diabetes </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">.</span></div>","textData":null,"removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"htmlSandbox","arguments":{}}},"output_type":"display_data","data":{"text/html":["\n<style>\n    @import url('https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;500;600;700&display=swap');\n    @import url('https://fonts.googleapis.com/css2?family=Vistol Regular:wght@300;400;500;600;700&display=swap');\n    \n    .spark-nlp-display-scroll-entities {\n        border: 1px solid #E7EDF0;\n        border-radius: 3px;\n        text-align: justify;\n        \n    }\n    .spark-nlp-display-scroll-entities span {  \n        font-size: 14px;\n        line-height: 24px;\n        color: #536B76;\n        font-family: 'Montserrat', sans-serif !important;\n    }\n    \n    .spark-nlp-display-entity-wrapper{\n    \n        display: inline-grid;\n        text-align: center;\n        border-radius: 4px;\n        margin: 0 2px 5px 2px;\n        padding: 1px\n    }\n    .spark-nlp-display-entity-name{\n        font-size: 14px;\n        line-height: 24px;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        background: #f1f2f3;\n        border-width: medium;\n        text-align: center;\n        \n        font-weight: 400;\n        \n        border-radius: 5px;\n        padding: 2px 5px;\n        display: block;\n        margin: 3px 2px;\n    \n    }\n    .spark-nlp-display-entity-type{\n        font-size: 14px;\n        line-height: 24px;\n        color: #ffffff;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        text-transform: uppercase;\n        \n        font-weight: 500;\n\n        display: block;\n        padding: 3px 5px;\n    }\n    \n    .spark-nlp-display-entity-resolution{\n        font-size: 14px;\n        line-height: 24px;\n        color: #ffffff;\n        font-family: 'Vistol Regular', sans-serif !important;\n        \n        text-transform: uppercase;\n        \n        font-weight: 500;\n\n        display: block;\n        padding: 3px 5px;\n    }\n    \n    .spark-nlp-display-others{\n        font-size: 14px;\n        line-height: 24px;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        font-weight: 400;\n    }\n\n</style>\n <span class=\"spark-nlp-display-others\" style=\"background-color: white\">The human KCNJ9 (Kir 3.3, GIRK3) is a member of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #008080B3\"><span class=\"spark-nlp-display-entity-name\">the G-protein-activated inwardly rectifying potassium (GIRK </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #008080FF\">conditional </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) channel family. Here we describe </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #008080B3\"><span class=\"spark-nlp-display-entity-name\">the genomicorganization </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #008080FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of the KCNJ9 locus on chromosome 1q21-23 as </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">a candidate gene forType II diabetes mellitus </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in the Pima Indian population. The gene spansapproximately 7.6 kb and contains one noncoding and two coding exons separated </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #008080B3\"><span class=\"spark-nlp-display-entity-name\">byapproximately </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #008080FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> 2.2 and approximately 2.6 kb introns, respectively. We identified14 </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #008080B3\"><span class=\"spark-nlp-display-entity-name\">single nucleotide polymorphisms </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #008080FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (SNPs), including one that predicts </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">aVal366Ala substitution </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">an 8 base-pair </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (bp) </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">insertion/deletion </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">absent </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">Ourexpression studies </span><span class=\"spark-nlp-display-entity-type\">TEST</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> revealed the presence of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">the transcript in various humantissues </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> including pancreas, and two major insulin-responsive tissues: </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">fat andskeletal muscle </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">possible </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. The characterization of the KCNJ9 gene should facilitate </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">furtherstudies </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> on the function of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #008080B3\"><span class=\"spark-nlp-display-entity-name\">the KCNJ9 protein </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #008080FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and allow </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">evaluation </span><span class=\"spark-nlp-display-entity-type\">TEST</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">possible </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of thepotential role of the locus in </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">Type II diabetes </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">present </span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">.</span></div>"]}}],"execution_count":0},{"cell_type":"markdown","source":["**If you want to go more over about assertion model examples, you can check this comprehensive notebook :**\n\nhttps://github.com/JohnSnowLabs/spark-nlp-workshop/blob/master/tutorials/Certification_Trainings/Healthcare/2.Clinical_Assertion_Model.ipynb"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"7b601b32-15da-4a9c-93cb-03c589d27bc1"}}},{"cell_type":"markdown","source":["## 3. Relation Extraction"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"4d219483-fd7c-49ed-979c-3111d32a13eb"}}},{"cell_type":"markdown","source":["In this section, we will show an example of relation extraction models. We will use the same NER pipeline that we created before to extract clinical entities and `re_clinical` model to extract relations between these entities. The set of relations defined in the 2010 i2b2 relation challenge:\n\n**TrIP:** A certain treatment has improved or cured a medical problem (eg, ‘infection resolved with antibiotic course’)\n\n**TrWP:** A patient's medical problem has deteriorated or worsened because of or in spite of a treatment being administered (eg, ‘the tumor was growing despite the drain’)\n\n**TrCP:** A treatment caused a medical problem (eg, ‘penicillin causes a rash’)\n\n**TrAP:** A treatment administered for a medical problem (eg, ‘Dexamphetamine for narcolepsy’)\n\n**TrNAP:** The administration of a treatment was avoided because of a medical problem (eg, ‘Ralafen which is contra-indicated because of ulcers’)\n\n**TeRP:** A test has revealed some medical problem (eg, ‘an echocardiogram revealed a pericardial effusion’)\n\n**TeCP:** A test was performed to investigate a medical problem (eg, ‘chest x-ray done to rule out pneumonia’)\n\n**PIP:** Two problems are related to each other (eg, ‘Azotemia presumed secondary to sepsis’)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"dcf292c2-729e-4db9-adb3-13cbcd844a5a"}}},{"cell_type":"code","source":["dependency_parser = DependencyParserModel()\\\n    .pretrained(\"dependency_conllu\", \"en\")\\\n    .setInputCols([\"sentence\", \"pos_tags\", \"token\"])\\\n    .setOutputCol(\"dependencies\")\n\nclinical_re_Model = RelationExtractionModel()\\\n    .pretrained(\"re_clinical\", \"en\", 'clinical/models')\\\n    .setInputCols([\"embeddings\", \"pos_tags\", \"ner_chunk\", \"dependencies\"])\\\n    .setOutputCol(\"relations\")\\\n    .setMaxSyntacticDistance(4)\\\n    #.setRelationPairs([\"problem-test\", \"problem-treatment\"]) we can set the possible relation pairs (if not set, all the relations will be calculated)\n\nrelPipeline = Pipeline(stages=[\n    nerPipeline,\n    dependency_parser,\n    clinical_re_Model\n])\n\n\nempty_data = spark.createDataFrame([[\"\"]]).toDF(\"text\")\n\nrel_model = relPipeline.fit(empty_data)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"98d851d8-7061-4aa5-bc52-ab04a79e1bfd"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">dependency_conllu download started this may take some time.\nApproximate size to download 16.7 MB\n\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[OK!]\nre_clinical download started this may take some time.\nApproximate size to download 6 MB\n\r[ | ]\r[ / ]\r[OK!]\n</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">dependency_conllu download started this may take some time.\nApproximate size to download 16.7 MB\n\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[OK!]\nre_clinical download started this may take some time.\nApproximate size to download 6 MB\n\r[ | ]\r[ / ]\r[OK!]\n</div>"]}}],"execution_count":0},{"cell_type":"code","source":["rel_model.stages"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"a648d263-f9c5-4e5e-9983-67ad1ea9e10a"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">Out[43]: [PipelineModel_53b72d314be0,\n dependency_d5a8da6c9093,\n RelationExtractionModel_9c255241fec3]</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">Out[43]: [PipelineModel_53b72d314be0,\n dependency_d5a8da6c9093,\n RelationExtractionModel_9c255241fec3]</div>"]}}],"execution_count":0},{"cell_type":"code","source":["sample_text[1]"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"cc77dc03-325e-415d-8331-0c93801799ae"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">Out[44]: &#39;BACKGROUND: At present, it is one of the most important issues for the treatment of breast cancer to develop the standard therapy for patients previously treated with anthracyclines and taxanes. With the objective of determining the usefulnessof vinorelbine monotherapy in patients with advanced or recurrent breast cancerafter standard therapy, we evaluated the efficacy and safety of vinorelbine inpatients previously treated with anthracyclines and taxanes. METHODS: Vinorelbinewas administered at a dose level of 25 mg/m(2) intravenously on days 1 and 8 of a3 week cycle. Patients were given three or more cycles in the absence of tumorprogression. A maximum of nine cycles were administered. RESULTS: The responserate in 50 evaluable patients was 20.0% (10 out of 50; 95% confidence interval,10.0-33.7%). Responders plus those who had minor response (MR) or no change (NC) accounted for 58.0% [10 partial responses (PRs) + one MR + 18 NCs out of 50]. TheKaplan-Meier estimate (50% point) of time to progression (TTP) was 115.0 days.The response rate in the visceral organs was 17.3% (nine PRs out of 52). Themajor toxicity was myelosuppression, which was reversible and did not requirediscontinuation of treatment. CONCLUSION: The results of this study show thatvinorelbine monotherapy is useful in patients with advanced or recurrent breastcancer previously exposed to both anthracyclines and taxanes.&#39;</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">Out[44]: &#39;BACKGROUND: At present, it is one of the most important issues for the treatment of breast cancer to develop the standard therapy for patients previously treated with anthracyclines and taxanes. With the objective of determining the usefulnessof vinorelbine monotherapy in patients with advanced or recurrent breast cancerafter standard therapy, we evaluated the efficacy and safety of vinorelbine inpatients previously treated with anthracyclines and taxanes. METHODS: Vinorelbinewas administered at a dose level of 25 mg/m(2) intravenously on days 1 and 8 of a3 week cycle. Patients were given three or more cycles in the absence of tumorprogression. A maximum of nine cycles were administered. RESULTS: The responserate in 50 evaluable patients was 20.0% (10 out of 50; 95% confidence interval,10.0-33.7%). Responders plus those who had minor response (MR) or no change (NC) accounted for 58.0% [10 partial responses (PRs) + one MR + 18 NCs out of 50]. TheKaplan-Meier estimate (50% point) of time to progression (TTP) was 115.0 days.The response rate in the visceral organs was 17.3% (nine PRs out of 52). Themajor toxicity was myelosuppression, which was reversible and did not requirediscontinuation of treatment. CONCLUSION: The results of this study show thatvinorelbine monotherapy is useful in patients with advanced or recurrent breastcancer previously exposed to both anthracyclines and taxanes.&#39;</div>"]}}],"execution_count":0},{"cell_type":"code","source":["rel_light = LightPipeline(rel_model)\nrelation_res = rel_light.fullAnnotate(sample_text[1])[0]"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"85319c49-fc50-49d4-a074-124e7a67af51"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\"></div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\"></div>"]}}],"execution_count":0},{"cell_type":"code","source":["relation_res.keys()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"fb924025-b926-4ffc-8e36-5d8a2fb39fd5"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">Out[46]: dict_keys([&#39;document&#39;, &#39;ner_chunk&#39;, &#39;token&#39;, &#39;relations&#39;, &#39;ner&#39;, &#39;embeddings&#39;, &#39;pos_tags&#39;, &#39;dependencies&#39;, &#39;sentence&#39;])</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">Out[46]: dict_keys([&#39;document&#39;, &#39;ner_chunk&#39;, &#39;token&#39;, &#39;relations&#39;, &#39;ner&#39;, &#39;embeddings&#39;, &#39;pos_tags&#39;, &#39;dependencies&#39;, &#39;sentence&#39;])</div>"]}}],"execution_count":0},{"cell_type":"code","source":["rel_pairs=[]\n  \nfor rel in relation_res[\"relations\"]:\n    rel_pairs.append((\n          rel.result, \n          rel.metadata['entity1'], \n          rel.metadata['entity1_begin'],\n          rel.metadata['entity1_end'],\n          rel.metadata['chunk1'], \n          rel.metadata['entity2'],\n          rel.metadata['entity2_begin'],\n          rel.metadata['entity2_end'],\n          rel.metadata['chunk2'], \n          rel.metadata['confidence']\n      ))\n\nrel_df = pd.DataFrame(rel_pairs, columns=['relation','entity1','entity1_begin','entity1_end','chunk1','entity2','entity2_begin','entity2_end','chunk2', 'confidence'])\nrel_df[rel_df.relation!=\"O\"]"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"965ac16d-1bd6-4641-a54b-dbbfb2b145aa"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">Out[47]: </div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">Out[47]: </div>"]}},{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>relation</th>\n      <th>entity1</th>\n      <th>entity1_begin</th>\n      <th>entity1_end</th>\n      <th>chunk1</th>\n      <th>entity2</th>\n      <th>entity2_begin</th>\n      <th>entity2_end</th>\n      <th>chunk2</th>\n      <th>confidence</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>1</th>\n      <td>TrWP</td>\n      <td>PROBLEM</td>\n      <td>84</td>\n      <td>96</td>\n      <td>breast cancer</td>\n      <td>TREATMENT</td>\n      <td>109</td>\n      <td>128</td>\n      <td>the standard therapy</td>\n      <td>0.6738779</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>TeRP</td>\n      <td>TREATMENT</td>\n      <td>109</td>\n      <td>128</td>\n      <td>the standard therapy</td>\n      <td>TREATMENT</td>\n      <td>186</td>\n      <td>192</td>\n      <td>taxanes</td>\n      <td>0.9952891</td>\n    </tr>\n    <tr>\n      <th>5</th>\n      <td>TeRP</td>\n      <td>TREATMENT</td>\n      <td>229</td>\n      <td>268</td>\n      <td>the usefulnessof vinorelbine monotherapy</td>\n      <td>TREATMENT</td>\n      <td>287</td>\n      <td>343</td>\n      <td>advanced or recurrent breast cancerafter standard therapy</td>\n      <td>0.9998728</td>\n    </tr>\n    <tr>\n      <th>14</th>\n      <td>TeRP</td>\n      <td>PROBLEM</td>\n      <td>1110</td>\n      <td>1126</td>\n      <td>Themajor toxicity</td>\n      <td>PROBLEM</td>\n      <td>1132</td>\n      <td>1147</td>\n      <td>myelosuppression</td>\n      <td>0.7527134</td>\n    </tr>\n    <tr>\n      <th>15</th>\n      <td>TeRP</td>\n      <td>PROBLEM</td>\n      <td>1110</td>\n      <td>1126</td>\n      <td>Themajor toxicity</td>\n      <td>TREATMENT</td>\n      <td>1183</td>\n      <td>1204</td>\n      <td>requirediscontinuation</td>\n      <td>0.7808279</td>\n    </tr>\n    <tr>\n      <th>16</th>\n      <td>TeRP</td>\n      <td>PROBLEM</td>\n      <td>1110</td>\n      <td>1126</td>\n      <td>Themajor toxicity</td>\n      <td>TREATMENT</td>\n      <td>1209</td>\n      <td>1217</td>\n      <td>treatment</td>\n      <td>0.9991315</td>\n    </tr>\n    <tr>\n      <th>17</th>\n      <td>TrWP</td>\n      <td>PROBLEM</td>\n      <td>1132</td>\n      <td>1147</td>\n      <td>myelosuppression</td>\n      <td>TREATMENT</td>\n      <td>1183</td>\n      <td>1204</td>\n      <td>requirediscontinuation</td>\n      <td>0.8995943</td>\n    </tr>\n    <tr>\n      <th>21</th>\n      <td>TeRP</td>\n      <td>TREATMENT</td>\n      <td>1263</td>\n      <td>1289</td>\n      <td>thatvinorelbine monotherapy</td>\n      <td>TREATMENT</td>\n      <td>1330</td>\n      <td>1351</td>\n      <td>recurrent breastcancer</td>\n      <td>0.9413687</td>\n    </tr>\n    <tr>\n      <th>22</th>\n      <td>TeRP</td>\n      <td>TREATMENT</td>\n      <td>1330</td>\n      <td>1351</td>\n      <td>recurrent breastcancer</td>\n      <td>TREATMENT</td>\n      <td>1380</td>\n      <td>1393</td>\n      <td>anthracyclines</td>\n      <td>0.9842151</td>\n    </tr>\n    <tr>\n      <th>23</th>\n      <td>TeRP</td>\n      <td>TREATMENT</td>\n      <td>1330</td>\n      <td>1351</td>\n      <td>recurrent breastcancer</td>\n      <td>TREATMENT</td>\n      <td>1399</td>\n      <td>1405</td>\n      <td>taxanes</td>\n      <td>0.9980427</td>\n    </tr>\n  </tbody>\n</table>\n</div>","textData":null,"removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"htmlSandbox","arguments":{}}},"output_type":"display_data","data":{"text/html":["<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>relation</th>\n      <th>entity1</th>\n      <th>entity1_begin</th>\n      <th>entity1_end</th>\n      <th>chunk1</th>\n      <th>entity2</th>\n      <th>entity2_begin</th>\n      <th>entity2_end</th>\n      <th>chunk2</th>\n      <th>confidence</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>1</th>\n      <td>TrWP</td>\n      <td>PROBLEM</td>\n      <td>84</td>\n      <td>96</td>\n      <td>breast cancer</td>\n      <td>TREATMENT</td>\n      <td>109</td>\n      <td>128</td>\n      <td>the standard therapy</td>\n      <td>0.6738779</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>TeRP</td>\n      <td>TREATMENT</td>\n      <td>109</td>\n      <td>128</td>\n      <td>the standard therapy</td>\n      <td>TREATMENT</td>\n      <td>186</td>\n      <td>192</td>\n      <td>taxanes</td>\n      <td>0.9952891</td>\n    </tr>\n    <tr>\n      <th>5</th>\n      <td>TeRP</td>\n      <td>TREATMENT</td>\n      <td>229</td>\n      <td>268</td>\n      <td>the usefulnessof vinorelbine monotherapy</td>\n      <td>TREATMENT</td>\n      <td>287</td>\n      <td>343</td>\n      <td>advanced or recurrent breast cancerafter standard therapy</td>\n      <td>0.9998728</td>\n    </tr>\n    <tr>\n      <th>14</th>\n      <td>TeRP</td>\n      <td>PROBLEM</td>\n      <td>1110</td>\n      <td>1126</td>\n      <td>Themajor toxicity</td>\n      <td>PROBLEM</td>\n      <td>1132</td>\n      <td>1147</td>\n      <td>myelosuppression</td>\n      <td>0.7527134</td>\n    </tr>\n    <tr>\n      <th>15</th>\n      <td>TeRP</td>\n      <td>PROBLEM</td>\n      <td>1110</td>\n      <td>1126</td>\n      <td>Themajor toxicity</td>\n      <td>TREATMENT</td>\n      <td>1183</td>\n      <td>1204</td>\n      <td>requirediscontinuation</td>\n      <td>0.7808279</td>\n    </tr>\n    <tr>\n      <th>16</th>\n      <td>TeRP</td>\n      <td>PROBLEM</td>\n      <td>1110</td>\n      <td>1126</td>\n      <td>Themajor toxicity</td>\n      <td>TREATMENT</td>\n      <td>1209</td>\n      <td>1217</td>\n      <td>treatment</td>\n      <td>0.9991315</td>\n    </tr>\n    <tr>\n      <th>17</th>\n      <td>TrWP</td>\n      <td>PROBLEM</td>\n      <td>1132</td>\n      <td>1147</td>\n      <td>myelosuppression</td>\n      <td>TREATMENT</td>\n      <td>1183</td>\n      <td>1204</td>\n      <td>requirediscontinuation</td>\n      <td>0.8995943</td>\n    </tr>\n    <tr>\n      <th>21</th>\n      <td>TeRP</td>\n      <td>TREATMENT</td>\n      <td>1263</td>\n      <td>1289</td>\n      <td>thatvinorelbine monotherapy</td>\n      <td>TREATMENT</td>\n      <td>1330</td>\n      <td>1351</td>\n      <td>recurrent breastcancer</td>\n      <td>0.9413687</td>\n    </tr>\n    <tr>\n      <th>22</th>\n      <td>TeRP</td>\n      <td>TREATMENT</td>\n      <td>1330</td>\n      <td>1351</td>\n      <td>recurrent breastcancer</td>\n      <td>TREATMENT</td>\n      <td>1380</td>\n      <td>1393</td>\n      <td>anthracyclines</td>\n      <td>0.9842151</td>\n    </tr>\n    <tr>\n      <th>23</th>\n      <td>TeRP</td>\n      <td>TREATMENT</td>\n      <td>1330</td>\n      <td>1351</td>\n      <td>recurrent breastcancer</td>\n      <td>TREATMENT</td>\n      <td>1399</td>\n      <td>1405</td>\n      <td>taxanes</td>\n      <td>0.9980427</td>\n    </tr>\n  </tbody>\n</table>\n</div>"]}}],"execution_count":0},{"cell_type":"markdown","source":["### Relation Visualization\n\nWe can visualize relations between entities by using `RelationExtractionVisualizer` module of `sparknlp_display` lìbrary."],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"42928f8c-d64e-4e50-8fa5-59850be8e266"}}},{"cell_type":"code","source":["from sparknlp_display import RelationExtractionVisualizer\n\nre_vis = RelationExtractionVisualizer()\n\nvis = re_vis.display(relation_res,\n                     relation_col = 'relations',\n                     document_col = 'document',\n                     show_relations=True,\n                     return_html=True)\n\ndisplayHTML(vis)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"8d00f2bd-358d-4aa9-900e-23c74e2b4799"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<svg baseProfile=\"full\" height=\"1775\" version=\"1.1\" width=\"1000\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:ev=\"http://www.w3.org/2001/xml-events\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"><defs><style type=\"text/css\"><![CDATA[@font-face{ \n    font-family: \"Lucida\"; \n    src: url(\"data:application/x-font-ttf;charset=utf-8;base64,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\"); \n}\n]]></style></defs><rect fill=\"#800080\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#800080\" stroke-width=\"1\" width=\"130.79999999999998\" x=\"7\" y=\"157\" /><rect fill=\"#8b6673\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#8b6673\" stroke-width=\"1\" width=\"198.7\" x=\"274.5\" y=\"157\" /><rect fill=\"#8b6673\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#8b6673\" stroke-width=\"1\" width=\"72.6\" x=\"201.3\" y=\"257\" /><rect fill=\"#8b6673\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#8b6673\" stroke-width=\"1\" width=\"392.7\" x=\"7\" y=\"357\" /><rect fill=\"#8b6673\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#8b6673\" stroke-width=\"1\" width=\"557.5999999999999\" x=\"7\" y=\"457\" /><rect fill=\"#800080\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#800080\" stroke-width=\"1\" width=\"169.6\" x=\"138.39999999999998\" y=\"1357\" /><rect fill=\"#800080\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#800080\" stroke-width=\"1\" width=\"159.89999999999998\" x=\"371.8\" y=\"1357\" /><rect fill=\"#8b6673\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#8b6673\" stroke-width=\"1\" width=\"218.1\" x=\"7\" y=\"1457\" /><rect fill=\"#8b6673\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#8b6673\" stroke-width=\"1\" width=\"92.0\" x=\"279.2\" y=\"1457\" /><rect fill=\"#8b6673\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#8b6673\" stroke-width=\"1\" width=\"266.59999999999997\" x=\"7\" y=\"1557\" /><rect fill=\"#8b6673\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#8b6673\" stroke-width=\"1\" width=\"218.1\" x=\"706.8999999999999\" y=\"1557\" /><rect fill=\"#8b6673\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#8b6673\" stroke-width=\"1\" width=\"140.5\" x=\"288.9\" y=\"1657\" /><rect fill=\"#8b6673\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#8b6673\" stroke-width=\"1\" width=\"72.6\" x=\"493.2\" y=\"1657\" /><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"75\">BACKGROUND:</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"131.39999999999998\" y=\"75\">At</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"165.49999999999997\" y=\"75\">present,</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"257.79999999999995\" y=\"75\">it</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"291.9\" y=\"75\">is</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"326.0\" y=\"75\">one</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"369.8\" y=\"75\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"403.9\" y=\"75\">the</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"447.7\" y=\"75\">most</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"501.2\" y=\"75\">important</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"603.2\" y=\"75\">issues</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"676.1\" y=\"75\">for</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"719.9\" y=\"75\">the</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"763.6999999999999\" y=\"75\">treatment</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"865.6999999999999\" y=\"75\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"175\">breast cancer</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"48.99999999999999\" y=\"195\">PROBLEM</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"160.79999999999998\" y=\"175\">to</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"194.89999999999998\" y=\"175\">develop</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"277.5\" y=\"175\">the standard therapy</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"343.3954545454546\" y=\"195\">TREATMENT</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"496.2\" y=\"175\">for</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"540.0\" y=\"175\">patients</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"632.3\" y=\"175\">previously</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"744.0\" y=\"175\">treated</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"826.6\" y=\"175\">with</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"275\">anthracyclines</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"160.5\" y=\"275\">and</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"204.3\" y=\"275\">taxanes</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"207.14545454545458\" y=\"295\">TREATMENT</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"296.9\" y=\"275\">.</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"321.29999999999995\" y=\"275\">With</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"374.79999999999995\" y=\"275\">the</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"418.59999999999997\" y=\"275\">objective</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"520.5999999999999\" y=\"275\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"554.6999999999999\" y=\"275\">determining</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"375\">the usefulnessof vinorelbine monotherapy</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"172.89545454545453\" y=\"395\">TREATMENT</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"422.7\" y=\"375\">in</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"456.79999999999995\" y=\"375\">patients</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"549.0999999999999\" y=\"375\">with</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"475\">advanced or recurrent breast cancerafter standard therapy</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"255.34545454545452\" y=\"495\">TREATMENT</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"587.5999999999999\" y=\"475\">,</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"611.9999999999999\" y=\"475\">we</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"646.0999999999999\" y=\"475\">evaluated</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"748.0999999999999\" y=\"475\">the</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"791.8999999999999\" y=\"475\">efficacy</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"884.1999999999998\" y=\"475\">and</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"575\">safety</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"82.89999999999999\" y=\"575\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"116.99999999999999\" y=\"575\">vinorelbine</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"238.39999999999998\" y=\"575\">inpatients</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"350.09999999999997\" y=\"575\">previously</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"461.79999999999995\" y=\"575\">treated</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"544.4\" y=\"575\">with</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"597.9\" y=\"575\">anthracyclines</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"748.4\" y=\"575\">and</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"792.1999999999999\" y=\"575\">taxanes.</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"884.4999999999999\" y=\"575\">METHODS:</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"675\">Vinorelbinewas</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"160.5\" y=\"675\">administered</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"291.6\" y=\"675\">at</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"325.70000000000005\" y=\"675\">a</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"350.1\" y=\"675\">dose</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"403.6\" y=\"675\">level</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"466.8\" y=\"675\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"500.9\" y=\"675\">25</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"535.0\" y=\"675\">mg/m(2)</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"617.6\" y=\"675\">intravenously</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"758.4\" y=\"675\">on</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"792.5\" y=\"675\">days</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"846.0\" y=\"675\">1</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"870.4\" y=\"675\">and</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"914.1999999999999\" y=\"675\">8</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"938.5999999999999\" y=\"675\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"775\">a3</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"44.099999999999994\" y=\"775\">week</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"97.6\" y=\"775\">cycle.</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"170.5\" y=\"775\">Patients</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"262.8\" y=\"775\">were</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"316.3\" y=\"775\">given</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"379.5\" y=\"775\">three</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"442.7\" y=\"775\">or</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"476.79999999999995\" y=\"775\">more</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"530.3\" y=\"775\">cycles</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"603.1999999999999\" y=\"775\">in</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"637.3\" y=\"775\">the</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"681.0999999999999\" y=\"775\">absence</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"763.6999999999999\" y=\"775\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"797.8\" y=\"775\">tumorprogression.</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"875\">A</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"34.4\" y=\"875\">maximum</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"117.0\" y=\"875\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"151.1\" y=\"875\">nine</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"204.6\" y=\"875\">cycles</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"277.5\" y=\"875\">were</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"331.0\" y=\"875\">administered.</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"471.79999999999995\" y=\"875\">RESULTS:</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"564.0999999999999\" y=\"875\">The</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"607.8999999999999\" y=\"875\">responserate</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"738.9999999999999\" y=\"875\">in</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"773.0999999999999\" y=\"875\">50</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"807.1999999999999\" y=\"875\">evaluable</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"975\">patients</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"102.3\" y=\"975\">was</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"146.1\" y=\"975\">20.0%</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"209.29999999999998\" y=\"975\">(10</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"253.09999999999997\" y=\"975\">out</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"296.9\" y=\"975\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"331.0\" y=\"975\">50;</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"374.8\" y=\"975\">95%</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"418.6\" y=\"975\">confidence</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"530.3\" y=\"975\">interval,10.0-33.7%).</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"748.6999999999999\" y=\"975\">Responders</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"860.3999999999999\" y=\"975\">plus</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"913.8999999999999\" y=\"975\">those</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"1075\">who</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"53.8\" y=\"1075\">had</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"97.6\" y=\"1075\">minor</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"160.79999999999998\" y=\"1075\">response</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"253.09999999999997\" y=\"1075\">(MR)</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"306.59999999999997\" y=\"1075\">or</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"340.69999999999993\" y=\"1075\">no</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"374.79999999999995\" y=\"1075\">change</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"447.69999999999993\" y=\"1075\">(NC)</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"501.19999999999993\" y=\"1075\">accounted</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"603.1999999999999\" y=\"1075\">for</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"646.9999999999999\" y=\"1075\">58.0%</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"710.1999999999999\" y=\"1075\">[10</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"753.9999999999999\" y=\"1075\">partial</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"836.5999999999999\" y=\"1075\">responses</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"1175\">(PRs)</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"73.19999999999999\" y=\"1175\">+</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"97.6\" y=\"1175\">one</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"141.39999999999998\" y=\"1175\">MR</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"175.49999999999997\" y=\"1175\">+</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"199.89999999999998\" y=\"1175\">18</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"233.99999999999997\" y=\"1175\">NCs</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"277.79999999999995\" y=\"1175\">out</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"321.59999999999997\" y=\"1175\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"355.69999999999993\" y=\"1175\">50].</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"409.19999999999993\" y=\"1175\">TheKaplan-Meier</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"569.3999999999999\" y=\"1175\">estimate</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"661.6999999999998\" y=\"1175\">(50%</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"715.1999999999998\" y=\"1175\">point)</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"788.0999999999998\" y=\"1175\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"822.1999999999998\" y=\"1175\">time</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"875.6999999999998\" y=\"1175\">to</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"1275\">progression</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"131.39999999999998\" y=\"1275\">(TTP)</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"194.59999999999997\" y=\"1275\">was</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"238.39999999999998\" y=\"1275\">115.0</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"301.59999999999997\" y=\"1275\">days.The</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"393.9\" y=\"1275\">response</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"486.2\" y=\"1275\">rate</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"539.7\" y=\"1275\">in</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"573.8000000000001\" y=\"1275\">the</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"617.6\" y=\"1275\">visceral</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"709.9\" y=\"1275\">organs</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"782.8\" y=\"1275\">was</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"826.5999999999999\" y=\"1275\">17.3%</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"889.8\" y=\"1275\">(nine</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"953.0\" y=\"1275\">PRs</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"1375\">out</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"53.8\" y=\"1375\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"87.89999999999999\" y=\"1375\">52).</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"141.39999999999998\" y=\"1375\">Themajor toxicity</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"199.79999999999998\" y=\"1395\">PROBLEM</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"331.0\" y=\"1375\">was</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"374.8\" y=\"1375\">myelosuppression</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"428.35\" y=\"1395\">PROBLEM</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"554.7\" y=\"1375\">,</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"579.1\" y=\"1375\">which</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"642.3000000000001\" y=\"1375\">was</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"686.1\" y=\"1375\">reversible</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"797.8\" y=\"1375\">and</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"841.5999999999999\" y=\"1375\">did</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"885.3999999999999\" y=\"1375\">not</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"1475\">requirediscontinuation</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"85.59545454545454\" y=\"1495\">TREATMENT</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"248.1\" y=\"1475\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"282.2\" y=\"1475\">treatment</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"294.74545454545455\" y=\"1495\">TREATMENT</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"394.2\" y=\"1475\">.</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"418.59999999999997\" y=\"1475\">CONCLUSION:</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"540.0\" y=\"1475\">The</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"583.8\" y=\"1475\">results</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"666.4\" y=\"1475\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"700.5\" y=\"1475\">this</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"754.0\" y=\"1475\">study</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"817.2\" y=\"1475\">show</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"1575\">thatvinorelbine monotherapy</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"109.84545454545453\" y=\"1595\">TREATMENT</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"296.59999999999997\" y=\"1575\">is</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"330.69999999999993\" y=\"1575\">useful</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"403.5999999999999\" y=\"1575\">in</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"437.69999999999993\" y=\"1575\">patients</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"529.9999999999999\" y=\"1575\">with</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"583.4999999999999\" y=\"1575\">advanced</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"675.7999999999998\" y=\"1575\">or</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"709.8999999999999\" y=\"1575\">recurrent breastcancer</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"785.4954545454543\" y=\"1595\">TREATMENT</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"1675\">previously</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"121.69999999999999\" y=\"1675\">exposed</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"204.29999999999998\" y=\"1675\">to</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"238.39999999999998\" y=\"1675\">both</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"291.9\" y=\"1675\">anthracyclines</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"328.69545454545454\" y=\"1695\">TREATMENT</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"452.4\" y=\"1675\">and</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"496.2\" y=\"1675\">taxanes</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"499.04545454545456\" y=\"1695\">TREATMENT</text><text fill=\"#546c77\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"588.8\" y=\"1675\">.</text><polyline fill=\"none\" points=\"283.0,455.0 282.6020408163265,454.3367346938775 282.204081632653,453.67346938775506 281.8061224489796,453.01020408163265 281.4081632653061,452.3469387755102 281.0102040816326,451.68367346938777 280.6122448979591,451.0204081632653 280.2142857142858,450.35714285714295 279.81632653061234,449.69387755102053 279.4183673469388,449.030612244898 279.02040816326524,448.3673469387755 278.6224489795918,447.7040816326531 278.2244897959183,447.04081632653055 277.8265306122449,446.3775510204082 277.42857142857144,445.7142857142858 277.030612244898,445.05102040816337 276.6326530612245,444.38775510204084 276.2346938775511,443.72448979591843 275.83673469387753,443.0612244897959 275.43877551020404,442.3979591836735 275.0408163265306,441.7346938775509 274.6428571428571,441.07142857142856 274.2448979591837,440.40816326530614 273.8469387755102,439.7448979591836 273.44897959183675,439.08163265306126 273.05102040816325,438.4183673469388 272.65306122448976,437.7551020408163 272.25510204081627,437.09183673469397 271.8571428571429,436.4285714285715 271.4591836734694,435.765306122449 271.0612244897959,435.10204081632656 270.6632653061224,434.43877551020415 270.265306122449,433.7755102040816 269.86734693877554,433.1122448979593 269.46938775510205,432.44897959183675 269.07142857142856,431.78571428571433 268.67346938775506,431.1224489795919 268.2755102040816,430.4591836734694 267.8775510204082,429.795918367347 267.4795918367347,429.13265306122446 267.0816326530612,428.46938775510205 266.68367346938777,427.8061224489796 266.28571428571433,427.1428571428572 265.88775510204084,426.4795918367347 265.48979591836735,425.8163265306123 265.09183673469386,425.1530612244898 264.6938775510204,424.48979591836735 264.2959183673469,423.8265306122449 263.89795918367344,423.1632653061224 263.5,422.5 263.5,422.5 263.1020408163265,421.83673469387753 262.7040816326531,421.173469387755 262.3061224489796,420.51020408163265 261.90816326530614,419.8469387755102 261.51020408163265,419.1836734693877 261.11224489795916,418.52040816326524 260.71428571428584,417.857142857143 260.3163265306123,417.1938775510205 259.9183673469388,416.530612244898 259.52040816326524,415.8673469387755 259.1224489795918,415.20408163265296 258.7244897959184,414.54081632653055 258.3265306122449,413.87755102040813 257.92857142857144,413.21428571428567 257.530612244898,412.55102040816325 257.1326530612245,411.88775510204084 256.734693877551,411.2244897959184 256.33673469387753,410.5612244897959 255.9387755102041,409.89795918367344 255.54081632653057,409.2346938775509 255.1428571428571,408.5714285714285 254.74489795918367,407.90816326530614 254.34693877551018,407.2448979591836 253.94897959183677,406.5816326530612 253.55102040816325,405.91836734693874 253.1530612244898,405.25510204081627 252.75510204081633,404.59183673469386 252.3571428571429,403.92857142857144 251.95918367346937,403.265306122449 251.5612244897959,402.6020408163265 251.16326530612247,401.9387755102041 250.76530612244898,401.2755102040816 250.36734693877554,400.61224489795916 249.96938775510205,399.94897959183675 249.57142857142856,399.2857142857143 249.17346938775512,398.6224489795918 248.77551020408166,397.9591836734694 248.37755102040813,397.295918367347 247.9795918367347,396.63265306122446 247.58163265306123,395.96938775510205 247.18367346938777,395.3061224489796 246.7857142857143,394.6428571428571 246.3877551020408,393.9795918367347 245.98979591836735,393.31632653061223 245.59183673469389,392.6530612244898 245.19387755102042,391.98979591836735 244.79591836734696,391.32653061224494 244.39795918367346,390.66326530612247 244.0,390.0\" stroke=\"#8c35cd\" stroke-width=\"1\" /><polyline fill=\"none\" points=\"242.28501415083736,396.8599433966506 244,390 250.85994339665058,391.71498584916264 244,390\" stroke=\"#8c35cd\" stroke-width=\"1\" /><rect fill=\"white\" height=\"13\" rx=\"2\" ry=\"2\" stroke=\"#8c35cd\" stroke-width=\"1\" transform=\"rotate(59.03624340311225 262.0 419.0)\" width=\"35.22222222222222\" x=\"244.38888888888889\" y=\"412.5\" /><text fill=\"#8c35cd\" font-family=\"courier\" font-size=\"12\" transform=\"rotate(59.03624340311225 262.0 419.0)\" x=\"247.38888888888889\" y=\"422.5\">TeRP</text><polyline fill=\"none\" points=\"323.0,1455.0 322.3265306122449,1454.3367346938774 321.65306122448976,1453.6734693877547 320.97959183673476,1453.0102040816328 320.30612244897964,1452.3469387755104 319.63265306122446,1451.6836734693877 318.95918367346934,1451.0204081632653 318.28571428571433,1450.3571428571433 317.6122448979592,1449.6938775510207 316.9387755102041,1449.0306122448983 316.2653061224489,1448.3673469387754 315.59183673469386,1447.704081632653 314.91836734693874,1447.0408163265304 314.2448979591836,1446.3775510204082 313.57142857142856,1445.7142857142858 312.8979591836735,1445.0510204081634 312.22448979591843,1444.387755102041 311.55102040816337,1443.7244897959185 310.87755102040813,1443.0612244897961 310.204081632653,1442.3979591836735 309.5306122448979,1441.7346938775509 308.85714285714283,1441.0714285714284 308.1836734693878,1440.4081632653063 307.5102040816326,1439.7448979591836 306.83673469387753,1439.0816326530614 306.1632653061224,1438.4183673469388 305.48979591836735,1437.7551020408164 304.8163265306123,1437.091836734694 304.14285714285717,1436.4285714285718 303.46938775510205,1435.7653061224491 302.7959183673469,1435.1020408163265 302.12244897959187,1434.4387755102043 301.44897959183675,1433.7755102040815 300.7755102040816,1433.1122448979593 300.1020408163265,1432.4489795918366 299.42857142857144,1431.7857142857142 298.7551020408164,1431.1224489795918 298.0816326530612,1430.4591836734694 297.40816326530614,1429.795918367347 296.734693877551,1429.1326530612246 296.0612244897959,1428.4693877551022 295.38775510204084,1427.8061224489797 294.7142857142858,1427.1428571428573 294.0408163265306,1426.4795918367347 293.3673469387755,1425.816326530612 292.6938775510204,1425.1530612244896 292.0204081632653,1424.4897959183672 291.34693877551024,1423.826530612245 290.6734693877551,1423.1632653061224 290.0,1422.5 290.0,1422.5 289.3265306122448,1421.8367346938776 288.65306122448976,1421.173469387755 287.97959183673476,1420.5102040816328 287.30612244897964,1419.8469387755104 286.63265306122446,1419.1836734693877 285.95918367346934,1418.520408163265 285.28571428571433,1417.8571428571431 284.6122448979592,1417.1938775510207 283.9387755102041,1416.530612244898 283.2653061224489,1415.8673469387752 282.59183673469386,1415.2040816326526 281.91836734693874,1414.5408163265304 281.2448979591836,1413.8775510204082 280.5714285714286,1413.2142857142856 279.8979591836735,1412.5510204081634 279.22448979591843,1411.8877551020407 278.55102040816325,1411.2244897959183 277.87755102040813,1410.561224489796 277.2040816326531,1409.8979591836733 276.5306122448979,1409.2346938775509 275.85714285714283,1408.5714285714284 275.18367346938777,1407.9081632653063 274.51020408163265,1407.2448979591834 273.8367346938776,1406.581632653061 273.16326530612247,1405.9183673469388 272.48979591836735,1405.2551020408162 271.81632653061223,1404.591836734694 271.14285714285717,1403.9285714285716 270.46938775510205,1403.265306122449 269.795918367347,1402.6020408163265 269.12244897959187,1401.938775510204 268.44897959183675,1401.2755102040815 267.7755102040816,1400.612244897959 267.1020408163265,1399.9489795918366 266.42857142857144,1399.2857142857142 265.7551020408163,1398.6224489795918 265.0816326530612,1397.9591836734694 264.40816326530614,1397.295918367347 263.734693877551,1396.6326530612243 263.06122448979596,1395.9693877551022 262.38775510204084,1395.3061224489797 261.7142857142857,1394.6428571428573 261.0408163265306,1393.9795918367347 260.36734693877554,1393.3163265306123 259.6938775510204,1392.6530612244896 259.0204081632653,1391.9897959183675 258.3469387755102,1391.326530612245 257.6734693877551,1390.6632653061224 257.0,1390.0\" stroke=\"#8c35cd\" stroke-width=\"1\" /><polyline fill=\"none\" points=\"257.0539760442122,1397.0708617917974 257,1390 264.0708617917973,1389.9460239557877 257,1390\" stroke=\"#8c35cd\" stroke-width=\"1\" /><rect fill=\"white\" height=\"13\" rx=\"2\" ry=\"2\" stroke=\"#8c35cd\" stroke-width=\"1\" transform=\"rotate(44.56263608907844 288.5 1419.0)\" width=\"35.22222222222222\" x=\"270.8888888888889\" y=\"1412.5\" /><text fill=\"#8c35cd\" font-family=\"courier\" font-size=\"12\" transform=\"rotate(44.56263608907844 288.5 1419.0)\" x=\"273.8888888888889\" y=\"1422.5\">TeRP</text><polyline fill=\"none\" points=\"124.0,1455.0 124.72448979591834,1454.3367346938774 125.44897959183673,1453.6734693877547 126.17346938775512,1453.0102040816328 126.89795918367346,1452.3469387755104 127.62244897959185,1451.6836734693877 128.34693877551018,1451.0204081632653 129.07142857142858,1450.3571428571433 129.79591836734693,1449.6938775510207 130.5204081632653,1449.0306122448983 131.24489795918367,1448.3673469387754 131.96938775510202,1447.704081632653 132.6938775510204,1447.0408163265304 133.41836734693877,1446.3775510204082 134.14285714285714,1445.7142857142858 134.86734693877554,1445.0510204081634 135.59183673469389,1444.387755102041 136.31632653061226,1443.7244897959185 137.0408163265306,1443.0612244897961 137.76530612244898,1442.3979591836735 138.48979591836735,1441.7346938775509 139.2142857142857,1441.0714285714284 139.9387755102041,1440.4081632653063 140.66326530612244,1439.7448979591836 141.38775510204084,1439.0816326530614 142.1122448979592,1438.4183673469388 142.83673469387756,1437.7551020408164 143.56122448979593,1437.091836734694 144.2857142857143,1436.4285714285718 145.01020408163265,1435.7653061224491 145.73469387755102,1435.1020408163265 146.45918367346943,1434.4387755102043 147.18367346938774,1433.7755102040815 147.90816326530614,1433.1122448979593 148.63265306122452,1432.4489795918366 149.35714285714286,1431.7857142857142 150.08163265306123,1431.1224489795918 150.80612244897958,1430.4591836734694 151.53061224489795,1429.795918367347 152.25510204081633,1429.1326530612246 152.9795918367347,1428.4693877551022 153.70408163265307,1427.8061224489797 154.42857142857144,1427.1428571428573 155.1530612244898,1426.4795918367347 155.87755102040816,1425.816326530612 156.60204081632654,1425.1530612244896 157.32653061224488,1424.4897959183672 158.05102040816328,1423.826530612245 158.77551020408163,1423.1632653061224 159.5,1422.5 159.5,1422.5 160.22448979591837,1421.8367346938776 160.94897959183672,1421.173469387755 161.67346938775512,1420.5102040816328 162.39795918367346,1419.8469387755104 163.12244897959184,1419.1836734693877 163.84693877551015,1418.520408163265 164.5714285714286,1417.8571428571431 165.29591836734696,1417.1938775510207 166.02040816326533,1416.530612244898 166.74489795918365,1415.8673469387752 167.469387755102,1415.2040816326526 168.19387755102036,1414.5408163265304 168.91836734693874,1413.8775510204082 169.6428571428571,1413.2142857142856 170.3673469387755,1412.5510204081634 171.09183673469389,1411.8877551020407 171.81632653061226,1411.2244897959183 172.5408163265306,1410.561224489796 173.26530612244898,1409.8979591836733 173.98979591836732,1409.2346938775509 174.7142857142857,1408.5714285714284 175.4387755102041,1407.9081632653063 176.16326530612244,1407.2448979591834 176.88775510204079,1406.581632653061 177.6122448979592,1405.9183673469388 178.33673469387753,1405.2551020408162 179.0612244897959,1404.591836734694 179.78571428571428,1403.9285714285716 180.51020408163262,1403.265306122449 181.23469387755102,1402.6020408163265 181.9591836734694,1401.938775510204 182.68367346938774,1401.2755102040815 183.40816326530611,1400.612244897959 184.1326530612245,1399.9489795918366 184.85714285714286,1399.2857142857142 185.5816326530612,1398.6224489795918 186.30612244897958,1397.9591836734694 187.03061224489795,1397.295918367347 187.75510204081633,1396.6326530612243 188.4795918367347,1395.9693877551022 189.20408163265307,1395.3061224489797 189.92857142857142,1394.6428571428573 190.6530612244898,1393.9795918367347 191.37755102040813,1393.3163265306123 192.10204081632654,1392.6530612244896 192.8265306122449,1391.9897959183675 193.55102040816328,1391.326530612245 194.27551020408163,1390.6632653061224 195.0,1390.0\" stroke=\"#8c35cd\" stroke-width=\"1\" /><polyline fill=\"none\" points=\"187.93580361212685,1389.6883442770056 195,1390 194.68834427700563,1397.0641963878732 195,1390\" stroke=\"#8c35cd\" stroke-width=\"1\" /><rect fill=\"white\" height=\"13\" rx=\"2\" ry=\"2\" stroke=\"#8c35cd\" stroke-width=\"1\" transform=\"rotate(-42.47388312857282 158.0 1419.0)\" width=\"35.22222222222222\" x=\"140.38888888888889\" y=\"1412.5\" /><text fill=\"#8c35cd\" font-family=\"courier\" font-size=\"12\" transform=\"rotate(-42.47388312857282 158.0 1419.0)\" x=\"143.38888888888889\" y=\"1422.5\">TeRP</text><polyline fill=\"none\" points=\"449.0,1355.0 446.7755102040816,1353.796079864682 444.5510204081632,1352.593128713376 442.32653061224494,1351.3921155300939 440.10204081632656,1350.1940092988466 437.87755102040825,1348.9997790036464 435.6530612244897,1347.8103936285052 433.42857142857156,1346.6268221574348 431.20408163265313,1345.4500335744463 428.9795918367347,1344.2809968635518 426.7551020408162,1343.1206810087633 424.53061224489795,1341.9700549940924 422.3061224489795,1340.830087803551 420.08163265306126,1339.701748421151 417.85714285714283,1338.586005830904 415.6326530612246,1337.4838290168216 413.4081632653062,1336.3961869629154 411.1836734693878,1335.3240486531975 408.9591836734694,1334.2683830716792 406.7346938775511,1333.2301592023732 404.5102040816326,1332.2103460292903 402.2857142857142,1331.2099125364432 400.06122448979596,1330.229827707843 397.83673469387753,1329.2710605275015 395.6122448979592,1328.3345799794306 393.38775510204084,1327.4213550476418 391.1632653061224,1326.5323547161472 388.9387755102041,1325.6685479689586 386.7142857142858,1324.8309037900879 384.4897959183674,1324.0203911635458 382.265306122449,1323.2379790733453 380.0408163265307,1322.4846365034978 377.81632653061223,1321.7613324380147 375.5918367346939,1321.0690358609083 373.36734693877554,1320.40871575619 371.14285714285717,1319.7813411078719 368.9183673469388,1319.1878808999652 366.6938775510204,1318.6293041164822 364.46938775510205,1318.1065797414344 362.24489795918373,1317.6206767588335 360.02040816326536,1317.1725641526914 357.795918367347,1316.76321090702 355.5714285714286,1316.393586005831 353.34693877551024,1316.0646584331357 351.1224489795918,1315.7773971729466 348.8979591836735,1315.532771209275 346.6734693877551,1315.3317495261329 344.44897959183675,1315.1753011075316 342.2244897959184,1315.0643949374835 340.0,1315.0 340.0,1315.0 337.77551020408157,1314.9827622844223 335.55102040816325,1315.012035801409 333.32653061224494,1315.0868515669492 331.10204081632656,1315.2062405970303 328.87755102040813,1315.3692339076406 326.65306122448976,1315.5748625147685 324.42857142857156,1315.8221574344027 322.2040816326531,1316.1101496825304 319.97959183673464,1316.4378702751405 317.7551020408162,1316.804350228221 315.5306122448979,1317.2086205577602 313.3061224489795,1317.649712279747 311.0816326530612,1318.126656410169 308.85714285714283,1318.6384839650145 306.6326530612245,1319.1842259602718 304.40816326530614,1319.7629134119288 302.18367346938777,1320.373577335974 299.95918367346934,1321.0152487483956 297.73469387755097,1321.6869586651821 295.5102040816326,1322.3877381023212 293.2857142857143,1323.1166180758016 291.06122448979596,1323.8726296016116 288.83673469387753,1324.654803695739 286.61224489795916,1325.4621713741722 284.3877551020408,1326.2937636528998 282.1632653061224,1327.1486115479092 279.9387755102041,1328.0257460751895 277.7142857142857,1328.9241982507288 275.48979591836735,1329.8429990905147 273.265306122449,1330.7811796105364 271.04081632653066,1331.7377708267813 268.81632653061223,1332.7118037552377 266.59183673469386,1333.7023094118945 264.3673469387755,1334.7083188127394 262.14285714285717,1335.728862973761 259.9183673469388,1336.762972910947 257.69387755102036,1337.809679640286 255.46938775510205,1338.868014177766 253.24489795918367,1339.9370075393754 251.0204081632653,1341.0156907411028 248.79591836734693,1342.1030947989357 246.57142857142856,1343.198250728863 244.34693877551018,1344.3001895468724 242.12244897959184,1345.4079422689524 239.8979591836735,1346.5205399110914 237.67346938775512,1347.6370134892775 235.44897959183675,1348.7563940194987 233.22448979591837,1349.8777125177435 231.0,1351.0\" stroke=\"#8c35cd\" stroke-width=\"1\" /><polyline fill=\"none\" points=\"237.55064736128753,1353.6625211855555 231,1351 233.6625211855556,1344.4493526387125 231,1351\" stroke=\"#8c35cd\" stroke-width=\"1\" /><rect fill=\"white\" height=\"13\" rx=\"2\" ry=\"2\" stroke=\"#8c35cd\" stroke-width=\"1\" transform=\"rotate(0 338.5 1316.5)\" width=\"35.22222222222222\" x=\"320.8888888888889\" y=\"1310\" /><text fill=\"#8c35cd\" font-family=\"courier\" font-size=\"12\" transform=\"rotate(0 338.5 1316.5)\" x=\"323.8888888888889\" y=\"1320\">TeRP</text><polyline fill=\"none\" points=\"245.0,255.0 245.94897959183675,254.33673469387753 246.8979591836734,253.67346938775506 247.84693877551024,253.0102040816327 248.79591836734693,252.3469387755102 249.74489795918367,251.68367346938777 250.6938775510204,251.02040816326527 251.6428571428572,250.35714285714292 252.5918367346939,249.69387755102048 253.54081632653063,249.03061224489795 254.4897959183673,248.36734693877548 255.43877551020404,247.70408163265301 256.3877551020408,247.04081632653057 257.33673469387753,246.37755102040813 258.2857142857143,245.71428571428572 259.2346938775511,245.0510204081633 260.18367346938777,244.38775510204087 261.1326530612245,243.7244897959184 262.0816326530612,243.0612244897959 263.03061224489795,242.3979591836735 263.97959183673464,241.734693877551 264.92857142857144,241.07142857142856 265.8775510204082,240.40816326530614 266.8265306122449,239.74489795918367 267.7755102040816,239.08163265306123 268.7244897959184,238.41836734693877 269.67346938775506,237.75510204081633 270.6224489795918,237.0918367346939 271.57142857142856,236.42857142857144 272.5204081632653,235.76530612244898 273.46938775510205,235.10204081632654 274.4183673469388,234.43877551020412 275.3673469387755,233.77551020408163 276.31632653061223,233.11224489795916 277.265306122449,232.44897959183675 278.2142857142857,231.7857142857143 279.1632653061224,231.12244897959184 280.11224489795916,230.4591836734694 281.0612244897959,229.79591836734696 282.01020408163265,229.13265306122452 282.9591836734694,228.46938775510205 283.90816326530614,227.80612244897958 284.8571428571429,227.14285714285717 285.8061224489796,226.4795918367347 286.7551020408163,225.81632653061223 287.7040816326531,225.15306122448982 288.6530612244898,224.48979591836735 289.6020408163265,223.8265306122449 290.55102040816325,223.16326530612244 291.5,222.5 291.5,222.5 292.4489795918367,221.83673469387753 293.3979591836734,221.17346938775506 294.34693877551024,220.51020408163268 295.2959183673469,219.84693877551018 296.2448979591836,219.18367346938777 297.19387755102036,218.52040816326527 298.1428571428572,217.85714285714292 299.0918367346939,217.19387755102045 300.0408163265307,216.53061224489798 300.98979591836735,215.86734693877548 301.938775510204,215.20408163265301 302.8877551020408,214.54081632653055 303.83673469387753,213.87755102040816 304.7857142857143,213.21428571428572 305.7346938775511,212.55102040816328 306.68367346938777,211.8877551020408 307.6326530612245,211.22448979591837 308.5816326530612,210.5612244897959 309.53061224489795,209.89795918367346 310.47959183673464,209.23469387755094 311.4285714285714,208.57142857142853 312.3775510204082,207.90816326530611 313.3265306122448,207.24489795918365 314.2755102040816,206.58163265306123 315.2244897959184,205.91836734693874 316.17346938775506,205.25510204081633 317.12244897959187,204.59183673469386 318.0714285714286,203.92857142857144 319.0204081632653,203.26530612244898 319.96938775510205,202.6020408163265 320.9183673469388,201.93877551020407 321.8673469387755,201.27551020408163 322.81632653061223,200.6122448979592 323.765306122449,199.94897959183672 324.71428571428567,199.2857142857143 325.66326530612247,198.62244897959184 326.61224489795916,197.9591836734694 327.5612244897959,197.29591836734693 328.51020408163265,196.6326530612245 329.4591836734694,195.96938775510205 330.40816326530614,195.30612244897958 331.3571428571429,194.64285714285717 332.3061224489796,193.9795918367347 333.25510204081627,193.31632653061223 334.204081632653,192.65306122448982 335.15306122448976,191.98979591836735 336.1020408163265,191.32653061224488 337.05102040816325,190.66326530612247 338.0,190.0\" stroke=\"#8c35cd\" stroke-width=\"1\" /><polyline fill=\"none\" points=\"331.0374177513621,188.76612466479833 338,190 336.7661246647983,196.9625822486379 338,190\" stroke=\"#8c35cd\" stroke-width=\"1\" /><rect fill=\"white\" height=\"13\" rx=\"2\" ry=\"2\" stroke=\"#8c35cd\" stroke-width=\"1\" transform=\"rotate(-34.9506514408034 290.0 219.0)\" width=\"35.22222222222222\" x=\"272.3888888888889\" y=\"212.5\" /><text fill=\"#8c35cd\" font-family=\"courier\" font-size=\"12\" transform=\"rotate(-34.9506514408034 290.0 219.0)\" x=\"275.3888888888889\" y=\"222.5\">TeRP</text><polyline fill=\"none\" points=\"371.0,155.0 368.03061224489795,153.7960798646822 365.0612244897959,152.59312871337622 362.0918367346939,151.39211553009378 359.12244897959175,150.19400929884657 356.15306122448976,148.99977900364644 353.1836734693877,147.81039362850512 350.2142857142858,146.62682215743445 347.24489795918373,145.45003357444605 344.2755102040817,144.28099686355176 341.3061224489796,143.12068100876337 338.33673469387753,141.97005499409258 335.3673469387754,140.83008780355124 332.39795918367344,139.70174842115105 329.42857142857144,138.5860058309038 326.4591836734695,137.48382901682123 323.48979591836735,136.39618696291512 320.52040816326536,135.32404865319725 317.5510204081633,134.2683830716793 314.5816326530612,133.23015920237316 311.61224489795916,132.2103460292905 308.64285714285705,131.20991253644314 305.6734693877551,130.22982770784282 302.704081632653,129.2710605275013 299.734693877551,128.33457997943034 296.765306122449,127.42135504764173 293.7959183673469,126.53235471614718 290.8265306122449,125.6685479689585 287.8571428571429,124.83090379008749 284.88775510204084,124.02039116354581 281.9183673469388,123.2379790733453 278.94897959183675,122.48463650349771 275.9795918367347,121.76133243801479 273.01020408163265,121.06903586090831 270.0408163265306,120.40871575619002 267.07142857142856,119.78134110787173 264.10204081632656,119.18788089996517 261.1326530612245,118.62930411648207 258.16326530612247,118.10657974143427 255.19387755102042,117.62067675883348 252.22448979591837,117.17256415269148 249.25510204081633,116.76321090702004 246.2857142857143,116.39358600583091 243.31632653061223,116.06465843313586 240.3469387755102,115.77739717294665 237.3775510204082,115.53277120927505 234.40816326530614,115.33174952613282 231.4387755102041,115.17530110753174 228.46938775510202,115.06439493748353 225.5,115.0 225.5,115.0 222.53061224489792,114.9827622844223 219.56122448979588,115.01203580140927 216.59183673469389,115.08685156694916 213.62244897959187,115.20624059703015 210.6530612244898,115.36923390764053 207.68367346938774,115.57486251476851 204.71428571428578,115.82215743440234 201.7448979591837,116.11014968253025 198.77551020408166,116.43787027514047 195.80612244897955,116.80435022822121 192.8367346938775,117.20862055776078 189.86734693877546,117.64971227974738 186.89795918367346,118.12665641016923 183.92857142857147,118.63848396501459 180.95918367346943,119.18422596027166 177.98979591836738,119.7629134119287 175.02040816326533,120.37357733597398 172.05102040816328,121.01524874839565 169.0816326530612,121.68695866518203 166.11224489795916,122.3877381023213 163.1428571428571,123.11661807580174 160.1734693877551,123.87262960161156 157.20408163265307,124.654803695739 154.23469387755102,125.46217137417233 151.26530612244898,126.29376365289971 148.29591836734696,127.14861154790944 145.3265306122449,128.02574607518974 142.3571428571429,128.92419825072886 139.38775510204084,129.842999090515 136.4183673469388,130.7811796105364 133.44897959183675,131.73777082678137 130.4795918367347,132.71180375523804 127.51020408163265,133.7023094118947 124.5408163265306,134.7083188127396 121.57142857142858,135.72886297376095 118.60204081632654,136.76297291094698 115.6326530612245,137.80967964028594 112.66326530612245,138.86801417776604 109.69387755102042,139.9370075393756 106.72448979591839,141.01569074110276 103.75510204081634,142.1030947989358 100.7857142857143,143.19825072886297 97.81632653061224,144.30018954687245 94.84693877551021,145.40794226895255 91.87755102040818,146.52053991109145 88.90816326530614,147.63701348927742 85.93877551020408,148.75639401949866 82.96938775510203,149.87771251774345 80.0,151.0\" stroke=\"#0398da\" stroke-width=\"1\" /><polyline fill=\"none\" points=\"86.27464275609455,154.26019297248777 80,151 83.26019297248777,144.72535724390545 80,151\" stroke=\"#0398da\" stroke-width=\"1\" /><rect fill=\"white\" height=\"13\" rx=\"2\" ry=\"2\" stroke=\"#0398da\" stroke-width=\"1\" transform=\"rotate(0 224.0 116.5)\" width=\"35.22222222222222\" x=\"206.38888888888889\" y=\"110\" /><text fill=\"#0398da\" font-family=\"courier\" font-size=\"12\" transform=\"rotate(0 224.0 116.5)\" x=\"209.38888888888889\" y=\"120\">TrWP</text><polyline fill=\"none\" points=\"537.0,1655.0 539.4795918367346,1654.3367346938776 541.9591836734693,1653.6734693877545 544.438775510204,1653.010204081633 546.9183673469387,1652.3469387755101 549.3979591836735,1651.6836734693875 551.8775510204081,1651.0204081632653 554.3571428571429,1650.3571428571436 556.8367346938777,1649.6938775510207 559.3163265306123,1649.030612244898 561.7959183673469,1648.3673469387752 564.2755102040816,1647.7040816326528 566.7551020408163,1647.0408163265304 569.2346938775509,1646.3775510204082 571.7142857142858,1645.7142857142858 574.1938775510205,1645.0510204081634 576.6734693877552,1644.387755102041 579.1530612244899,1643.7244897959188 581.6326530612245,1643.061224489796 584.1122448979592,1642.3979591836733 586.5918367346937,1641.734693877551 589.0714285714284,1641.0714285714287 591.5510204081633,1640.4081632653063 594.030612244898,1639.7448979591838 596.5102040816327,1639.0816326530612 598.9897959183673,1638.4183673469388 601.4693877551019,1637.7551020408162 603.9489795918367,1637.091836734694 606.4285714285714,1636.4285714285716 608.9081632653061,1635.7653061224491 611.3877551020407,1635.1020408163265 613.8673469387755,1634.4387755102043 616.3469387755101,1633.7755102040815 618.8265306122448,1633.1122448979593 621.3061224489795,1632.4489795918369 623.7857142857142,1631.7857142857147 626.2653061224489,1631.1224489795918 628.7448979591836,1630.4591836734694 631.2244897959183,1629.795918367347 633.704081632653,1629.1326530612246 636.1836734693877,1628.4693877551022 638.6632653061224,1627.8061224489797 641.1428571428571,1627.1428571428573 643.6224489795918,1626.4795918367345 646.1020408163265,1625.816326530612 648.5816326530612,1625.1530612244899 651.0612244897959,1624.4897959183675 653.5408163265306,1623.8265306122448 656.0204081632653,1623.1632653061224 658.5,1622.5 658.5,1622.5 660.9795918367347,1621.8367346938774 663.4591836734692,1621.1734693877547 665.9387755102041,1620.5102040816328 668.4183673469388,1619.8469387755104 670.8979591836735,1619.1836734693877 673.377551020408,1618.5204081632648 675.857142857143,1617.8571428571433 678.3367346938776,1617.1938775510203 680.8163265306123,1616.5306122448978 683.2959183673469,1615.8673469387754 685.7755102040817,1615.2040816326526 688.2551020408162,1614.5408163265304 690.734693877551,1613.8775510204082 693.2142857142857,1613.2142857142858 695.6938775510205,1612.5510204081634 698.1734693877552,1611.887755102041 700.6530612244899,1611.2244897959188 703.1326530612245,1610.5612244897957 705.6122448979593,1609.8979591836733 708.0918367346937,1609.2346938775506 710.5714285714286,1608.5714285714282 713.0510204081634,1607.908163265306 715.5306122448978,1607.2448979591834 718.0102040816328,1606.5816326530612 720.4897959183673,1605.9183673469386 722.9693877551019,1605.2551020408164 725.4489795918367,1604.591836734694 727.9285714285716,1603.9285714285716 730.4081632653061,1603.265306122449 732.8877551020407,1602.6020408163267 735.3673469387754,1601.938775510204 737.8469387755101,1601.2755102040815 740.3265306122448,1600.612244897959 742.8061224489795,1599.9489795918366 745.2857142857143,1599.2857142857142 747.7653061224489,1598.6224489795918 750.2448979591836,1597.9591836734694 752.7244897959183,1597.295918367347 755.204081632653,1596.6326530612246 757.6836734693877,1595.9693877551022 760.1632653061224,1595.3061224489795 762.6428571428571,1594.6428571428573 765.1224489795918,1593.9795918367345 767.6020408163265,1593.316326530612 770.0816326530612,1592.6530612244896 772.5612244897959,1591.9897959183675 775.0408163265306,1591.3265306122448 777.5204081632653,1590.6632653061224 780.0,1590.0\" stroke=\"#8c35cd\" stroke-width=\"1\" /><polyline fill=\"none\" points=\"773.8777920697321,1586.4618408714687 780,1590 776.4618408714687,1596.122207930268 780,1590\" stroke=\"#8c35cd\" stroke-width=\"1\" /><rect fill=\"white\" height=\"13\" rx=\"2\" ry=\"2\" stroke=\"#8c35cd\" stroke-width=\"1\" transform=\"rotate(-14.975434419547927 657.0 1619.0)\" width=\"35.22222222222222\" x=\"639.3888888888889\" y=\"1612.5\" /><text fill=\"#8c35cd\" font-family=\"courier\" font-size=\"12\" transform=\"rotate(-14.975434419547927 657.0 1619.0)\" x=\"642.3888888888889\" y=\"1622.5\">TeRP</text><polyline fill=\"none\" points=\"124.0,1455.0 127.05102040816325,1454.3367346938774 130.1020408163265,1453.6734693877547 133.15306122448982,1453.0102040816328 136.20408163265304,1452.3469387755104 139.25510204081633,1451.6836734693877 142.30612244897958,1451.0204081632653 145.3571428571429,1450.3571428571433 148.40816326530614,1449.6938775510207 151.4591836734694,1449.0306122448983 154.51020408163265,1448.3673469387754 157.56122448979588,1447.704081632653 160.61224489795916,1447.0408163265304 163.66326530612244,1446.3775510204082 166.71428571428572,1445.7142857142858 169.765306122449,1445.0510204081634 172.81632653061226,1444.387755102041 175.86734693877554,1443.7244897959185 178.91836734693877,1443.0612244897961 181.96938775510205,1442.3979591836735 185.0204081632653,1441.7346938775509 188.07142857142856,1441.0714285714284 191.12244897959184,1440.4081632653063 194.1734693877551,1439.7448979591836 197.2244897959184,1439.0816326530614 200.27551020408163,1438.4183673469388 203.32653061224488,1437.7551020408164 206.37755102040813,1437.091836734694 209.42857142857144,1436.4285714285718 212.4795918367347,1435.7653061224491 215.53061224489795,1435.1020408163265 218.58163265306126,1434.4387755102043 221.6326530612245,1433.7755102040815 224.68367346938774,1433.1122448979593 227.73469387755102,1432.4489795918366 230.7857142857143,1431.7857142857142 233.83673469387756,1431.1224489795918 236.88775510204084,1430.4591836734694 239.9387755102041,1429.795918367347 242.98979591836735,1429.1326530612246 246.0408163265306,1428.4693877551022 249.09183673469386,1427.8061224489797 252.14285714285717,1427.1428571428573 255.19387755102042,1426.4795918367347 258.2448979591836,1425.816326530612 261.2959183673469,1425.1530612244896 264.3469387755102,1424.4897959183672 267.3979591836735,1423.826530612245 270.44897959183675,1423.1632653061224 273.5,1422.5 273.5,1422.5 276.5510204081632,1421.8367346938776 279.60204081632645,1421.173469387755 282.6530612244898,1420.5102040816328 285.704081632653,1419.8469387755104 288.7551020408163,1419.1836734693877 291.8061224489796,1418.520408163265 294.8571428571429,1417.8571428571431 297.9081632653062,1417.1938775510207 300.9591836734694,1416.530612244898 304.0102040816326,1415.8673469387752 307.06122448979585,1415.2040816326526 310.11224489795916,1414.5408163265304 313.1632653061224,1413.8775510204082 316.2142857142857,1413.2142857142856 319.26530612244903,1412.5510204081634 322.3163265306123,1411.8877551020407 325.36734693877554,1411.2244897959183 328.41836734693874,1410.561224489796 331.469387755102,1409.8979591836733 334.5204081632652,1409.2346938775509 337.57142857142856,1408.5714285714284 340.6224489795918,1407.9081632653063 343.673469387755,1407.2448979591834 346.7244897959183,1406.581632653061 349.7755102040816,1405.9183673469388 352.8265306122449,1405.2551020408162 355.87755102040813,1404.591836734694 358.92857142857144,1403.9285714285716 361.9795918367347,1403.265306122449 365.03061224489795,1402.6020408163265 368.08163265306126,1401.938775510204 371.13265306122446,1401.2755102040815 374.1836734693877,1400.612244897959 377.23469387755097,1399.9489795918366 380.2857142857142,1399.2857142857142 383.33673469387753,1398.6224489795918 386.3877551020408,1397.9591836734694 389.4387755102041,1397.295918367347 392.48979591836735,1396.6326530612243 395.5408163265306,1395.9693877551022 398.59183673469386,1395.3061224489797 401.64285714285717,1394.6428571428573 404.69387755102036,1393.9795918367347 407.7448979591836,1393.3163265306123 410.7959183673469,1392.6530612244896 413.84693877551024,1391.9897959183675 416.89795918367344,1391.326530612245 419.94897959183675,1390.6632653061224 423.0,1390.0\" stroke=\"#0398da\" stroke-width=\"1\" /><polyline fill=\"none\" points=\"417.05196996067474,1386.1762664032908 423,1390 419.17626640329075,1395.9480300393252 423,1390\" stroke=\"#0398da\" stroke-width=\"1\" /><rect fill=\"white\" height=\"13\" rx=\"2\" ry=\"2\" stroke=\"#0398da\" stroke-width=\"1\" transform=\"rotate(-12.264773731870172 272.0 1419.0)\" width=\"35.22222222222222\" x=\"254.3888888888889\" y=\"1412.5\" /><text fill=\"#0398da\" font-family=\"courier\" font-size=\"12\" transform=\"rotate(-12.264773731870172 272.0 1419.0)\" x=\"257.3888888888889\" y=\"1422.5\">TrWP</text><polyline fill=\"none\" points=\"367.0,1655.0 371.21428571428567,1654.3367346938776 375.4285714285714,1653.6734693877545 379.6428571428572,1653.010204081633 383.8571428571429,1652.3469387755101 388.07142857142856,1651.6836734693875 392.2857142857143,1651.0204081632653 396.5000000000001,1650.3571428571436 400.7142857142858,1649.6938775510207 404.92857142857144,1649.030612244898 409.1428571428571,1648.3673469387752 413.35714285714283,1647.7040816326528 417.57142857142856,1647.0408163265304 421.78571428571433,1646.3775510204082 426.00000000000006,1645.7142857142858 430.2142857142857,1645.0510204081634 434.42857142857144,1644.387755102041 438.64285714285717,1643.7244897959188 442.8571428571429,1643.061224489796 447.07142857142856,1642.3979591836733 451.2857142857142,1641.734693877551 455.5,1641.0714285714287 459.7142857142857,1640.4081632653063 463.92857142857144,1639.7448979591838 468.1428571428572,1639.0816326530612 472.3571428571429,1638.4183673469388 476.57142857142856,1637.7551020408162 480.78571428571433,1637.091836734694 485.00000000000006,1636.4285714285716 489.2142857142858,1635.7653061224491 493.42857142857144,1635.1020408163265 497.6428571428572,1634.4387755102043 501.8571428571429,1633.7755102040815 506.07142857142856,1633.1122448979593 510.28571428571433,1632.4489795918369 514.5,1631.7857142857147 518.7142857142858,1631.1224489795918 522.9285714285714,1630.4591836734694 527.1428571428571,1629.795918367347 531.3571428571429,1629.1326530612246 535.5714285714287,1628.4693877551022 539.7857142857143,1627.8061224489797 544.0,1627.1428571428573 548.2142857142858,1626.4795918367345 552.4285714285714,1625.816326530612 556.6428571428571,1625.1530612244899 560.8571428571429,1624.4897959183675 565.0714285714286,1623.8265306122448 569.2857142857142,1623.1632653061224 573.5,1622.5 573.5,1622.5 577.7142857142857,1621.8367346938774 581.9285714285713,1621.1734693877547 586.1428571428571,1620.5102040816328 590.3571428571428,1619.8469387755104 594.5714285714286,1619.1836734693877 598.7857142857141,1618.5204081632648 603.0000000000002,1617.8571428571433 607.2142857142858,1617.1938775510203 611.4285714285714,1616.5306122448978 615.6428571428571,1615.8673469387754 619.8571428571427,1615.2040816326526 624.0714285714284,1614.5408163265304 628.2857142857142,1613.8775510204082 632.5,1613.2142857142858 636.7142857142858,1612.5510204081634 640.9285714285714,1611.887755102041 645.1428571428571,1611.2244897959188 649.3571428571428,1610.5612244897957 653.5714285714286,1609.8979591836733 657.7857142857142,1609.2346938775506 661.9999999999999,1608.5714285714282 666.2142857142858,1607.908163265306 670.4285714285713,1607.2448979591834 674.6428571428571,1606.5816326530612 678.8571428571428,1605.9183673469386 683.0714285714284,1605.2551020408164 687.2857142857142,1604.591836734694 691.5,1603.9285714285716 695.7142857142857,1603.265306122449 699.9285714285713,1602.6020408163267 704.1428571428571,1601.938775510204 708.3571428571428,1601.2755102040815 712.5714285714286,1600.612244897959 716.7857142857142,1599.9489795918366 721.0,1599.2857142857142 725.2142857142857,1598.6224489795918 729.4285714285714,1597.9591836734694 733.6428571428571,1597.295918367347 737.8571428571429,1596.6326530612246 742.0714285714286,1595.9693877551022 746.2857142857142,1595.3061224489795 750.5,1594.6428571428573 754.7142857142858,1593.9795918367345 758.9285714285713,1593.316326530612 763.1428571428571,1592.6530612244896 767.3571428571429,1591.9897959183675 771.5714285714287,1591.3265306122448 775.7857142857143,1590.6632653061224 780.0,1590.0\" stroke=\"#8c35cd\" stroke-width=\"1\" /><polyline fill=\"none\" points=\"774.2834416550987,1585.8381541756785 780,1590 775.8381541756786,1595.7165583449014 780,1590\" stroke=\"#8c35cd\" stroke-width=\"1\" /><rect fill=\"white\" height=\"13\" rx=\"2\" ry=\"2\" stroke=\"#8c35cd\" stroke-width=\"1\" transform=\"rotate(-8.944128345558154 572.0 1619.0)\" width=\"35.22222222222222\" x=\"554.3888888888889\" y=\"1612.5\" /><text fill=\"#8c35cd\" font-family=\"courier\" font-size=\"12\" transform=\"rotate(-8.944128345558154 572.0 1619.0)\" x=\"557.3888888888889\" y=\"1622.5\">TeRP</text><polyline fill=\"none\" points=\"813.0,1555.0 806.2142857142857,1553.7960798646823 799.4285714285713,1552.593128713376 792.6428571428572,1551.3921155300939 785.8571428571429,1550.1940092988466 779.0714285714287,1548.9997790036466 772.2857142857142,1547.810393628505 765.5000000000001,1546.6268221574346 758.7142857142859,1545.4500335744465 751.9285714285716,1544.280996863552 745.1428571428571,1543.120681008763 738.3571428571429,1541.9700549940926 731.5714285714286,1540.8300878035511 724.7857142857142,1539.701748421151 718.0,1538.5860058309038 711.214285714286,1537.4838290168213 704.4285714285716,1536.3961869629154 697.6428571428572,1535.3240486531975 690.8571428571429,1534.2683830716792 684.0714285714287,1533.2301592023734 677.2857142857142,1532.2103460292903 670.5,1531.209912536443 663.7142857142858,1530.229827707843 656.9285714285714,1529.2710605275013 650.1428571428572,1528.3345799794304 643.357142857143,1527.4213550476416 636.5714285714287,1526.5323547161472 629.7857142857143,1525.6685479689586 623.0000000000001,1524.8309037900876 616.2142857142858,1524.0203911635458 609.4285714285714,1523.2379790733453 602.6428571428572,1522.484636503498 595.8571428571429,1521.7613324380147 589.0714285714287,1521.0690358609083 582.2857142857144,1520.40871575619 575.5000000000001,1519.7813411078719 568.7142857142858,1519.1878808999654 561.9285714285714,1518.6293041164822 555.1428571428572,1518.1065797414344 548.3571428571429,1517.6206767588337 541.5714285714287,1517.1725641526916 534.7857142857143,1516.76321090702 528.0,1516.393586005831 521.2142857142858,1516.0646584331357 514.4285714285714,1515.7773971729466 507.6428571428572,1515.5327712092749 500.8571428571429,1515.3317495261329 494.0714285714286,1515.1753011075316 487.2857142857143,1515.0643949374835 480.5,1515.0 480.5,1515.0 473.7142857142857,1514.9827622844223 466.92857142857133,1515.012035801409 460.14285714285717,1515.0868515669492 453.3571428571429,1515.2062405970303 446.57142857142856,1515.3692339076404 439.7857142857142,1515.5748625147685 433.0000000000001,1515.822157434403 426.2142857142857,1516.1101496825304 419.4285714285714,1516.4378702751405 412.6428571428571,1516.804350228221 405.85714285714283,1517.2086205577605 399.0714285714285,1517.649712279747 392.2857142857143,1518.126656410169 385.5,1518.6384839650143 378.7142857142858,1519.184225960272 371.9285714285715,1519.7629134119288 365.14285714285717,1520.373577335974 358.3571428571429,1521.0152487483956 351.57142857142856,1521.686958665182 344.78571428571416,1522.387738102321 337.99999999999994,1523.1166180758016 331.2142857142857,1523.8726296016116 324.4285714285714,1524.654803695739 317.6428571428571,1525.4621713741722 310.85714285714283,1526.2937636528998 304.07142857142856,1527.1486115479092 297.28571428571433,1528.0257460751895 290.5,1528.9241982507288 283.7142857142857,1529.8429990905147 276.9285714285715,1530.7811796105364 270.14285714285717,1531.7377708267813 263.35714285714283,1532.7118037552382 256.57142857142856,1533.7023094118945 249.78571428571428,1534.7083188127394 243.0,1535.728862973761 236.21428571428572,1536.7629729109467 229.42857142857144,1537.809679640286 222.64285714285717,1538.8680141777659 215.8571428571429,1539.9370075393756 209.0714285714286,1541.0156907411028 202.2857142857143,1542.1030947989357 195.5,1543.198250728863 188.71428571428572,1544.3001895468724 181.92857142857144,1545.4079422689524 175.14285714285717,1546.5205399110914 168.35714285714286,1547.6370134892775 161.57142857142858,1548.7563940194987 154.78571428571428,1549.8777125177435 148.0,1551.0\" stroke=\"#8c35cd\" stroke-width=\"1\" /><polyline fill=\"none\" points=\"153.63803028702657,1555.2676239821217 148,1551 152.26762398212165,1545.3619697129734 148,1551\" stroke=\"#8c35cd\" stroke-width=\"1\" /><rect fill=\"white\" height=\"13\" rx=\"2\" ry=\"2\" stroke=\"#8c35cd\" stroke-width=\"1\" transform=\"rotate(0 479.0 1516.5)\" width=\"35.22222222222222\" x=\"461.3888888888889\" y=\"1510\" /><text fill=\"#8c35cd\" font-family=\"courier\" font-size=\"12\" transform=\"rotate(0 479.0 1516.5)\" x=\"464.3888888888889\" y=\"1520\">TeRP</text></svg>","textData":null,"removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"htmlSandbox","arguments":{}}},"output_type":"display_data","data":{"text/html":["<svg baseProfile=\"full\" height=\"1775\" version=\"1.1\" width=\"1000\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:ev=\"http://www.w3.org/2001/xml-events\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"><defs><style type=\"text/css\"><![CDATA[@font-face{ \n    font-family: \"Lucida\"; \n    src: url(\"data:application/x-font-ttf;charset=utf-8;base64,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\"); \n}\n]]></style></defs><rect fill=\"#800080\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#800080\" stroke-width=\"1\" width=\"130.79999999999998\" x=\"7\" y=\"157\" /><rect fill=\"#8b6673\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#8b6673\" stroke-width=\"1\" width=\"198.7\" x=\"274.5\" y=\"157\" /><rect fill=\"#8b6673\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#8b6673\" stroke-width=\"1\" width=\"72.6\" x=\"201.3\" y=\"257\" /><rect fill=\"#8b6673\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#8b6673\" stroke-width=\"1\" width=\"392.7\" x=\"7\" y=\"357\" /><rect fill=\"#8b6673\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#8b6673\" stroke-width=\"1\" width=\"557.5999999999999\" x=\"7\" y=\"457\" /><rect fill=\"#800080\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#800080\" stroke-width=\"1\" width=\"169.6\" x=\"138.39999999999998\" y=\"1357\" /><rect fill=\"#800080\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#800080\" stroke-width=\"1\" width=\"159.89999999999998\" x=\"371.8\" y=\"1357\" /><rect fill=\"#8b6673\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#8b6673\" stroke-width=\"1\" width=\"218.1\" x=\"7\" y=\"1457\" /><rect fill=\"#8b6673\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#8b6673\" stroke-width=\"1\" width=\"92.0\" x=\"279.2\" y=\"1457\" /><rect fill=\"#8b6673\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#8b6673\" stroke-width=\"1\" width=\"266.59999999999997\" x=\"7\" y=\"1557\" /><rect fill=\"#8b6673\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#8b6673\" stroke-width=\"1\" width=\"218.1\" x=\"706.8999999999999\" y=\"1557\" /><rect fill=\"#8b6673\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#8b6673\" stroke-width=\"1\" width=\"140.5\" x=\"288.9\" y=\"1657\" /><rect fill=\"#8b6673\" fill-opacity=\"0.2\" height=\"25\" rx=\"2\" ry=\"2\" stroke=\"#8b6673\" stroke-width=\"1\" width=\"72.6\" x=\"493.2\" y=\"1657\" /><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"75\">BACKGROUND:</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"131.39999999999998\" y=\"75\">At</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"165.49999999999997\" y=\"75\">present,</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"257.79999999999995\" y=\"75\">it</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"291.9\" y=\"75\">is</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"326.0\" y=\"75\">one</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"369.8\" y=\"75\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"403.9\" y=\"75\">the</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"447.7\" y=\"75\">most</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"501.2\" y=\"75\">important</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"603.2\" y=\"75\">issues</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"676.1\" y=\"75\">for</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"719.9\" y=\"75\">the</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"763.6999999999999\" y=\"75\">treatment</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"865.6999999999999\" y=\"75\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"175\">breast cancer</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"48.99999999999999\" y=\"195\">PROBLEM</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"160.79999999999998\" y=\"175\">to</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"194.89999999999998\" y=\"175\">develop</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"277.5\" y=\"175\">the standard therapy</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"343.3954545454546\" y=\"195\">TREATMENT</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"496.2\" y=\"175\">for</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"540.0\" y=\"175\">patients</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"632.3\" y=\"175\">previously</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"744.0\" y=\"175\">treated</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"826.6\" y=\"175\">with</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"275\">anthracyclines</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"160.5\" y=\"275\">and</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"204.3\" y=\"275\">taxanes</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"207.14545454545458\" y=\"295\">TREATMENT</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"296.9\" y=\"275\">.</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"321.29999999999995\" y=\"275\">With</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"374.79999999999995\" y=\"275\">the</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"418.59999999999997\" y=\"275\">objective</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"520.5999999999999\" y=\"275\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"554.6999999999999\" y=\"275\">determining</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"375\">the usefulnessof vinorelbine monotherapy</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"172.89545454545453\" y=\"395\">TREATMENT</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"422.7\" y=\"375\">in</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"456.79999999999995\" y=\"375\">patients</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"549.0999999999999\" y=\"375\">with</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"475\">advanced or recurrent breast cancerafter standard therapy</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"255.34545454545452\" y=\"495\">TREATMENT</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"587.5999999999999\" y=\"475\">,</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"611.9999999999999\" y=\"475\">we</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"646.0999999999999\" y=\"475\">evaluated</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"748.0999999999999\" y=\"475\">the</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"791.8999999999999\" y=\"475\">efficacy</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"884.1999999999998\" y=\"475\">and</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"575\">safety</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"82.89999999999999\" y=\"575\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"116.99999999999999\" y=\"575\">vinorelbine</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"238.39999999999998\" y=\"575\">inpatients</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"350.09999999999997\" y=\"575\">previously</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"461.79999999999995\" y=\"575\">treated</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"544.4\" y=\"575\">with</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"597.9\" y=\"575\">anthracyclines</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"748.4\" y=\"575\">and</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"792.1999999999999\" y=\"575\">taxanes.</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"884.4999999999999\" y=\"575\">METHODS:</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"675\">Vinorelbinewas</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"160.5\" y=\"675\">administered</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"291.6\" y=\"675\">at</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"325.70000000000005\" y=\"675\">a</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"350.1\" y=\"675\">dose</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"403.6\" y=\"675\">level</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"466.8\" y=\"675\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"500.9\" y=\"675\">25</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"535.0\" y=\"675\">mg/m(2)</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"617.6\" y=\"675\">intravenously</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"758.4\" y=\"675\">on</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"792.5\" y=\"675\">days</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"846.0\" y=\"675\">1</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"870.4\" y=\"675\">and</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"914.1999999999999\" y=\"675\">8</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"938.5999999999999\" y=\"675\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"775\">a3</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"44.099999999999994\" y=\"775\">week</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"97.6\" y=\"775\">cycle.</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"170.5\" y=\"775\">Patients</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"262.8\" y=\"775\">were</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"316.3\" y=\"775\">given</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"379.5\" y=\"775\">three</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"442.7\" y=\"775\">or</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"476.79999999999995\" y=\"775\">more</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"530.3\" y=\"775\">cycles</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"603.1999999999999\" y=\"775\">in</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"637.3\" y=\"775\">the</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"681.0999999999999\" y=\"775\">absence</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"763.6999999999999\" y=\"775\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"797.8\" y=\"775\">tumorprogression.</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"875\">A</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"34.4\" y=\"875\">maximum</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"117.0\" y=\"875\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"151.1\" y=\"875\">nine</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"204.6\" y=\"875\">cycles</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"277.5\" y=\"875\">were</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"331.0\" y=\"875\">administered.</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"471.79999999999995\" y=\"875\">RESULTS:</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"564.0999999999999\" y=\"875\">The</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"607.8999999999999\" y=\"875\">responserate</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"738.9999999999999\" y=\"875\">in</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"773.0999999999999\" y=\"875\">50</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"807.1999999999999\" y=\"875\">evaluable</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"975\">patients</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"102.3\" y=\"975\">was</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"146.1\" y=\"975\">20.0%</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"209.29999999999998\" y=\"975\">(10</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"253.09999999999997\" y=\"975\">out</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"296.9\" y=\"975\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"331.0\" y=\"975\">50;</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"374.8\" y=\"975\">95%</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"418.6\" y=\"975\">confidence</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"530.3\" y=\"975\">interval,10.0-33.7%).</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"748.6999999999999\" y=\"975\">Responders</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"860.3999999999999\" y=\"975\">plus</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"913.8999999999999\" y=\"975\">those</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"1075\">who</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"53.8\" y=\"1075\">had</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"97.6\" y=\"1075\">minor</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"160.79999999999998\" y=\"1075\">response</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"253.09999999999997\" y=\"1075\">(MR)</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"306.59999999999997\" y=\"1075\">or</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"340.69999999999993\" y=\"1075\">no</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"374.79999999999995\" y=\"1075\">change</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"447.69999999999993\" y=\"1075\">(NC)</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"501.19999999999993\" y=\"1075\">accounted</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"603.1999999999999\" y=\"1075\">for</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"646.9999999999999\" y=\"1075\">58.0%</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"710.1999999999999\" y=\"1075\">[10</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"753.9999999999999\" y=\"1075\">partial</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"836.5999999999999\" y=\"1075\">responses</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"1175\">(PRs)</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"73.19999999999999\" y=\"1175\">+</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"97.6\" y=\"1175\">one</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"141.39999999999998\" y=\"1175\">MR</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"175.49999999999997\" y=\"1175\">+</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"199.89999999999998\" y=\"1175\">18</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"233.99999999999997\" y=\"1175\">NCs</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"277.79999999999995\" y=\"1175\">out</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"321.59999999999997\" y=\"1175\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"355.69999999999993\" y=\"1175\">50].</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"409.19999999999993\" y=\"1175\">TheKaplan-Meier</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"569.3999999999999\" y=\"1175\">estimate</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"661.6999999999998\" y=\"1175\">(50%</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"715.1999999999998\" y=\"1175\">point)</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"788.0999999999998\" y=\"1175\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"822.1999999999998\" y=\"1175\">time</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"875.6999999999998\" y=\"1175\">to</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"1275\">progression</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"131.39999999999998\" y=\"1275\">(TTP)</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"194.59999999999997\" y=\"1275\">was</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"238.39999999999998\" y=\"1275\">115.0</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"301.59999999999997\" y=\"1275\">days.The</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"393.9\" y=\"1275\">response</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"486.2\" y=\"1275\">rate</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"539.7\" y=\"1275\">in</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"573.8000000000001\" y=\"1275\">the</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"617.6\" y=\"1275\">visceral</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"709.9\" y=\"1275\">organs</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"782.8\" y=\"1275\">was</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"826.5999999999999\" y=\"1275\">17.3%</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"889.8\" y=\"1275\">(nine</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"953.0\" y=\"1275\">PRs</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"1375\">out</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"53.8\" y=\"1375\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"87.89999999999999\" y=\"1375\">52).</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"141.39999999999998\" y=\"1375\">Themajor toxicity</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"199.79999999999998\" y=\"1395\">PROBLEM</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"331.0\" y=\"1375\">was</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"374.8\" y=\"1375\">myelosuppression</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"428.35\" y=\"1395\">PROBLEM</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"554.7\" y=\"1375\">,</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"579.1\" y=\"1375\">which</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"642.3000000000001\" y=\"1375\">was</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"686.1\" y=\"1375\">reversible</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"797.8\" y=\"1375\">and</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"841.5999999999999\" y=\"1375\">did</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"885.3999999999999\" y=\"1375\">not</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"1475\">requirediscontinuation</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"85.59545454545454\" y=\"1495\">TREATMENT</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"248.1\" y=\"1475\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"282.2\" y=\"1475\">treatment</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"294.74545454545455\" y=\"1495\">TREATMENT</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"394.2\" y=\"1475\">.</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"418.59999999999997\" y=\"1475\">CONCLUSION:</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"540.0\" y=\"1475\">The</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"583.8\" y=\"1475\">results</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"666.4\" y=\"1475\">of</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"700.5\" y=\"1475\">this</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"754.0\" y=\"1475\">study</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"817.2\" y=\"1475\">show</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"1575\">thatvinorelbine monotherapy</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"109.84545454545453\" y=\"1595\">TREATMENT</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"296.59999999999997\" y=\"1575\">is</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"330.69999999999993\" y=\"1575\">useful</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"403.5999999999999\" y=\"1575\">in</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"437.69999999999993\" y=\"1575\">patients</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"529.9999999999999\" y=\"1575\">with</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"583.4999999999999\" y=\"1575\">advanced</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"675.7999999999998\" y=\"1575\">or</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"709.8999999999999\" y=\"1575\">recurrent breastcancer</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"785.4954545454543\" y=\"1595\">TREATMENT</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"10\" y=\"1675\">previously</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"121.69999999999999\" y=\"1675\">exposed</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"204.29999999999998\" y=\"1675\">to</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"238.39999999999998\" y=\"1675\">both</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"291.9\" y=\"1675\">anthracyclines</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"328.69545454545454\" y=\"1695\">TREATMENT</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"452.4\" y=\"1675\">and</text><text fill=\"#546c74\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"496.2\" y=\"1675\">taxanes</text><text fill=\"#1f77b7\" font-family=\"Lucida\" font-size=\"12\" style=\"font-weight:lighter\" x=\"499.04545454545456\" y=\"1695\">TREATMENT</text><text fill=\"#546c77\" font-family=\"Lucida\" font-size=\"16\" style=\"font-weight:100\" x=\"588.8\" y=\"1675\">.</text><polyline fill=\"none\" points=\"283.0,455.0 282.6020408163265,454.3367346938775 282.204081632653,453.67346938775506 281.8061224489796,453.01020408163265 281.4081632653061,452.3469387755102 281.0102040816326,451.68367346938777 280.6122448979591,451.0204081632653 280.2142857142858,450.35714285714295 279.81632653061234,449.69387755102053 279.4183673469388,449.030612244898 279.02040816326524,448.3673469387755 278.6224489795918,447.7040816326531 278.2244897959183,447.04081632653055 277.8265306122449,446.3775510204082 277.42857142857144,445.7142857142858 277.030612244898,445.05102040816337 276.6326530612245,444.38775510204084 276.2346938775511,443.72448979591843 275.83673469387753,443.0612244897959 275.43877551020404,442.3979591836735 275.0408163265306,441.7346938775509 274.6428571428571,441.07142857142856 274.2448979591837,440.40816326530614 273.8469387755102,439.7448979591836 273.44897959183675,439.08163265306126 273.05102040816325,438.4183673469388 272.65306122448976,437.7551020408163 272.25510204081627,437.09183673469397 271.8571428571429,436.4285714285715 271.4591836734694,435.765306122449 271.0612244897959,435.10204081632656 270.6632653061224,434.43877551020415 270.265306122449,433.7755102040816 269.86734693877554,433.1122448979593 269.46938775510205,432.44897959183675 269.07142857142856,431.78571428571433 268.67346938775506,431.1224489795919 268.2755102040816,430.4591836734694 267.8775510204082,429.795918367347 267.4795918367347,429.13265306122446 267.0816326530612,428.46938775510205 266.68367346938777,427.8061224489796 266.28571428571433,427.1428571428572 265.88775510204084,426.4795918367347 265.48979591836735,425.8163265306123 265.09183673469386,425.1530612244898 264.6938775510204,424.48979591836735 264.2959183673469,423.8265306122449 263.89795918367344,423.1632653061224 263.5,422.5 263.5,422.5 263.1020408163265,421.83673469387753 262.7040816326531,421.173469387755 262.3061224489796,420.51020408163265 261.90816326530614,419.8469387755102 261.51020408163265,419.1836734693877 261.11224489795916,418.52040816326524 260.71428571428584,417.857142857143 260.3163265306123,417.1938775510205 259.9183673469388,416.530612244898 259.52040816326524,415.8673469387755 259.1224489795918,415.20408163265296 258.7244897959184,414.54081632653055 258.3265306122449,413.87755102040813 257.92857142857144,413.21428571428567 257.530612244898,412.55102040816325 257.1326530612245,411.88775510204084 256.734693877551,411.2244897959184 256.33673469387753,410.5612244897959 255.9387755102041,409.89795918367344 255.54081632653057,409.2346938775509 255.1428571428571,408.5714285714285 254.74489795918367,407.90816326530614 254.34693877551018,407.2448979591836 253.94897959183677,406.5816326530612 253.55102040816325,405.91836734693874 253.1530612244898,405.25510204081627 252.75510204081633,404.59183673469386 252.3571428571429,403.92857142857144 251.95918367346937,403.265306122449 251.5612244897959,402.6020408163265 251.16326530612247,401.9387755102041 250.76530612244898,401.2755102040816 250.36734693877554,400.61224489795916 249.96938775510205,399.94897959183675 249.57142857142856,399.2857142857143 249.17346938775512,398.6224489795918 248.77551020408166,397.9591836734694 248.37755102040813,397.295918367347 247.9795918367347,396.63265306122446 247.58163265306123,395.96938775510205 247.18367346938777,395.3061224489796 246.7857142857143,394.6428571428571 246.3877551020408,393.9795918367347 245.98979591836735,393.31632653061223 245.59183673469389,392.6530612244898 245.19387755102042,391.98979591836735 244.79591836734696,391.32653061224494 244.39795918367346,390.66326530612247 244.0,390.0\" stroke=\"#8c35cd\" stroke-width=\"1\" /><polyline fill=\"none\" points=\"242.28501415083736,396.8599433966506 244,390 250.85994339665058,391.71498584916264 244,390\" stroke=\"#8c35cd\" stroke-width=\"1\" /><rect fill=\"white\" height=\"13\" rx=\"2\" ry=\"2\" stroke=\"#8c35cd\" stroke-width=\"1\" transform=\"rotate(59.03624340311225 262.0 419.0)\" width=\"35.22222222222222\" x=\"244.38888888888889\" y=\"412.5\" /><text fill=\"#8c35cd\" font-family=\"courier\" font-size=\"12\" transform=\"rotate(59.03624340311225 262.0 419.0)\" x=\"247.38888888888889\" y=\"422.5\">TeRP</text><polyline fill=\"none\" points=\"323.0,1455.0 322.3265306122449,1454.3367346938774 321.65306122448976,1453.6734693877547 320.97959183673476,1453.0102040816328 320.30612244897964,1452.3469387755104 319.63265306122446,1451.6836734693877 318.95918367346934,1451.0204081632653 318.28571428571433,1450.3571428571433 317.6122448979592,1449.6938775510207 316.9387755102041,1449.0306122448983 316.2653061224489,1448.3673469387754 315.59183673469386,1447.704081632653 314.91836734693874,1447.0408163265304 314.2448979591836,1446.3775510204082 313.57142857142856,1445.7142857142858 312.8979591836735,1445.0510204081634 312.22448979591843,1444.387755102041 311.55102040816337,1443.7244897959185 310.87755102040813,1443.0612244897961 310.204081632653,1442.3979591836735 309.5306122448979,1441.7346938775509 308.85714285714283,1441.0714285714284 308.1836734693878,1440.4081632653063 307.5102040816326,1439.7448979591836 306.83673469387753,1439.0816326530614 306.1632653061224,1438.4183673469388 305.48979591836735,1437.7551020408164 304.8163265306123,1437.091836734694 304.14285714285717,1436.4285714285718 303.46938775510205,1435.7653061224491 302.7959183673469,1435.1020408163265 302.12244897959187,1434.4387755102043 301.44897959183675,1433.7755102040815 300.7755102040816,1433.1122448979593 300.1020408163265,1432.4489795918366 299.42857142857144,1431.7857142857142 298.7551020408164,1431.1224489795918 298.0816326530612,1430.4591836734694 297.40816326530614,1429.795918367347 296.734693877551,1429.1326530612246 296.0612244897959,1428.4693877551022 295.38775510204084,1427.8061224489797 294.7142857142858,1427.1428571428573 294.0408163265306,1426.4795918367347 293.3673469387755,1425.816326530612 292.6938775510204,1425.1530612244896 292.0204081632653,1424.4897959183672 291.34693877551024,1423.826530612245 290.6734693877551,1423.1632653061224 290.0,1422.5 290.0,1422.5 289.3265306122448,1421.8367346938776 288.65306122448976,1421.173469387755 287.97959183673476,1420.5102040816328 287.30612244897964,1419.8469387755104 286.63265306122446,1419.1836734693877 285.95918367346934,1418.520408163265 285.28571428571433,1417.8571428571431 284.6122448979592,1417.1938775510207 283.9387755102041,1416.530612244898 283.2653061224489,1415.8673469387752 282.59183673469386,1415.2040816326526 281.91836734693874,1414.5408163265304 281.2448979591836,1413.8775510204082 280.5714285714286,1413.2142857142856 279.8979591836735,1412.5510204081634 279.22448979591843,1411.8877551020407 278.55102040816325,1411.2244897959183 277.87755102040813,1410.561224489796 277.2040816326531,1409.8979591836733 276.5306122448979,1409.2346938775509 275.85714285714283,1408.5714285714284 275.18367346938777,1407.9081632653063 274.51020408163265,1407.2448979591834 273.8367346938776,1406.581632653061 273.16326530612247,1405.9183673469388 272.48979591836735,1405.2551020408162 271.81632653061223,1404.591836734694 271.14285714285717,1403.9285714285716 270.46938775510205,1403.265306122449 269.795918367347,1402.6020408163265 269.12244897959187,1401.938775510204 268.44897959183675,1401.2755102040815 267.7755102040816,1400.612244897959 267.1020408163265,1399.9489795918366 266.42857142857144,1399.2857142857142 265.7551020408163,1398.6224489795918 265.0816326530612,1397.9591836734694 264.40816326530614,1397.295918367347 263.734693877551,1396.6326530612243 263.06122448979596,1395.9693877551022 262.38775510204084,1395.3061224489797 261.7142857142857,1394.6428571428573 261.0408163265306,1393.9795918367347 260.36734693877554,1393.3163265306123 259.6938775510204,1392.6530612244896 259.0204081632653,1391.9897959183675 258.3469387755102,1391.326530612245 257.6734693877551,1390.6632653061224 257.0,1390.0\" stroke=\"#8c35cd\" stroke-width=\"1\" /><polyline fill=\"none\" points=\"257.0539760442122,1397.0708617917974 257,1390 264.0708617917973,1389.9460239557877 257,1390\" stroke=\"#8c35cd\" stroke-width=\"1\" /><rect fill=\"white\" height=\"13\" rx=\"2\" ry=\"2\" stroke=\"#8c35cd\" stroke-width=\"1\" transform=\"rotate(44.56263608907844 288.5 1419.0)\" width=\"35.22222222222222\" x=\"270.8888888888889\" y=\"1412.5\" /><text fill=\"#8c35cd\" font-family=\"courier\" font-size=\"12\" transform=\"rotate(44.56263608907844 288.5 1419.0)\" x=\"273.8888888888889\" y=\"1422.5\">TeRP</text><polyline fill=\"none\" points=\"124.0,1455.0 124.72448979591834,1454.3367346938774 125.44897959183673,1453.6734693877547 126.17346938775512,1453.0102040816328 126.89795918367346,1452.3469387755104 127.62244897959185,1451.6836734693877 128.34693877551018,1451.0204081632653 129.07142857142858,1450.3571428571433 129.79591836734693,1449.6938775510207 130.5204081632653,1449.0306122448983 131.24489795918367,1448.3673469387754 131.96938775510202,1447.704081632653 132.6938775510204,1447.0408163265304 133.41836734693877,1446.3775510204082 134.14285714285714,1445.7142857142858 134.86734693877554,1445.0510204081634 135.59183673469389,1444.387755102041 136.31632653061226,1443.7244897959185 137.0408163265306,1443.0612244897961 137.76530612244898,1442.3979591836735 138.48979591836735,1441.7346938775509 139.2142857142857,1441.0714285714284 139.9387755102041,1440.4081632653063 140.66326530612244,1439.7448979591836 141.38775510204084,1439.0816326530614 142.1122448979592,1438.4183673469388 142.83673469387756,1437.7551020408164 143.56122448979593,1437.091836734694 144.2857142857143,1436.4285714285718 145.01020408163265,1435.7653061224491 145.73469387755102,1435.1020408163265 146.45918367346943,1434.4387755102043 147.18367346938774,1433.7755102040815 147.90816326530614,1433.1122448979593 148.63265306122452,1432.4489795918366 149.35714285714286,1431.7857142857142 150.08163265306123,1431.1224489795918 150.80612244897958,1430.4591836734694 151.53061224489795,1429.795918367347 152.25510204081633,1429.1326530612246 152.9795918367347,1428.4693877551022 153.70408163265307,1427.8061224489797 154.42857142857144,1427.1428571428573 155.1530612244898,1426.4795918367347 155.87755102040816,1425.816326530612 156.60204081632654,1425.1530612244896 157.32653061224488,1424.4897959183672 158.05102040816328,1423.826530612245 158.77551020408163,1423.1632653061224 159.5,1422.5 159.5,1422.5 160.22448979591837,1421.8367346938776 160.94897959183672,1421.173469387755 161.67346938775512,1420.5102040816328 162.39795918367346,1419.8469387755104 163.12244897959184,1419.1836734693877 163.84693877551015,1418.520408163265 164.5714285714286,1417.8571428571431 165.29591836734696,1417.1938775510207 166.02040816326533,1416.530612244898 166.74489795918365,1415.8673469387752 167.469387755102,1415.2040816326526 168.19387755102036,1414.5408163265304 168.91836734693874,1413.8775510204082 169.6428571428571,1413.2142857142856 170.3673469387755,1412.5510204081634 171.09183673469389,1411.8877551020407 171.81632653061226,1411.2244897959183 172.5408163265306,1410.561224489796 173.26530612244898,1409.8979591836733 173.98979591836732,1409.2346938775509 174.7142857142857,1408.5714285714284 175.4387755102041,1407.9081632653063 176.16326530612244,1407.2448979591834 176.88775510204079,1406.581632653061 177.6122448979592,1405.9183673469388 178.33673469387753,1405.2551020408162 179.0612244897959,1404.591836734694 179.78571428571428,1403.9285714285716 180.51020408163262,1403.265306122449 181.23469387755102,1402.6020408163265 181.9591836734694,1401.938775510204 182.68367346938774,1401.2755102040815 183.40816326530611,1400.612244897959 184.1326530612245,1399.9489795918366 184.85714285714286,1399.2857142857142 185.5816326530612,1398.6224489795918 186.30612244897958,1397.9591836734694 187.03061224489795,1397.295918367347 187.75510204081633,1396.6326530612243 188.4795918367347,1395.9693877551022 189.20408163265307,1395.3061224489797 189.92857142857142,1394.6428571428573 190.6530612244898,1393.9795918367347 191.37755102040813,1393.3163265306123 192.10204081632654,1392.6530612244896 192.8265306122449,1391.9897959183675 193.55102040816328,1391.326530612245 194.27551020408163,1390.6632653061224 195.0,1390.0\" stroke=\"#8c35cd\" stroke-width=\"1\" /><polyline fill=\"none\" points=\"187.93580361212685,1389.6883442770056 195,1390 194.68834427700563,1397.0641963878732 195,1390\" stroke=\"#8c35cd\" stroke-width=\"1\" /><rect fill=\"white\" height=\"13\" rx=\"2\" ry=\"2\" stroke=\"#8c35cd\" stroke-width=\"1\" transform=\"rotate(-42.47388312857282 158.0 1419.0)\" width=\"35.22222222222222\" x=\"140.38888888888889\" y=\"1412.5\" /><text fill=\"#8c35cd\" font-family=\"courier\" font-size=\"12\" transform=\"rotate(-42.47388312857282 158.0 1419.0)\" x=\"143.38888888888889\" y=\"1422.5\">TeRP</text><polyline fill=\"none\" points=\"449.0,1355.0 446.7755102040816,1353.796079864682 444.5510204081632,1352.593128713376 442.32653061224494,1351.3921155300939 440.10204081632656,1350.1940092988466 437.87755102040825,1348.9997790036464 435.6530612244897,1347.8103936285052 433.42857142857156,1346.6268221574348 431.20408163265313,1345.4500335744463 428.9795918367347,1344.2809968635518 426.7551020408162,1343.1206810087633 424.53061224489795,1341.9700549940924 422.3061224489795,1340.830087803551 420.08163265306126,1339.701748421151 417.85714285714283,1338.586005830904 415.6326530612246,1337.4838290168216 413.4081632653062,1336.3961869629154 411.1836734693878,1335.3240486531975 408.9591836734694,1334.2683830716792 406.7346938775511,1333.2301592023732 404.5102040816326,1332.2103460292903 402.2857142857142,1331.2099125364432 400.06122448979596,1330.229827707843 397.83673469387753,1329.2710605275015 395.6122448979592,1328.3345799794306 393.38775510204084,1327.4213550476418 391.1632653061224,1326.5323547161472 388.9387755102041,1325.6685479689586 386.7142857142858,1324.8309037900879 384.4897959183674,1324.0203911635458 382.265306122449,1323.2379790733453 380.0408163265307,1322.4846365034978 377.81632653061223,1321.7613324380147 375.5918367346939,1321.0690358609083 373.36734693877554,1320.40871575619 371.14285714285717,1319.7813411078719 368.9183673469388,1319.1878808999652 366.6938775510204,1318.6293041164822 364.46938775510205,1318.1065797414344 362.24489795918373,1317.6206767588335 360.02040816326536,1317.1725641526914 357.795918367347,1316.76321090702 355.5714285714286,1316.393586005831 353.34693877551024,1316.0646584331357 351.1224489795918,1315.7773971729466 348.8979591836735,1315.532771209275 346.6734693877551,1315.3317495261329 344.44897959183675,1315.1753011075316 342.2244897959184,1315.0643949374835 340.0,1315.0 340.0,1315.0 337.77551020408157,1314.9827622844223 335.55102040816325,1315.012035801409 333.32653061224494,1315.0868515669492 331.10204081632656,1315.2062405970303 328.87755102040813,1315.3692339076406 326.65306122448976,1315.5748625147685 324.42857142857156,1315.8221574344027 322.2040816326531,1316.1101496825304 319.97959183673464,1316.4378702751405 317.7551020408162,1316.804350228221 315.5306122448979,1317.2086205577602 313.3061224489795,1317.649712279747 311.0816326530612,1318.126656410169 308.85714285714283,1318.6384839650145 306.6326530612245,1319.1842259602718 304.40816326530614,1319.7629134119288 302.18367346938777,1320.373577335974 299.95918367346934,1321.0152487483956 297.73469387755097,1321.6869586651821 295.5102040816326,1322.3877381023212 293.2857142857143,1323.1166180758016 291.06122448979596,1323.8726296016116 288.83673469387753,1324.654803695739 286.61224489795916,1325.4621713741722 284.3877551020408,1326.2937636528998 282.1632653061224,1327.1486115479092 279.9387755102041,1328.0257460751895 277.7142857142857,1328.9241982507288 275.48979591836735,1329.8429990905147 273.265306122449,1330.7811796105364 271.04081632653066,1331.7377708267813 268.81632653061223,1332.7118037552377 266.59183673469386,1333.7023094118945 264.3673469387755,1334.7083188127394 262.14285714285717,1335.728862973761 259.9183673469388,1336.762972910947 257.69387755102036,1337.809679640286 255.46938775510205,1338.868014177766 253.24489795918367,1339.9370075393754 251.0204081632653,1341.0156907411028 248.79591836734693,1342.1030947989357 246.57142857142856,1343.198250728863 244.34693877551018,1344.3001895468724 242.12244897959184,1345.4079422689524 239.8979591836735,1346.5205399110914 237.67346938775512,1347.6370134892775 235.44897959183675,1348.7563940194987 233.22448979591837,1349.8777125177435 231.0,1351.0\" stroke=\"#8c35cd\" stroke-width=\"1\" /><polyline fill=\"none\" points=\"237.55064736128753,1353.6625211855555 231,1351 233.6625211855556,1344.4493526387125 231,1351\" stroke=\"#8c35cd\" stroke-width=\"1\" /><rect fill=\"white\" height=\"13\" rx=\"2\" ry=\"2\" stroke=\"#8c35cd\" stroke-width=\"1\" transform=\"rotate(0 338.5 1316.5)\" width=\"35.22222222222222\" x=\"320.8888888888889\" y=\"1310\" /><text fill=\"#8c35cd\" font-family=\"courier\" font-size=\"12\" transform=\"rotate(0 338.5 1316.5)\" x=\"323.8888888888889\" y=\"1320\">TeRP</text><polyline fill=\"none\" points=\"245.0,255.0 245.94897959183675,254.33673469387753 246.8979591836734,253.67346938775506 247.84693877551024,253.0102040816327 248.79591836734693,252.3469387755102 249.74489795918367,251.68367346938777 250.6938775510204,251.02040816326527 251.6428571428572,250.35714285714292 252.5918367346939,249.69387755102048 253.54081632653063,249.03061224489795 254.4897959183673,248.36734693877548 255.43877551020404,247.70408163265301 256.3877551020408,247.04081632653057 257.33673469387753,246.37755102040813 258.2857142857143,245.71428571428572 259.2346938775511,245.0510204081633 260.18367346938777,244.38775510204087 261.1326530612245,243.7244897959184 262.0816326530612,243.0612244897959 263.03061224489795,242.3979591836735 263.97959183673464,241.734693877551 264.92857142857144,241.07142857142856 265.8775510204082,240.40816326530614 266.8265306122449,239.74489795918367 267.7755102040816,239.08163265306123 268.7244897959184,238.41836734693877 269.67346938775506,237.75510204081633 270.6224489795918,237.0918367346939 271.57142857142856,236.42857142857144 272.5204081632653,235.76530612244898 273.46938775510205,235.10204081632654 274.4183673469388,234.43877551020412 275.3673469387755,233.77551020408163 276.31632653061223,233.11224489795916 277.265306122449,232.44897959183675 278.2142857142857,231.7857142857143 279.1632653061224,231.12244897959184 280.11224489795916,230.4591836734694 281.0612244897959,229.79591836734696 282.01020408163265,229.13265306122452 282.9591836734694,228.46938775510205 283.90816326530614,227.80612244897958 284.8571428571429,227.14285714285717 285.8061224489796,226.4795918367347 286.7551020408163,225.81632653061223 287.7040816326531,225.15306122448982 288.6530612244898,224.48979591836735 289.6020408163265,223.8265306122449 290.55102040816325,223.16326530612244 291.5,222.5 291.5,222.5 292.4489795918367,221.83673469387753 293.3979591836734,221.17346938775506 294.34693877551024,220.51020408163268 295.2959183673469,219.84693877551018 296.2448979591836,219.18367346938777 297.19387755102036,218.52040816326527 298.1428571428572,217.85714285714292 299.0918367346939,217.19387755102045 300.0408163265307,216.53061224489798 300.98979591836735,215.86734693877548 301.938775510204,215.20408163265301 302.8877551020408,214.54081632653055 303.83673469387753,213.87755102040816 304.7857142857143,213.21428571428572 305.7346938775511,212.55102040816328 306.68367346938777,211.8877551020408 307.6326530612245,211.22448979591837 308.5816326530612,210.5612244897959 309.53061224489795,209.89795918367346 310.47959183673464,209.23469387755094 311.4285714285714,208.57142857142853 312.3775510204082,207.90816326530611 313.3265306122448,207.24489795918365 314.2755102040816,206.58163265306123 315.2244897959184,205.91836734693874 316.17346938775506,205.25510204081633 317.12244897959187,204.59183673469386 318.0714285714286,203.92857142857144 319.0204081632653,203.26530612244898 319.96938775510205,202.6020408163265 320.9183673469388,201.93877551020407 321.8673469387755,201.27551020408163 322.81632653061223,200.6122448979592 323.765306122449,199.94897959183672 324.71428571428567,199.2857142857143 325.66326530612247,198.62244897959184 326.61224489795916,197.9591836734694 327.5612244897959,197.29591836734693 328.51020408163265,196.6326530612245 329.4591836734694,195.96938775510205 330.40816326530614,195.30612244897958 331.3571428571429,194.64285714285717 332.3061224489796,193.9795918367347 333.25510204081627,193.31632653061223 334.204081632653,192.65306122448982 335.15306122448976,191.98979591836735 336.1020408163265,191.32653061224488 337.05102040816325,190.66326530612247 338.0,190.0\" stroke=\"#8c35cd\" stroke-width=\"1\" /><polyline fill=\"none\" points=\"331.0374177513621,188.76612466479833 338,190 336.7661246647983,196.9625822486379 338,190\" stroke=\"#8c35cd\" stroke-width=\"1\" /><rect fill=\"white\" height=\"13\" rx=\"2\" ry=\"2\" stroke=\"#8c35cd\" stroke-width=\"1\" transform=\"rotate(-34.9506514408034 290.0 219.0)\" width=\"35.22222222222222\" x=\"272.3888888888889\" y=\"212.5\" /><text fill=\"#8c35cd\" font-family=\"courier\" font-size=\"12\" transform=\"rotate(-34.9506514408034 290.0 219.0)\" x=\"275.3888888888889\" y=\"222.5\">TeRP</text><polyline fill=\"none\" points=\"371.0,155.0 368.03061224489795,153.7960798646822 365.0612244897959,152.59312871337622 362.0918367346939,151.39211553009378 359.12244897959175,150.19400929884657 356.15306122448976,148.99977900364644 353.1836734693877,147.81039362850512 350.2142857142858,146.62682215743445 347.24489795918373,145.45003357444605 344.2755102040817,144.28099686355176 341.3061224489796,143.12068100876337 338.33673469387753,141.97005499409258 335.3673469387754,140.83008780355124 332.39795918367344,139.70174842115105 329.42857142857144,138.5860058309038 326.4591836734695,137.48382901682123 323.48979591836735,136.39618696291512 320.52040816326536,135.32404865319725 317.5510204081633,134.2683830716793 314.5816326530612,133.23015920237316 311.61224489795916,132.2103460292905 308.64285714285705,131.20991253644314 305.6734693877551,130.22982770784282 302.704081632653,129.2710605275013 299.734693877551,128.33457997943034 296.765306122449,127.42135504764173 293.7959183673469,126.53235471614718 290.8265306122449,125.6685479689585 287.8571428571429,124.83090379008749 284.88775510204084,124.02039116354581 281.9183673469388,123.2379790733453 278.94897959183675,122.48463650349771 275.9795918367347,121.76133243801479 273.01020408163265,121.06903586090831 270.0408163265306,120.40871575619002 267.07142857142856,119.78134110787173 264.10204081632656,119.18788089996517 261.1326530612245,118.62930411648207 258.16326530612247,118.10657974143427 255.19387755102042,117.62067675883348 252.22448979591837,117.17256415269148 249.25510204081633,116.76321090702004 246.2857142857143,116.39358600583091 243.31632653061223,116.06465843313586 240.3469387755102,115.77739717294665 237.3775510204082,115.53277120927505 234.40816326530614,115.33174952613282 231.4387755102041,115.17530110753174 228.46938775510202,115.06439493748353 225.5,115.0 225.5,115.0 222.53061224489792,114.9827622844223 219.56122448979588,115.01203580140927 216.59183673469389,115.08685156694916 213.62244897959187,115.20624059703015 210.6530612244898,115.36923390764053 207.68367346938774,115.57486251476851 204.71428571428578,115.82215743440234 201.7448979591837,116.11014968253025 198.77551020408166,116.43787027514047 195.80612244897955,116.80435022822121 192.8367346938775,117.20862055776078 189.86734693877546,117.64971227974738 186.89795918367346,118.12665641016923 183.92857142857147,118.63848396501459 180.95918367346943,119.18422596027166 177.98979591836738,119.7629134119287 175.02040816326533,120.37357733597398 172.05102040816328,121.01524874839565 169.0816326530612,121.68695866518203 166.11224489795916,122.3877381023213 163.1428571428571,123.11661807580174 160.1734693877551,123.87262960161156 157.20408163265307,124.654803695739 154.23469387755102,125.46217137417233 151.26530612244898,126.29376365289971 148.29591836734696,127.14861154790944 145.3265306122449,128.02574607518974 142.3571428571429,128.92419825072886 139.38775510204084,129.842999090515 136.4183673469388,130.7811796105364 133.44897959183675,131.73777082678137 130.4795918367347,132.71180375523804 127.51020408163265,133.7023094118947 124.5408163265306,134.7083188127396 121.57142857142858,135.72886297376095 118.60204081632654,136.76297291094698 115.6326530612245,137.80967964028594 112.66326530612245,138.86801417776604 109.69387755102042,139.9370075393756 106.72448979591839,141.01569074110276 103.75510204081634,142.1030947989358 100.7857142857143,143.19825072886297 97.81632653061224,144.30018954687245 94.84693877551021,145.40794226895255 91.87755102040818,146.52053991109145 88.90816326530614,147.63701348927742 85.93877551020408,148.75639401949866 82.96938775510203,149.87771251774345 80.0,151.0\" stroke=\"#0398da\" stroke-width=\"1\" /><polyline fill=\"none\" points=\"86.27464275609455,154.26019297248777 80,151 83.26019297248777,144.72535724390545 80,151\" stroke=\"#0398da\" stroke-width=\"1\" /><rect fill=\"white\" height=\"13\" rx=\"2\" ry=\"2\" stroke=\"#0398da\" stroke-width=\"1\" transform=\"rotate(0 224.0 116.5)\" width=\"35.22222222222222\" x=\"206.38888888888889\" y=\"110\" /><text fill=\"#0398da\" font-family=\"courier\" font-size=\"12\" transform=\"rotate(0 224.0 116.5)\" x=\"209.38888888888889\" y=\"120\">TrWP</text><polyline fill=\"none\" points=\"537.0,1655.0 539.4795918367346,1654.3367346938776 541.9591836734693,1653.6734693877545 544.438775510204,1653.010204081633 546.9183673469387,1652.3469387755101 549.3979591836735,1651.6836734693875 551.8775510204081,1651.0204081632653 554.3571428571429,1650.3571428571436 556.8367346938777,1649.6938775510207 559.3163265306123,1649.030612244898 561.7959183673469,1648.3673469387752 564.2755102040816,1647.7040816326528 566.7551020408163,1647.0408163265304 569.2346938775509,1646.3775510204082 571.7142857142858,1645.7142857142858 574.1938775510205,1645.0510204081634 576.6734693877552,1644.387755102041 579.1530612244899,1643.7244897959188 581.6326530612245,1643.061224489796 584.1122448979592,1642.3979591836733 586.5918367346937,1641.734693877551 589.0714285714284,1641.0714285714287 591.5510204081633,1640.4081632653063 594.030612244898,1639.7448979591838 596.5102040816327,1639.0816326530612 598.9897959183673,1638.4183673469388 601.4693877551019,1637.7551020408162 603.9489795918367,1637.091836734694 606.4285714285714,1636.4285714285716 608.9081632653061,1635.7653061224491 611.3877551020407,1635.1020408163265 613.8673469387755,1634.4387755102043 616.3469387755101,1633.7755102040815 618.8265306122448,1633.1122448979593 621.3061224489795,1632.4489795918369 623.7857142857142,1631.7857142857147 626.2653061224489,1631.1224489795918 628.7448979591836,1630.4591836734694 631.2244897959183,1629.795918367347 633.704081632653,1629.1326530612246 636.1836734693877,1628.4693877551022 638.6632653061224,1627.8061224489797 641.1428571428571,1627.1428571428573 643.6224489795918,1626.4795918367345 646.1020408163265,1625.816326530612 648.5816326530612,1625.1530612244899 651.0612244897959,1624.4897959183675 653.5408163265306,1623.8265306122448 656.0204081632653,1623.1632653061224 658.5,1622.5 658.5,1622.5 660.9795918367347,1621.8367346938774 663.4591836734692,1621.1734693877547 665.9387755102041,1620.5102040816328 668.4183673469388,1619.8469387755104 670.8979591836735,1619.1836734693877 673.377551020408,1618.5204081632648 675.857142857143,1617.8571428571433 678.3367346938776,1617.1938775510203 680.8163265306123,1616.5306122448978 683.2959183673469,1615.8673469387754 685.7755102040817,1615.2040816326526 688.2551020408162,1614.5408163265304 690.734693877551,1613.8775510204082 693.2142857142857,1613.2142857142858 695.6938775510205,1612.5510204081634 698.1734693877552,1611.887755102041 700.6530612244899,1611.2244897959188 703.1326530612245,1610.5612244897957 705.6122448979593,1609.8979591836733 708.0918367346937,1609.2346938775506 710.5714285714286,1608.5714285714282 713.0510204081634,1607.908163265306 715.5306122448978,1607.2448979591834 718.0102040816328,1606.5816326530612 720.4897959183673,1605.9183673469386 722.9693877551019,1605.2551020408164 725.4489795918367,1604.591836734694 727.9285714285716,1603.9285714285716 730.4081632653061,1603.265306122449 732.8877551020407,1602.6020408163267 735.3673469387754,1601.938775510204 737.8469387755101,1601.2755102040815 740.3265306122448,1600.612244897959 742.8061224489795,1599.9489795918366 745.2857142857143,1599.2857142857142 747.7653061224489,1598.6224489795918 750.2448979591836,1597.9591836734694 752.7244897959183,1597.295918367347 755.204081632653,1596.6326530612246 757.6836734693877,1595.9693877551022 760.1632653061224,1595.3061224489795 762.6428571428571,1594.6428571428573 765.1224489795918,1593.9795918367345 767.6020408163265,1593.316326530612 770.0816326530612,1592.6530612244896 772.5612244897959,1591.9897959183675 775.0408163265306,1591.3265306122448 777.5204081632653,1590.6632653061224 780.0,1590.0\" stroke=\"#8c35cd\" stroke-width=\"1\" /><polyline fill=\"none\" points=\"773.8777920697321,1586.4618408714687 780,1590 776.4618408714687,1596.122207930268 780,1590\" stroke=\"#8c35cd\" stroke-width=\"1\" /><rect fill=\"white\" height=\"13\" rx=\"2\" ry=\"2\" stroke=\"#8c35cd\" stroke-width=\"1\" transform=\"rotate(-14.975434419547927 657.0 1619.0)\" width=\"35.22222222222222\" x=\"639.3888888888889\" y=\"1612.5\" /><text fill=\"#8c35cd\" font-family=\"courier\" font-size=\"12\" transform=\"rotate(-14.975434419547927 657.0 1619.0)\" x=\"642.3888888888889\" y=\"1622.5\">TeRP</text><polyline fill=\"none\" points=\"124.0,1455.0 127.05102040816325,1454.3367346938774 130.1020408163265,1453.6734693877547 133.15306122448982,1453.0102040816328 136.20408163265304,1452.3469387755104 139.25510204081633,1451.6836734693877 142.30612244897958,1451.0204081632653 145.3571428571429,1450.3571428571433 148.40816326530614,1449.6938775510207 151.4591836734694,1449.0306122448983 154.51020408163265,1448.3673469387754 157.56122448979588,1447.704081632653 160.61224489795916,1447.0408163265304 163.66326530612244,1446.3775510204082 166.71428571428572,1445.7142857142858 169.765306122449,1445.0510204081634 172.81632653061226,1444.387755102041 175.86734693877554,1443.7244897959185 178.91836734693877,1443.0612244897961 181.96938775510205,1442.3979591836735 185.0204081632653,1441.7346938775509 188.07142857142856,1441.0714285714284 191.12244897959184,1440.4081632653063 194.1734693877551,1439.7448979591836 197.2244897959184,1439.0816326530614 200.27551020408163,1438.4183673469388 203.32653061224488,1437.7551020408164 206.37755102040813,1437.091836734694 209.42857142857144,1436.4285714285718 212.4795918367347,1435.7653061224491 215.53061224489795,1435.1020408163265 218.58163265306126,1434.4387755102043 221.6326530612245,1433.7755102040815 224.68367346938774,1433.1122448979593 227.73469387755102,1432.4489795918366 230.7857142857143,1431.7857142857142 233.83673469387756,1431.1224489795918 236.88775510204084,1430.4591836734694 239.9387755102041,1429.795918367347 242.98979591836735,1429.1326530612246 246.0408163265306,1428.4693877551022 249.09183673469386,1427.8061224489797 252.14285714285717,1427.1428571428573 255.19387755102042,1426.4795918367347 258.2448979591836,1425.816326530612 261.2959183673469,1425.1530612244896 264.3469387755102,1424.4897959183672 267.3979591836735,1423.826530612245 270.44897959183675,1423.1632653061224 273.5,1422.5 273.5,1422.5 276.5510204081632,1421.8367346938776 279.60204081632645,1421.173469387755 282.6530612244898,1420.5102040816328 285.704081632653,1419.8469387755104 288.7551020408163,1419.1836734693877 291.8061224489796,1418.520408163265 294.8571428571429,1417.8571428571431 297.9081632653062,1417.1938775510207 300.9591836734694,1416.530612244898 304.0102040816326,1415.8673469387752 307.06122448979585,1415.2040816326526 310.11224489795916,1414.5408163265304 313.1632653061224,1413.8775510204082 316.2142857142857,1413.2142857142856 319.26530612244903,1412.5510204081634 322.3163265306123,1411.8877551020407 325.36734693877554,1411.2244897959183 328.41836734693874,1410.561224489796 331.469387755102,1409.8979591836733 334.5204081632652,1409.2346938775509 337.57142857142856,1408.5714285714284 340.6224489795918,1407.9081632653063 343.673469387755,1407.2448979591834 346.7244897959183,1406.581632653061 349.7755102040816,1405.9183673469388 352.8265306122449,1405.2551020408162 355.87755102040813,1404.591836734694 358.92857142857144,1403.9285714285716 361.9795918367347,1403.265306122449 365.03061224489795,1402.6020408163265 368.08163265306126,1401.938775510204 371.13265306122446,1401.2755102040815 374.1836734693877,1400.612244897959 377.23469387755097,1399.9489795918366 380.2857142857142,1399.2857142857142 383.33673469387753,1398.6224489795918 386.3877551020408,1397.9591836734694 389.4387755102041,1397.295918367347 392.48979591836735,1396.6326530612243 395.5408163265306,1395.9693877551022 398.59183673469386,1395.3061224489797 401.64285714285717,1394.6428571428573 404.69387755102036,1393.9795918367347 407.7448979591836,1393.3163265306123 410.7959183673469,1392.6530612244896 413.84693877551024,1391.9897959183675 416.89795918367344,1391.326530612245 419.94897959183675,1390.6632653061224 423.0,1390.0\" stroke=\"#0398da\" stroke-width=\"1\" /><polyline fill=\"none\" points=\"417.05196996067474,1386.1762664032908 423,1390 419.17626640329075,1395.9480300393252 423,1390\" stroke=\"#0398da\" stroke-width=\"1\" /><rect fill=\"white\" height=\"13\" rx=\"2\" ry=\"2\" stroke=\"#0398da\" stroke-width=\"1\" transform=\"rotate(-12.264773731870172 272.0 1419.0)\" width=\"35.22222222222222\" x=\"254.3888888888889\" y=\"1412.5\" /><text fill=\"#0398da\" font-family=\"courier\" font-size=\"12\" transform=\"rotate(-12.264773731870172 272.0 1419.0)\" x=\"257.3888888888889\" y=\"1422.5\">TrWP</text><polyline fill=\"none\" points=\"367.0,1655.0 371.21428571428567,1654.3367346938776 375.4285714285714,1653.6734693877545 379.6428571428572,1653.010204081633 383.8571428571429,1652.3469387755101 388.07142857142856,1651.6836734693875 392.2857142857143,1651.0204081632653 396.5000000000001,1650.3571428571436 400.7142857142858,1649.6938775510207 404.92857142857144,1649.030612244898 409.1428571428571,1648.3673469387752 413.35714285714283,1647.7040816326528 417.57142857142856,1647.0408163265304 421.78571428571433,1646.3775510204082 426.00000000000006,1645.7142857142858 430.2142857142857,1645.0510204081634 434.42857142857144,1644.387755102041 438.64285714285717,1643.7244897959188 442.8571428571429,1643.061224489796 447.07142857142856,1642.3979591836733 451.2857142857142,1641.734693877551 455.5,1641.0714285714287 459.7142857142857,1640.4081632653063 463.92857142857144,1639.7448979591838 468.1428571428572,1639.0816326530612 472.3571428571429,1638.4183673469388 476.57142857142856,1637.7551020408162 480.78571428571433,1637.091836734694 485.00000000000006,1636.4285714285716 489.2142857142858,1635.7653061224491 493.42857142857144,1635.1020408163265 497.6428571428572,1634.4387755102043 501.8571428571429,1633.7755102040815 506.07142857142856,1633.1122448979593 510.28571428571433,1632.4489795918369 514.5,1631.7857142857147 518.7142857142858,1631.1224489795918 522.9285714285714,1630.4591836734694 527.1428571428571,1629.795918367347 531.3571428571429,1629.1326530612246 535.5714285714287,1628.4693877551022 539.7857142857143,1627.8061224489797 544.0,1627.1428571428573 548.2142857142858,1626.4795918367345 552.4285714285714,1625.816326530612 556.6428571428571,1625.1530612244899 560.8571428571429,1624.4897959183675 565.0714285714286,1623.8265306122448 569.2857142857142,1623.1632653061224 573.5,1622.5 573.5,1622.5 577.7142857142857,1621.8367346938774 581.9285714285713,1621.1734693877547 586.1428571428571,1620.5102040816328 590.3571428571428,1619.8469387755104 594.5714285714286,1619.1836734693877 598.7857142857141,1618.5204081632648 603.0000000000002,1617.8571428571433 607.2142857142858,1617.1938775510203 611.4285714285714,1616.5306122448978 615.6428571428571,1615.8673469387754 619.8571428571427,1615.2040816326526 624.0714285714284,1614.5408163265304 628.2857142857142,1613.8775510204082 632.5,1613.2142857142858 636.7142857142858,1612.5510204081634 640.9285714285714,1611.887755102041 645.1428571428571,1611.2244897959188 649.3571428571428,1610.5612244897957 653.5714285714286,1609.8979591836733 657.7857142857142,1609.2346938775506 661.9999999999999,1608.5714285714282 666.2142857142858,1607.908163265306 670.4285714285713,1607.2448979591834 674.6428571428571,1606.5816326530612 678.8571428571428,1605.9183673469386 683.0714285714284,1605.2551020408164 687.2857142857142,1604.591836734694 691.5,1603.9285714285716 695.7142857142857,1603.265306122449 699.9285714285713,1602.6020408163267 704.1428571428571,1601.938775510204 708.3571428571428,1601.2755102040815 712.5714285714286,1600.612244897959 716.7857142857142,1599.9489795918366 721.0,1599.2857142857142 725.2142857142857,1598.6224489795918 729.4285714285714,1597.9591836734694 733.6428571428571,1597.295918367347 737.8571428571429,1596.6326530612246 742.0714285714286,1595.9693877551022 746.2857142857142,1595.3061224489795 750.5,1594.6428571428573 754.7142857142858,1593.9795918367345 758.9285714285713,1593.316326530612 763.1428571428571,1592.6530612244896 767.3571428571429,1591.9897959183675 771.5714285714287,1591.3265306122448 775.7857142857143,1590.6632653061224 780.0,1590.0\" stroke=\"#8c35cd\" stroke-width=\"1\" /><polyline fill=\"none\" points=\"774.2834416550987,1585.8381541756785 780,1590 775.8381541756786,1595.7165583449014 780,1590\" stroke=\"#8c35cd\" stroke-width=\"1\" /><rect fill=\"white\" height=\"13\" rx=\"2\" ry=\"2\" stroke=\"#8c35cd\" stroke-width=\"1\" transform=\"rotate(-8.944128345558154 572.0 1619.0)\" width=\"35.22222222222222\" x=\"554.3888888888889\" y=\"1612.5\" /><text fill=\"#8c35cd\" font-family=\"courier\" font-size=\"12\" transform=\"rotate(-8.944128345558154 572.0 1619.0)\" x=\"557.3888888888889\" y=\"1622.5\">TeRP</text><polyline fill=\"none\" points=\"813.0,1555.0 806.2142857142857,1553.7960798646823 799.4285714285713,1552.593128713376 792.6428571428572,1551.3921155300939 785.8571428571429,1550.1940092988466 779.0714285714287,1548.9997790036466 772.2857142857142,1547.810393628505 765.5000000000001,1546.6268221574346 758.7142857142859,1545.4500335744465 751.9285714285716,1544.280996863552 745.1428571428571,1543.120681008763 738.3571428571429,1541.9700549940926 731.5714285714286,1540.8300878035511 724.7857142857142,1539.701748421151 718.0,1538.5860058309038 711.214285714286,1537.4838290168213 704.4285714285716,1536.3961869629154 697.6428571428572,1535.3240486531975 690.8571428571429,1534.2683830716792 684.0714285714287,1533.2301592023734 677.2857142857142,1532.2103460292903 670.5,1531.209912536443 663.7142857142858,1530.229827707843 656.9285714285714,1529.2710605275013 650.1428571428572,1528.3345799794304 643.357142857143,1527.4213550476416 636.5714285714287,1526.5323547161472 629.7857142857143,1525.6685479689586 623.0000000000001,1524.8309037900876 616.2142857142858,1524.0203911635458 609.4285714285714,1523.2379790733453 602.6428571428572,1522.484636503498 595.8571428571429,1521.7613324380147 589.0714285714287,1521.0690358609083 582.2857142857144,1520.40871575619 575.5000000000001,1519.7813411078719 568.7142857142858,1519.1878808999654 561.9285714285714,1518.6293041164822 555.1428571428572,1518.1065797414344 548.3571428571429,1517.6206767588337 541.5714285714287,1517.1725641526916 534.7857142857143,1516.76321090702 528.0,1516.393586005831 521.2142857142858,1516.0646584331357 514.4285714285714,1515.7773971729466 507.6428571428572,1515.5327712092749 500.8571428571429,1515.3317495261329 494.0714285714286,1515.1753011075316 487.2857142857143,1515.0643949374835 480.5,1515.0 480.5,1515.0 473.7142857142857,1514.9827622844223 466.92857142857133,1515.012035801409 460.14285714285717,1515.0868515669492 453.3571428571429,1515.2062405970303 446.57142857142856,1515.3692339076404 439.7857142857142,1515.5748625147685 433.0000000000001,1515.822157434403 426.2142857142857,1516.1101496825304 419.4285714285714,1516.4378702751405 412.6428571428571,1516.804350228221 405.85714285714283,1517.2086205577605 399.0714285714285,1517.649712279747 392.2857142857143,1518.126656410169 385.5,1518.6384839650143 378.7142857142858,1519.184225960272 371.9285714285715,1519.7629134119288 365.14285714285717,1520.373577335974 358.3571428571429,1521.0152487483956 351.57142857142856,1521.686958665182 344.78571428571416,1522.387738102321 337.99999999999994,1523.1166180758016 331.2142857142857,1523.8726296016116 324.4285714285714,1524.654803695739 317.6428571428571,1525.4621713741722 310.85714285714283,1526.2937636528998 304.07142857142856,1527.1486115479092 297.28571428571433,1528.0257460751895 290.5,1528.9241982507288 283.7142857142857,1529.8429990905147 276.9285714285715,1530.7811796105364 270.14285714285717,1531.7377708267813 263.35714285714283,1532.7118037552382 256.57142857142856,1533.7023094118945 249.78571428571428,1534.7083188127394 243.0,1535.728862973761 236.21428571428572,1536.7629729109467 229.42857142857144,1537.809679640286 222.64285714285717,1538.8680141777659 215.8571428571429,1539.9370075393756 209.0714285714286,1541.0156907411028 202.2857142857143,1542.1030947989357 195.5,1543.198250728863 188.71428571428572,1544.3001895468724 181.92857142857144,1545.4079422689524 175.14285714285717,1546.5205399110914 168.35714285714286,1547.6370134892775 161.57142857142858,1548.7563940194987 154.78571428571428,1549.8777125177435 148.0,1551.0\" stroke=\"#8c35cd\" stroke-width=\"1\" /><polyline fill=\"none\" points=\"153.63803028702657,1555.2676239821217 148,1551 152.26762398212165,1545.3619697129734 148,1551\" stroke=\"#8c35cd\" stroke-width=\"1\" /><rect fill=\"white\" height=\"13\" rx=\"2\" ry=\"2\" stroke=\"#8c35cd\" stroke-width=\"1\" transform=\"rotate(0 479.0 1516.5)\" width=\"35.22222222222222\" x=\"461.3888888888889\" y=\"1510\" /><text fill=\"#8c35cd\" font-family=\"courier\" font-size=\"12\" transform=\"rotate(0 479.0 1516.5)\" x=\"464.3888888888889\" y=\"1520\">TeRP</text></svg>"]}}],"execution_count":0},{"cell_type":"markdown","source":["**If you want to go more over about relation extraction model examples, you can check this comprehensive notebook :**\n\nhttps://github.com/JohnSnowLabs/spark-nlp-workshop/blob/master/tutorials/Certification_Trainings/Healthcare/10.Clinical_Relation_Extraction.ipynb"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"a28156d0-ae31-4bd7-8227-26c5cfda45a9"}}},{"cell_type":"markdown","source":["## 4. Entity Resolution"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"3f81f6d7-04f7-45e1-a58e-e0578ebb509b"}}},{"cell_type":"markdown","source":["There are many entity resolution models for different kinds of purposes in Spark NLP. But mainly, we can collect these models in two categories:\n\n* Chunk Entity Resolver Models\n* Sentence Entity Resolver Models\n\nHere are some of the resolver models in Spark NLP:\n\n- sbiobertresolve_icd10cm \n- sbiobertresolve_icd10cm_augmented\n- sbiobertresolve_icd10cm_slim_normalized\n- sbiobertresolve_icd10cm_slim_billable_hcc\n- sbertresolve_icd10cm_slim_billable_hcc_med\n- sbiobertresolve_icd10pcs\n- sbiobertresolve_snomed_findings (with clinical_findings concepts from CT version)\n- sbiobertresolve_snomed_findings_int  (with clinical_findings concepts from INT version)\n- sbiobertresolve_snomed_auxConcepts (with Morph Abnormality, Procedure, Substance, Physical Object, Body Structure concepts from CT version)\n- sbiobertresolve_snomed_auxConcepts_int  (with Morph Abnormality, Procedure, Substance, Physical Object, Body Structure concepts from INT version)\n- sbiobertresolve_rxnorm\n- sbiobertresolve_rxcui\n- sbiobertresolve_icdo\n- sbiobertresolve_cpt\n- sbiobertresolve_loinc\n- sbiobertresolve_HPO\n- sbiobertresolve_umls_major_concepts\n- sbiobertresolve_umls_findings\n- ..."],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"49c45702-a71e-43f6-8d3c-02583f4b5e02"}}},{"cell_type":"markdown","source":["We will use the same NER pipeline and `sbiobertresolve_icd10cm_slim_billable_hcc` ICD10 CM entity resolver model."],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"70561239-6096-4266-a3fd-bc8d1f3575f5"}}},{"cell_type":"code","source":["c2doc = Chunk2Doc()\\\n      .setInputCols(\"ner_chunk\")\\\n      .setOutputCol(\"ner_chunk_doc\") \n\nsbert_embedder = BertSentenceEmbeddings\\\n      .pretrained(\"sbert_jsl_medium_uncased\",'en','clinical/models')\\\n      .setInputCols([\"ner_chunk_doc\"])\\\n      .setOutputCol(\"sbert_embeddings\")\n\nicd_resolver = SentenceEntityResolverModel.pretrained(\"sbertresolve_icd10cm_slim_billable_hcc_med\",\"en\", \"clinical/models\") \\\n      .setInputCols([\"ner_chunk\", \"sbert_embeddings\"]) \\\n      .setOutputCol(\"icd10_code\")\\\n      .setDistanceFunction(\"EUCLIDEAN\")\n\n\nresolverPipeline = Pipeline(stages=[\n        nerPipeline,\n        c2doc,\n        sbert_embedder,\n        icd_resolver\n    \n])\n\nempty_data = spark.createDataFrame([[\"\"]]).toDF(\"text\")\nresolver_model = resolverPipeline.fit(empty_data)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"954faa34-e7f3-43d8-a79d-5cd36c856db2"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">sbert_jsl_medium_uncased download started this may take some time.\nApproximate size to download 146.8 MB\n\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[OK!]\nsbertresolve_icd10cm_slim_billable_hcc_med download started this may take some time.\nApproximate size to download 580.3 MB\n\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[OK!]\n</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">sbert_jsl_medium_uncased download started this may take some time.\nApproximate size to download 146.8 MB\n\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[OK!]\nsbertresolve_icd10cm_slim_billable_hcc_med download started this may take some time.\nApproximate size to download 580.3 MB\n\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[ / ]\r[ — ]\r[ \\ ]\r[ | ]\r[OK!]\n</div>"]}}],"execution_count":0},{"cell_type":"code","source":["res_light = LightPipeline(resolver_model)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"32605553-c863-43e4-b326-845cca65d4ad"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\"></div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\"></div>"]}}],"execution_count":0},{"cell_type":"code","source":["res_anno = res_light.annotate(\"bladder cancer\")"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"a0554554-7464-4f55-84b7-ac8a1e820c65"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\"></div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\"></div>"]}}],"execution_count":0},{"cell_type":"code","source":["res_anno"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"17f71923-6536-4492-b680-ecdbc35b88b5"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">Out[54]: {&#39;document&#39;: [&#39;bladder cancer&#39;],\n &#39;ner_chunk&#39;: [&#39;bladder cancer&#39;],\n &#39;token&#39;: [&#39;bladder&#39;, &#39;cancer&#39;],\n &#39;sbert_embeddings&#39;: [&#39;bladder cancer&#39;],\n &#39;ner&#39;: [&#39;B-PROBLEM&#39;, &#39;I-PROBLEM&#39;],\n &#39;embeddings&#39;: [&#39;bladder&#39;, &#39;cancer&#39;],\n &#39;pos_tags&#39;: [&#39;JJR&#39;, &#39;NN&#39;],\n &#39;icd10_code&#39;: [&#39;C671&#39;],\n &#39;ner_chunk_doc&#39;: [&#39;bladder cancer&#39;],\n &#39;sentence&#39;: [&#39;bladder cancer&#39;]}</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">Out[54]: {&#39;document&#39;: [&#39;bladder cancer&#39;],\n &#39;ner_chunk&#39;: [&#39;bladder cancer&#39;],\n &#39;token&#39;: [&#39;bladder&#39;, &#39;cancer&#39;],\n &#39;sbert_embeddings&#39;: [&#39;bladder cancer&#39;],\n &#39;ner&#39;: [&#39;B-PROBLEM&#39;, &#39;I-PROBLEM&#39;],\n &#39;embeddings&#39;: [&#39;bladder&#39;, &#39;cancer&#39;],\n &#39;pos_tags&#39;: [&#39;JJR&#39;, &#39;NN&#39;],\n &#39;icd10_code&#39;: [&#39;C671&#39;],\n &#39;ner_chunk_doc&#39;: [&#39;bladder cancer&#39;],\n &#39;sentence&#39;: [&#39;bladder cancer&#39;]}</div>"]}}],"execution_count":0},{"cell_type":"code","source":["list(zip(res_anno[\"ner_chunk\"], res_anno[\"icd10_code\"]))"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"b20b9b95-bbe4-439a-8c71-a02cf5a8dd9c"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">Out[55]: [(&#39;bladder cancer&#39;, &#39;C671&#39;)]</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">Out[55]: [(&#39;bladder cancer&#39;, &#39;C671&#39;)]</div>"]}}],"execution_count":0},{"cell_type":"code","source":["resolver_res = res_light.fullAnnotate(sample_text[1])[0]"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"61fe3cfd-9a8b-4db6-94f6-666ba0cd52b9"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\"></div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\"></div>"]}}],"execution_count":0},{"cell_type":"code","source":["resolver_res.keys()"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"3036b8a0-5396-4f7d-9af5-6a8e5518bfd4"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">Out[57]: dict_keys([&#39;document&#39;, &#39;ner_chunk&#39;, &#39;token&#39;, &#39;sbert_embeddings&#39;, &#39;ner&#39;, &#39;embeddings&#39;, &#39;pos_tags&#39;, &#39;icd10_code&#39;, &#39;ner_chunk_doc&#39;, &#39;sentence&#39;])</div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">Out[57]: dict_keys([&#39;document&#39;, &#39;ner_chunk&#39;, &#39;token&#39;, &#39;sbert_embeddings&#39;, &#39;ner&#39;, &#39;embeddings&#39;, &#39;pos_tags&#39;, &#39;icd10_code&#39;, &#39;ner_chunk_doc&#39;, &#39;sentence&#39;])</div>"]}}],"execution_count":0},{"cell_type":"code","source":["chunks = []\ncodes = []\nbegin = []\nend = []\nresolutions= []\nall_distances = []\nall_codes= []\nall_cosines = []\nall_k_aux_labels= []\nconfidence = []\nentity = []\n\nfor chunk, code in zip(resolver_res['ner_chunk'], resolver_res[\"icd10_code\"]):\n\n    begin.append(chunk.begin)\n    entity.append(chunk.metadata['entity'])\n    end.append(chunk.end)\n    chunks.append(chunk.result)\n    codes.append(code.result) \n    confidence.append(code.metadata['confidence'])\n    all_codes.append(code.metadata['all_k_results'].split(':::'))\n    resolutions.append(code.metadata['all_k_resolutions'].split(':::'))\n    all_distances.append(code.metadata['all_k_distances'].split(':::'))\n    all_cosines.append(code.metadata['all_k_cosine_distances'].split(':::'))\n    all_k_aux_labels.append(code.metadata['all_k_aux_labels'].split(':::'))\n    \ndf = pd.DataFrame({'chunks':chunks, 'entity':entity, 'begin': begin, 'end':end, 'code':codes, 'all_codes':all_codes, \n                   'resolutions':resolutions, 'all_k_aux_labels':all_k_aux_labels,'all_distances':all_cosines})\n\n\n\ndf['billable'] = df['all_k_aux_labels'].apply(lambda x: [i.split('||')[0] for i in x])\ndf['hcc_status'] = df['all_k_aux_labels'].apply(lambda x: [i.split('||')[1] for i in x])\ndf['hcc_score'] = df['all_k_aux_labels'].apply(lambda x: [i.split('||')[2] for i in x])\ndf['confidence'] = confidence\n\ndf = df.drop(['all_k_aux_labels'], axis=1)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"32920c2f-f381-44e9-8c1a-a456c8c7043f"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\"></div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\"></div>"]}}],"execution_count":0},{"cell_type":"code","source":["pd.set_option(\"display.max_colwidth\", 100)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"90b5cdbf-46b4-4db1-9194-981f1a9dc5aa"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\"></div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\"></div>"]}}],"execution_count":0},{"cell_type":"code","source":["df"],"metadata":{"scrolled":false,"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"49e2c7b8-e92c-4a8d-b818-df929b559964"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">Out[60]: </div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">Out[60]: </div>"]}},{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>chunks</th>\n      <th>entity</th>\n      <th>begin</th>\n      <th>end</th>\n      <th>code</th>\n      <th>all_codes</th>\n      <th>resolutions</th>\n      <th>all_distances</th>\n      <th>billable</th>\n      <th>hcc_status</th>\n      <th>hcc_score</th>\n      <th>confidence</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>the treatment</td>\n      <td>TREATMENT</td>\n      <td>67</td>\n      <td>79</td>\n      <td>Z7689</td>\n      <td>[Z7689, Z789, F4329, N5313, Z3141, Z37, Q438, E45, Z9189, T66XXXA, Z7189]</td>\n      <td>[response to treatment [Persons encountering health services in other specified circumstances], ...</td>\n      <td>[0.2620, 0.2690, 0.2773, 0.2850, 0.2940, 0.2921, 0.3030, 0.2976, 0.3103, 0.3050, 0.2962]</td>\n      <td>[1, 1, 1, 1, 1, 0, 1, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 21, 0, 0, 0]</td>\n      <td>0.1487</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>breast cancer</td>\n      <td>PROBLEM</td>\n      <td>84</td>\n      <td>96</td>\n      <td>C50919</td>\n      <td>[C50919, Z1239, C50911, C4452, D0590, D493, C61, C44501, Z853, C50819, C50111, C50929, C50921, C...</td>\n      <td>[breast cancer [Malignant neoplasm of unspecified site of unspecified female breast], screening ...</td>\n      <td>[0.0000, 0.1055, 0.1108, 0.1151, 0.1247, 0.1303, 0.1323, 0.1391, 0.1372, 0.1420, 0.1439, 0.1440,...</td>\n      <td>[1, 1, 1, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 12, 0, 0, 0, 0, 0, 0, 12, 0, 0, 0, 9, 12]</td>\n      <td>0.9984</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>the standard therapy</td>\n      <td>TREATMENT</td>\n      <td>109</td>\n      <td>128</td>\n      <td>Z789</td>\n      <td>[Z789, Z7689, Z9289, Z5181, Z7189]</td>\n      <td>[complete therapeutic response [Other specified health status], ideal weight discussed (regime/t...</td>\n      <td>[0.2608, 0.2806, 0.2919, 0.2893, 0.3101]</td>\n      <td>[1, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0]</td>\n      <td>0.2919</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>anthracyclines</td>\n      <td>TREATMENT</td>\n      <td>167</td>\n      <td>180</td>\n      <td>A220</td>\n      <td>[A220, A229, A22, A222, L940, Z1629, B999, D239, A599, A227, Q821, A5272, H5054, L998, N897, A22...</td>\n      <td>[skin anthrax [Cutaneous anthrax], anthrax infection [Anthrax, unspecified], anthrax [Anthrax], ...</td>\n      <td>[0.2478, 0.2633, 0.2688, 0.2688, 0.2868, 0.2857, 0.2857, 0.2944, 0.2948, 0.2823, 0.2905, 0.2970,...</td>\n      <td>[1, 1, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 115, 6, 0, 0, 0, 0, 0]</td>\n      <td>0.0817</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>taxanes</td>\n      <td>TREATMENT</td>\n      <td>186</td>\n      <td>192</td>\n      <td>H1511</td>\n      <td>[H1511, H15119, D4989, C7220, Q103, C781, L293, L291, I722, P2810, I714, R198, Q702, Q7649, L812...</td>\n      <td>[episcleritis periodica fugax [Episcleritis periodica fugax], episcleritis periodica fugax [Epis...</td>\n      <td>[0.3039, 0.3039, 0.2873, 0.2735, 0.2948, 0.3006, 0.2971, 0.2971, 0.2937, 0.3039, 0.3005, 0.2809,...</td>\n      <td>[0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 1, 0, 1, 0, 0, 1, 0, 1, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 1, 1, 1]</td>\n      <td>[0, 0, 0, 10, 0, 8, 0, 0, 108, 0, 108, 0, 0, 0, 0, 108, nan, 111, 11, 11, 0, 0, 11, 108, 107]</td>\n      <td>0.0579</td>\n    </tr>\n    <tr>\n      <th>5</th>\n      <td>the usefulnessof vinorelbine monotherapy</td>\n      <td>TREATMENT</td>\n      <td>229</td>\n      <td>268</td>\n      <td>Z7189</td>\n      <td>[Z7189, Z7689, Z4931, L049, T464X4S, Z713, K5900, Z3183, Z4932, F1621, F1921, T43214, F18921, Z4...</td>\n      <td>[accutane treatment counseling [Other specified counseling], incretin mimetic therapy started (s...</td>\n      <td>[0.1702, 0.1904, 0.2058, 0.2281, 0.2153, 0.2091, 0.2091, 0.2194, 0.2257, 0.2462, 0.2462, 0.2356,...</td>\n      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1]</td>\n      <td>[0, 0, 1, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 1, 0, 0]</td>\n      <td>[0, 0, 134, 0, 0, 0, 0, 0, 134, 55, 55, 0, 0, 134, 0, 0]</td>\n      <td>0.1363</td>\n    </tr>\n    <tr>\n      <th>6</th>\n      <td>advanced or recurrent breast cancerafter standard therapy</td>\n      <td>TREATMENT</td>\n      <td>287</td>\n      <td>343</td>\n      <td>Z1239</td>\n      <td>[Z1239, Z8541, Z923, Z125, C802, T8649, R9721, T86818, Z1503, O3412, O3413, C5091, O3410, O3411,...</td>\n      <td>[screening exam for breast cancer [Encounter for other screening for malignant neoplasm of breas...</td>\n      <td>[0.1534, 0.1573, 0.1573, 0.1514, 0.1550, 0.1550, 0.1631, 0.1582, 0.1690, 0.1640, 0.1650, 0.1732,...</td>\n      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1, 0, 1, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 1, 0, 0, 1, 1, 0, 1, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 12, 186, 0, 0, 0, 0, 0, 12, 0, 0, 186, 8, 0, 11, 0, 0, 0, 0]</td>\n      <td>0.0606</td>\n    </tr>\n    <tr>\n      <th>7</th>\n      <td>vinorelbine</td>\n      <td>TREATMENT</td>\n      <td>386</td>\n      <td>396</td>\n      <td>E7201</td>\n      <td>[E7201, H5353, N8181, O418X, L708, F488, R7989, S0082, S0082XA, I7389, S0082XD, J3489, I898, Y95...</td>\n      <td>[cystinuria, type 1 [Cystinuria], deuteranomaly [Deuteranomaly], perineocele [Perineocele], find...</td>\n      <td>[0.2897, 0.2942, 0.2888, 0.3018, 0.2972, 0.3220, 0.3120, 0.3416, 0.3416, 0.3567, 0.3461, 0.3205,...</td>\n      <td>[1, 1, 1, 0, 1, 1, 1, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]</td>\n      <td>[1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>[23, 0, 0, 0, 0, 0, 0, 0, 0, 108, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>0.0937</td>\n    </tr>\n    <tr>\n      <th>8</th>\n      <td>anthracyclines</td>\n      <td>TREATMENT</td>\n      <td>433</td>\n      <td>446</td>\n      <td>A220</td>\n      <td>[A220, A229, A22, A222, L940, Z1629, B999, D239, A599, A227, Q821, A5272, H5054, L998, N897, A22...</td>\n      <td>[skin anthrax [Cutaneous anthrax], anthrax infection [Anthrax, unspecified], anthrax [Anthrax], ...</td>\n      <td>[0.2478, 0.2633, 0.2688, 0.2688, 0.2868, 0.2857, 0.2857, 0.2944, 0.2948, 0.2823, 0.2905, 0.2970,...</td>\n      <td>[1, 1, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 115, 6, 0, 0, 0, 0, 0]</td>\n      <td>0.0817</td>\n    </tr>\n    <tr>\n      <th>9</th>\n      <td>taxanes</td>\n      <td>TREATMENT</td>\n      <td>452</td>\n      <td>458</td>\n      <td>H1511</td>\n      <td>[H1511, H15119, D4989, C7220, Q103, C781, L293, L291, I722, P2810, I714, R198, Q702, Q7649, L812...</td>\n      <td>[episcleritis periodica fugax [Episcleritis periodica fugax], episcleritis periodica fugax [Epis...</td>\n      <td>[0.3039, 0.3039, 0.2873, 0.2735, 0.2948, 0.3006, 0.2971, 0.2971, 0.2937, 0.3039, 0.3005, 0.2809,...</td>\n      <td>[0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 1, 0, 1, 0, 0, 1, 0, 1, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 1, 1, 1]</td>\n      <td>[0, 0, 0, 10, 0, 8, 0, 0, 108, 0, 108, 0, 0, 0, 0, 108, nan, 111, 11, 11, 0, 0, 11, 108, 107]</td>\n      <td>0.0579</td>\n    </tr>\n    <tr>\n      <th>10</th>\n      <td>Vinorelbinewas</td>\n      <td>TREATMENT</td>\n      <td>470</td>\n      <td>483</td>\n      <td>Z7689</td>\n      <td>[Z7689, T691X, T691XXA, L708, T691XXS, S0082, S0082XA, E511, E5111, B748, R6889, Z79899, D720, H...</td>\n      <td>[under care of cmhn [Persons encountering health services in other specified circumstances], chi...</td>\n      <td>[0.2952, 0.2929, 0.2929, 0.2963, 0.3108, 0.3360, 0.3360, 0.3123, 0.3123, 0.3020, 0.3249, 0.3460,...</td>\n      <td>[1, 1, 1, 1, 1, 0, 1, 0, 1, 1, 1, 1, 1, 1, 1, 1, 0, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 47, 0, 52, 0, 0, 0]</td>\n      <td>0.1032</td>\n    </tr>\n    <tr>\n      <th>11</th>\n      <td>tumorprogression</td>\n      <td>TREATMENT</td>\n      <td>635</td>\n      <td>650</td>\n      <td>R3989</td>\n      <td>[R3989, D492, L744, C212, C889, K033, M8418, M960, R4189, E220, M619, Y408, D4989, F22, D495, T6...</td>\n      <td>[pseudoemission [Other symptoms and signs involving the genitourinary system], neoplasm of natur...</td>\n      <td>[0.2067, 0.2428, 0.2456, 0.2462, 0.2722, 0.2684, 0.2619, 0.2619, 0.2532, 0.2594, 0.2615, 0.2642,...</td>\n      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 1, 1, 0, 0, 0, 0, 1, 0, 0, 0, 1, 0, 0, 1, 0, 0, 1, 0]</td>\n      <td>[0, 0, 0, 11, 10, 0, 0, 0, 0, 23, 0, 0, 0, 59, 0, 0, 11, 0, 0, 12, 0]</td>\n      <td>0.1567</td>\n    </tr>\n    <tr>\n      <th>12</th>\n      <td>MR)</td>\n      <td>TEST</td>\n      <td>856</td>\n      <td>858</td>\n      <td>N469</td>\n      <td>[N469, N46, Z634, Z7689, R4189, K1379, G932, Z0389, L290, L298, M40299, Z30433, Z621, R448]</td>\n      <td>[primary male infertility [Male infertility, unspecified], secondary male infertility [Male infe...</td>\n      <td>[0.3564, 0.3628, 0.3917, 0.3965, 0.4001, 0.4345, 0.4588, 0.4340, 0.4625, 0.4478, 0.4373, 0.4495,...</td>\n      <td>[1, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>0.1431</td>\n    </tr>\n    <tr>\n      <th>13</th>\n      <td>change</td>\n      <td>PROBLEM</td>\n      <td>866</td>\n      <td>871</td>\n      <td>F6089</td>\n      <td>[F6089, Z561, F629, Z7689, G4726, L678, Z9189, Z4803, T819X, T819XXA, R009, Z924, R0989]</td>\n      <td>[personality change [Other specific personality disorders], change of job [Change of job], chang...</td>\n      <td>[0.2340, 0.2476, 0.2594, 0.2807, 0.2908, 0.3184, 0.3197, 0.3236, 0.3273, 0.3273, 0.3327, 0.3438,...</td>\n      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]</td>\n      <td>[1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>[60, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>0.2581</td>\n    </tr>\n    <tr>\n      <th>14</th>\n      <td>NC)</td>\n      <td>TEST</td>\n      <td>874</td>\n      <td>876</td>\n      <td>Z30431</td>\n      <td>[Z30431, W2209XD, W2209, Z7689, Y288XXD, R293, H332, R4189, M6285, H360, S96911A, S0911XA, S0911...</td>\n      <td>[iud, surveillance [Encounter for routine checking of intrauterine contraceptive device], striki...</td>\n      <td>[0.3145, 0.3158, 0.3158, 0.3052, 0.3479, 0.3228, 0.3113, 0.3294, 0.3250, 0.3218, 0.3260, 0.3231,...</td>\n      <td>[1, 1, 0, 1, 1, 1, 0, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>0.0748</td>\n    </tr>\n    <tr>\n      <th>15</th>\n      <td>partial responses</td>\n      <td>TEST</td>\n      <td>902</td>\n      <td>918</td>\n      <td>Z789</td>\n      <td>[Z789, K5660, K5669, K566, R4789, R0989, Z712, K084, Z7689, N971, Q922, Z9119, H332, E230, F6589...</td>\n      <td>[partial response to treatment [Other specified health status], partial obstruction of small bow...</td>\n      <td>[0.1588, 0.2428, 0.2428, 0.2366, 0.2361, 0.2366, 0.2396, 0.2418, 0.2456, 0.2631, 0.2611, 0.2572,...</td>\n      <td>[1, 0, 0, 0, 1, 1, 1, 0, 1, 1, 1, 1, 0, 1, 1, 1]</td>\n      <td>[0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0]</td>\n      <td>[0, 33, 33, 0, 0, 0, 0, 0, 0, 0, nan, 0, 0, 23, 0, 0]</td>\n      <td>0.4619</td>\n    </tr>\n    <tr>\n      <th>16</th>\n      <td>PRs</td>\n      <td>TEST</td>\n      <td>921</td>\n      <td>923</td>\n      <td>Z30431</td>\n      <td>[Z30431, R198, X19XXXD, X19XX, W301X, W301XXD, L282, X19XXXA, Z8774, F902, T796XXA, F909, L200, ...</td>\n      <td>[iud, surveillance [Encounter for routine checking of intrauterine contraceptive device], psoas ...</td>\n      <td>[0.3105, 0.3207, 0.3489, 0.3489, 0.3531, 0.3531, 0.3442, 0.3482, 0.3481, 0.3229, 0.3467, 0.3290,...</td>\n      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, nan, 0, nan, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>0.1158</td>\n    </tr>\n    <tr>\n      <th>17</th>\n      <td>MR</td>\n      <td>TEST</td>\n      <td>932</td>\n      <td>933</td>\n      <td>H360</td>\n      <td>[H360, N469, N46, Z7689, Y610, N468, D475, Q251, N460, R198, L604, E291, R222, L298, Q983, R4189...</td>\n      <td>[dr [Retinal disorders in diseases classified elsewhere], primary male infertility [Male inferti...</td>\n      <td>[0.3007, 0.3549, 0.3540, 0.4256, 0.4195, 0.4072, 0.4223, 0.4138, 0.4311, 0.4438, 0.4297, 0.4306,...</td>\n      <td>[1, 1, 0, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 52]</td>\n      <td>0.3767</td>\n    </tr>\n    <tr>\n      <th>18</th>\n      <td>NCs out</td>\n      <td>TEST</td>\n      <td>940</td>\n      <td>946</td>\n      <td>Z789</td>\n      <td>[Z789, Z9289, Z7689, X52XXXD, X52XX, H54511, H542X2, Q959, H542X1, O4210, H33051, O4700]</td>\n      <td>[patient in remission [Other specified health status], treatment completed (procedure) [Personal...</td>\n      <td>[0.3253, 0.3490, 0.3728, 0.3878, 0.3878, 0.3867, 0.3760, 0.3632, 0.3783, 0.3846, 0.3700, 0.3879]</td>\n      <td>[1, 1, 1, 1, 1, 0, 0, 1, 0, 1, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>0.1554</td>\n    </tr>\n    <tr>\n      <th>19</th>\n      <td>TheKaplan-Meier estimate</td>\n      <td>TEST</td>\n      <td>956</td>\n      <td>979</td>\n      <td>Z7689</td>\n      <td>[Z7689, D720, R700]</td>\n      <td>[seen by endocrinology service (finding) [Persons encountering health services in other specifie...</td>\n      <td>[0.2599, 0.3172, 0.3300]</td>\n      <td>[1, 1, 1]</td>\n      <td>[0, 1, 0]</td>\n      <td>[0, 47, 0]</td>\n      <td>0.5512</td>\n    </tr>\n    <tr>\n      <th>20</th>\n      <td>The response rate in the visceral organs</td>\n      <td>TEST</td>\n      <td>1037</td>\n      <td>1076</td>\n      <td>S278</td>\n      <td>[S278, N992, R840, D4989, N9489, S2789, S27898, S27893S, M9912, H35011, M9914, Q335, I715, H3501...</td>\n      <td>[injury of other specified intrathoracic organs [Injury of other specified intrathoracic organs]...</td>\n      <td>[0.1780, 0.1772, 0.1780, 0.1939, 0.1855, 0.1923, 0.1923, 0.1961, 0.1916, 0.1926, 0.1957, 0.1891,...</td>\n      <td>[0, 1, 1, 1, 1, 0, 0, 1, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 107, 0, 0, 0, 0, 0, 107]</td>\n      <td>0.0751</td>\n    </tr>\n    <tr>\n      <th>21</th>\n      <td>Themajor toxicity</td>\n      <td>PROBLEM</td>\n      <td>1110</td>\n      <td>1126</td>\n      <td>T460X1A</td>\n      <td>[T460X1A, T604X, T603X, X49, X48, D8989, T5291, T531X4D, T531X, X46, T600, T594X, T594X4A, T590X...</td>\n      <td>[digoxin toxicity [Poisoning by cardiac-stimulant glycosides and drugs of similar action, accide...</td>\n      <td>[0.1514, 0.1835, 0.2043, 0.2205, 0.2274, 0.2309, 0.2354, 0.2519, 0.2519, 0.2504, 0.2386, 0.2663,...</td>\n      <td>[1, 0, 0, 1, 1, 1, 0, 1, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0, 1, 1, 1, 1, 1, 1]</td>\n      <td>[0, 1, 1, 0, 0, 1, 0, 0, 1, 0, 0, 1, 0, 1, 0, 0, 1, 0, 0, 0, 1, 0, 0, 0]</td>\n      <td>[0, 59, 59, 0, 0, 47, 0, 0, 59, 0, 0, 59, 0, 59, 0, 0, 59, 0, 0, 0, 55, 0, 0, 0]</td>\n      <td>0.3070</td>\n    </tr>\n    <tr>\n      <th>22</th>\n      <td>myelosuppression</td>\n      <td>PROBLEM</td>\n      <td>1132</td>\n      <td>1147</td>\n      <td>D759</td>\n      <td>[D759, D7589, N9489, Q059, C900, Z8579, C9001, D471, Z807, C9000, T441X, T441X6S, A804, R631, Q0...</td>\n      <td>[myelosuppression [Disease of blood and blood-forming organs, unspecified], myelosuppression [Ot...</td>\n      <td>[0.0000, 0.0000, 0.2969, 0.2885, 0.2985, 0.3011, 0.3153, 0.3476, 0.3276, 0.3330, 0.3438, 0.3438,...</td>\n      <td>[1, 1, 1, 1, 0, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1, 0, 1, 1]</td>\n      <td>[0, 0, 0, 1, 0, 0, 1, 1, 0, 1, 1, 0, 0, 0, 1, 1, 0, 1]</td>\n      <td>[0, 0, 0, 72, 0, 0, 9, 48, 0, 9, 59, 0, 0, 0, 72, 59, 0, 23]</td>\n      <td>0.5000</td>\n    </tr>\n    <tr>\n      <th>23</th>\n      <td>requirediscontinuation</td>\n      <td>TREATMENT</td>\n      <td>1183</td>\n      <td>1204</td>\n      <td>N3949</td>\n      <td>[N3949, N39498, M2653, J349, J3489, R159, R15, T698XXD, T698X, T698XXA, Q6211, R3981, T7589, T75...</td>\n      <td>[other specified urinary incontinence [Other specified urinary incontinence], other specified ur...</td>\n      <td>[0.2526, 0.2526, 0.2601, 0.2745, 0.2745, 0.2617, 0.2680, 0.2918, 0.2918, 0.3024, 0.3012, 0.2721,...</td>\n      <td>[0, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1, 1, 0, 1, 0, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>0.0802</td>\n    </tr>\n    <tr>\n      <th>24</th>\n      <td>treatment</td>\n      <td>TREATMENT</td>\n      <td>1209</td>\n      <td>1217</td>\n      <td>Z9289</td>\n      <td>[Z9289, Z7689, T66XXXA, Z789, T829XXA, T859XXA, T8181XA, T8579XA, T814, Z7189, T86829, T8181, F4...</td>\n      <td>[treatment given (regime/therapy) [Personal history of other medical treatment], response to tre...</td>\n      <td>[0.1914, 0.2055, 0.2419, 0.2329, 0.2402, 0.2438, 0.2450, 0.2431, 0.2467, 0.2518, 0.2501, 0.2607,...</td>\n      <td>[1, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 0, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>0.2374</td>\n    </tr>\n    <tr>\n      <th>25</th>\n      <td>this study</td>\n      <td>TEST</td>\n      <td>1247</td>\n      <td>1256</td>\n      <td>Z7689</td>\n      <td>[Z7689, Z30431, R2689, H5232, Q131, Z331, Z33, Z3141, Z139, N3582, O2685, O26859, R4589]</td>\n      <td>[patient in local study [Persons encountering health services in other specified circumstances],...</td>\n      <td>[0.2919, 0.3441, 0.3495, 0.3460, 0.3460, 0.3286, 0.3286, 0.3369, 0.3274, 0.3588, 0.3348, 0.3348,...</td>\n      <td>[1, 1, 1, 1, 1, 1, 0, 1, 1, 1, 0, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>0.1741</td>\n    </tr>\n    <tr>\n      <th>26</th>\n      <td>thatvinorelbine monotherapy</td>\n      <td>TREATMENT</td>\n      <td>1263</td>\n      <td>1289</td>\n      <td>Z7689</td>\n      <td>[Z7689, I7389, T45626, T4562, T477X6S, T477X, Y721, Z7189, T45626S, T448X1S, T415X6S, Z3183, N46...</td>\n      <td>[incretin mimetic therapy started (situation) [Persons encountering health services in other spe...</td>\n      <td>[0.2691, 0.2901, 0.2826, 0.2826, 0.2809, 0.2809, 0.2971, 0.2756, 0.2905, 0.2984, 0.2837, 0.2892,...</td>\n      <td>[1, 1, 0, 0, 1, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 0, 1]</td>\n      <td>[0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0]</td>\n      <td>[0, 108, 0, 59, 0, 59, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 59, 0, 55, 59, 0]</td>\n      <td>0.0824</td>\n    </tr>\n    <tr>\n      <th>27</th>\n      <td>recurrent breastcancer</td>\n      <td>TREATMENT</td>\n      <td>1330</td>\n      <td>1351</td>\n      <td>I830</td>\n      <td>[I830, K269, E11622, L98499, E10622, K263, K265, E1162, K260, I87031, I8703, I87032, K261, K633,...</td>\n      <td>[recurrent venous leg ulcer [Varicose veins of lower extremities with ulcer], duodenal ulcer dis...</td>\n      <td>[0.0932, 0.1144, 0.1191, 0.1191, 0.1222, 0.1190, 0.1218, 0.1246, 0.1240, 0.1350, 0.1350, 0.1356,...</td>\n      <td>[0, 1, 1, 1, 1, 1, 1, 0, 1, 1, 0, 1, 1, 1, 1, 1, 1, 0, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 33, 18/161, 0, 0, 107, 0, 33, 0, 0, 0, 0, 0, 0]</td>\n      <td>0.1577</td>\n    </tr>\n    <tr>\n      <th>28</th>\n      <td>anthracyclines</td>\n      <td>TREATMENT</td>\n      <td>1380</td>\n      <td>1393</td>\n      <td>A220</td>\n      <td>[A220, A229, A22, A222, L940, Z1629, B999, D239, A599, A227, Q821, A5272, H5054, L998, N897, A22...</td>\n      <td>[skin anthrax [Cutaneous anthrax], anthrax infection [Anthrax, unspecified], anthrax [Anthrax], ...</td>\n      <td>[0.2478, 0.2633, 0.2688, 0.2688, 0.2868, 0.2857, 0.2857, 0.2944, 0.2948, 0.2823, 0.2905, 0.2970,...</td>\n      <td>[1, 1, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 115, 6, 0, 0, 0, 0, 0]</td>\n      <td>0.0817</td>\n    </tr>\n    <tr>\n      <th>29</th>\n      <td>taxanes</td>\n      <td>TREATMENT</td>\n      <td>1399</td>\n      <td>1405</td>\n      <td>H1511</td>\n      <td>[H1511, H15119, D4989, C7220, Q103, C781, L293, L291, I722, P2810, I714, R198, Q702, Q7649, L812...</td>\n      <td>[episcleritis periodica fugax [Episcleritis periodica fugax], episcleritis periodica fugax [Epis...</td>\n      <td>[0.3039, 0.3039, 0.2873, 0.2735, 0.2948, 0.3006, 0.2971, 0.2971, 0.2937, 0.3039, 0.3005, 0.2809,...</td>\n      <td>[0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 1, 0, 1, 0, 0, 1, 0, 1, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 1, 1, 1]</td>\n      <td>[0, 0, 0, 10, 0, 8, 0, 0, 108, 0, 108, 0, 0, 0, 0, 108, nan, 111, 11, 11, 0, 0, 11, 108, 107]</td>\n      <td>0.0579</td>\n    </tr>\n  </tbody>\n</table>\n</div>","textData":null,"removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"htmlSandbox","arguments":{}}},"output_type":"display_data","data":{"text/html":["<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>chunks</th>\n      <th>entity</th>\n      <th>begin</th>\n      <th>end</th>\n      <th>code</th>\n      <th>all_codes</th>\n      <th>resolutions</th>\n      <th>all_distances</th>\n      <th>billable</th>\n      <th>hcc_status</th>\n      <th>hcc_score</th>\n      <th>confidence</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>the treatment</td>\n      <td>TREATMENT</td>\n      <td>67</td>\n      <td>79</td>\n      <td>Z7689</td>\n      <td>[Z7689, Z789, F4329, N5313, Z3141, Z37, Q438, E45, Z9189, T66XXXA, Z7189]</td>\n      <td>[response to treatment [Persons encountering health services in other specified circumstances], ...</td>\n      <td>[0.2620, 0.2690, 0.2773, 0.2850, 0.2940, 0.2921, 0.3030, 0.2976, 0.3103, 0.3050, 0.2962]</td>\n      <td>[1, 1, 1, 1, 1, 0, 1, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 21, 0, 0, 0]</td>\n      <td>0.1487</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>breast cancer</td>\n      <td>PROBLEM</td>\n      <td>84</td>\n      <td>96</td>\n      <td>C50919</td>\n      <td>[C50919, Z1239, C50911, C4452, D0590, D493, C61, C44501, Z853, C50819, C50111, C50929, C50921, C...</td>\n      <td>[breast cancer [Malignant neoplasm of unspecified site of unspecified female breast], screening ...</td>\n      <td>[0.0000, 0.1055, 0.1108, 0.1151, 0.1247, 0.1303, 0.1323, 0.1391, 0.1372, 0.1420, 0.1439, 0.1440,...</td>\n      <td>[1, 1, 1, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 12, 0, 0, 0, 0, 0, 0, 12, 0, 0, 0, 9, 12]</td>\n      <td>0.9984</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>the standard therapy</td>\n      <td>TREATMENT</td>\n      <td>109</td>\n      <td>128</td>\n      <td>Z789</td>\n      <td>[Z789, Z7689, Z9289, Z5181, Z7189]</td>\n      <td>[complete therapeutic response [Other specified health status], ideal weight discussed (regime/t...</td>\n      <td>[0.2608, 0.2806, 0.2919, 0.2893, 0.3101]</td>\n      <td>[1, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0]</td>\n      <td>0.2919</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>anthracyclines</td>\n      <td>TREATMENT</td>\n      <td>167</td>\n      <td>180</td>\n      <td>A220</td>\n      <td>[A220, A229, A22, A222, L940, Z1629, B999, D239, A599, A227, Q821, A5272, H5054, L998, N897, A22...</td>\n      <td>[skin anthrax [Cutaneous anthrax], anthrax infection [Anthrax, unspecified], anthrax [Anthrax], ...</td>\n      <td>[0.2478, 0.2633, 0.2688, 0.2688, 0.2868, 0.2857, 0.2857, 0.2944, 0.2948, 0.2823, 0.2905, 0.2970,...</td>\n      <td>[1, 1, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 115, 6, 0, 0, 0, 0, 0]</td>\n      <td>0.0817</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>taxanes</td>\n      <td>TREATMENT</td>\n      <td>186</td>\n      <td>192</td>\n      <td>H1511</td>\n      <td>[H1511, H15119, D4989, C7220, Q103, C781, L293, L291, I722, P2810, I714, R198, Q702, Q7649, L812...</td>\n      <td>[episcleritis periodica fugax [Episcleritis periodica fugax], episcleritis periodica fugax [Epis...</td>\n      <td>[0.3039, 0.3039, 0.2873, 0.2735, 0.2948, 0.3006, 0.2971, 0.2971, 0.2937, 0.3039, 0.3005, 0.2809,...</td>\n      <td>[0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 1, 0, 1, 0, 0, 1, 0, 1, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 1, 1, 1]</td>\n      <td>[0, 0, 0, 10, 0, 8, 0, 0, 108, 0, 108, 0, 0, 0, 0, 108, nan, 111, 11, 11, 0, 0, 11, 108, 107]</td>\n      <td>0.0579</td>\n    </tr>\n    <tr>\n      <th>5</th>\n      <td>the usefulnessof vinorelbine monotherapy</td>\n      <td>TREATMENT</td>\n      <td>229</td>\n      <td>268</td>\n      <td>Z7189</td>\n      <td>[Z7189, Z7689, Z4931, L049, T464X4S, Z713, K5900, Z3183, Z4932, F1621, F1921, T43214, F18921, Z4...</td>\n      <td>[accutane treatment counseling [Other specified counseling], incretin mimetic therapy started (s...</td>\n      <td>[0.1702, 0.1904, 0.2058, 0.2281, 0.2153, 0.2091, 0.2091, 0.2194, 0.2257, 0.2462, 0.2462, 0.2356,...</td>\n      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1]</td>\n      <td>[0, 0, 1, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 1, 0, 0]</td>\n      <td>[0, 0, 134, 0, 0, 0, 0, 0, 134, 55, 55, 0, 0, 134, 0, 0]</td>\n      <td>0.1363</td>\n    </tr>\n    <tr>\n      <th>6</th>\n      <td>advanced or recurrent breast cancerafter standard therapy</td>\n      <td>TREATMENT</td>\n      <td>287</td>\n      <td>343</td>\n      <td>Z1239</td>\n      <td>[Z1239, Z8541, Z923, Z125, C802, T8649, R9721, T86818, Z1503, O3412, O3413, C5091, O3410, O3411,...</td>\n      <td>[screening exam for breast cancer [Encounter for other screening for malignant neoplasm of breas...</td>\n      <td>[0.1534, 0.1573, 0.1573, 0.1514, 0.1550, 0.1550, 0.1631, 0.1582, 0.1690, 0.1640, 0.1650, 0.1732,...</td>\n      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1, 0, 1, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 1, 0, 0, 1, 1, 0, 1, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 12, 186, 0, 0, 0, 0, 0, 12, 0, 0, 186, 8, 0, 11, 0, 0, 0, 0]</td>\n      <td>0.0606</td>\n    </tr>\n    <tr>\n      <th>7</th>\n      <td>vinorelbine</td>\n      <td>TREATMENT</td>\n      <td>386</td>\n      <td>396</td>\n      <td>E7201</td>\n      <td>[E7201, H5353, N8181, O418X, L708, F488, R7989, S0082, S0082XA, I7389, S0082XD, J3489, I898, Y95...</td>\n      <td>[cystinuria, type 1 [Cystinuria], deuteranomaly [Deuteranomaly], perineocele [Perineocele], find...</td>\n      <td>[0.2897, 0.2942, 0.2888, 0.3018, 0.2972, 0.3220, 0.3120, 0.3416, 0.3416, 0.3567, 0.3461, 0.3205,...</td>\n      <td>[1, 1, 1, 0, 1, 1, 1, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]</td>\n      <td>[1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>[23, 0, 0, 0, 0, 0, 0, 0, 0, 108, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>0.0937</td>\n    </tr>\n    <tr>\n      <th>8</th>\n      <td>anthracyclines</td>\n      <td>TREATMENT</td>\n      <td>433</td>\n      <td>446</td>\n      <td>A220</td>\n      <td>[A220, A229, A22, A222, L940, Z1629, B999, D239, A599, A227, Q821, A5272, H5054, L998, N897, A22...</td>\n      <td>[skin anthrax [Cutaneous anthrax], anthrax infection [Anthrax, unspecified], anthrax [Anthrax], ...</td>\n      <td>[0.2478, 0.2633, 0.2688, 0.2688, 0.2868, 0.2857, 0.2857, 0.2944, 0.2948, 0.2823, 0.2905, 0.2970,...</td>\n      <td>[1, 1, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 115, 6, 0, 0, 0, 0, 0]</td>\n      <td>0.0817</td>\n    </tr>\n    <tr>\n      <th>9</th>\n      <td>taxanes</td>\n      <td>TREATMENT</td>\n      <td>452</td>\n      <td>458</td>\n      <td>H1511</td>\n      <td>[H1511, H15119, D4989, C7220, Q103, C781, L293, L291, I722, P2810, I714, R198, Q702, Q7649, L812...</td>\n      <td>[episcleritis periodica fugax [Episcleritis periodica fugax], episcleritis periodica fugax [Epis...</td>\n      <td>[0.3039, 0.3039, 0.2873, 0.2735, 0.2948, 0.3006, 0.2971, 0.2971, 0.2937, 0.3039, 0.3005, 0.2809,...</td>\n      <td>[0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 1, 0, 1, 0, 0, 1, 0, 1, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 1, 1, 1]</td>\n      <td>[0, 0, 0, 10, 0, 8, 0, 0, 108, 0, 108, 0, 0, 0, 0, 108, nan, 111, 11, 11, 0, 0, 11, 108, 107]</td>\n      <td>0.0579</td>\n    </tr>\n    <tr>\n      <th>10</th>\n      <td>Vinorelbinewas</td>\n      <td>TREATMENT</td>\n      <td>470</td>\n      <td>483</td>\n      <td>Z7689</td>\n      <td>[Z7689, T691X, T691XXA, L708, T691XXS, S0082, S0082XA, E511, E5111, B748, R6889, Z79899, D720, H...</td>\n      <td>[under care of cmhn [Persons encountering health services in other specified circumstances], chi...</td>\n      <td>[0.2952, 0.2929, 0.2929, 0.2963, 0.3108, 0.3360, 0.3360, 0.3123, 0.3123, 0.3020, 0.3249, 0.3460,...</td>\n      <td>[1, 1, 1, 1, 1, 0, 1, 0, 1, 1, 1, 1, 1, 1, 1, 1, 0, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 47, 0, 52, 0, 0, 0]</td>\n      <td>0.1032</td>\n    </tr>\n    <tr>\n      <th>11</th>\n      <td>tumorprogression</td>\n      <td>TREATMENT</td>\n      <td>635</td>\n      <td>650</td>\n      <td>R3989</td>\n      <td>[R3989, D492, L744, C212, C889, K033, M8418, M960, R4189, E220, M619, Y408, D4989, F22, D495, T6...</td>\n      <td>[pseudoemission [Other symptoms and signs involving the genitourinary system], neoplasm of natur...</td>\n      <td>[0.2067, 0.2428, 0.2456, 0.2462, 0.2722, 0.2684, 0.2619, 0.2619, 0.2532, 0.2594, 0.2615, 0.2642,...</td>\n      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 1, 1, 0, 0, 0, 0, 1, 0, 0, 0, 1, 0, 0, 1, 0, 0, 1, 0]</td>\n      <td>[0, 0, 0, 11, 10, 0, 0, 0, 0, 23, 0, 0, 0, 59, 0, 0, 11, 0, 0, 12, 0]</td>\n      <td>0.1567</td>\n    </tr>\n    <tr>\n      <th>12</th>\n      <td>MR)</td>\n      <td>TEST</td>\n      <td>856</td>\n      <td>858</td>\n      <td>N469</td>\n      <td>[N469, N46, Z634, Z7689, R4189, K1379, G932, Z0389, L290, L298, M40299, Z30433, Z621, R448]</td>\n      <td>[primary male infertility [Male infertility, unspecified], secondary male infertility [Male infe...</td>\n      <td>[0.3564, 0.3628, 0.3917, 0.3965, 0.4001, 0.4345, 0.4588, 0.4340, 0.4625, 0.4478, 0.4373, 0.4495,...</td>\n      <td>[1, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>0.1431</td>\n    </tr>\n    <tr>\n      <th>13</th>\n      <td>change</td>\n      <td>PROBLEM</td>\n      <td>866</td>\n      <td>871</td>\n      <td>F6089</td>\n      <td>[F6089, Z561, F629, Z7689, G4726, L678, Z9189, Z4803, T819X, T819XXA, R009, Z924, R0989]</td>\n      <td>[personality change [Other specific personality disorders], change of job [Change of job], chang...</td>\n      <td>[0.2340, 0.2476, 0.2594, 0.2807, 0.2908, 0.3184, 0.3197, 0.3236, 0.3273, 0.3273, 0.3327, 0.3438,...</td>\n      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]</td>\n      <td>[1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>[60, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>0.2581</td>\n    </tr>\n    <tr>\n      <th>14</th>\n      <td>NC)</td>\n      <td>TEST</td>\n      <td>874</td>\n      <td>876</td>\n      <td>Z30431</td>\n      <td>[Z30431, W2209XD, W2209, Z7689, Y288XXD, R293, H332, R4189, M6285, H360, S96911A, S0911XA, S0911...</td>\n      <td>[iud, surveillance [Encounter for routine checking of intrauterine contraceptive device], striki...</td>\n      <td>[0.3145, 0.3158, 0.3158, 0.3052, 0.3479, 0.3228, 0.3113, 0.3294, 0.3250, 0.3218, 0.3260, 0.3231,...</td>\n      <td>[1, 1, 0, 1, 1, 1, 0, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>0.0748</td>\n    </tr>\n    <tr>\n      <th>15</th>\n      <td>partial responses</td>\n      <td>TEST</td>\n      <td>902</td>\n      <td>918</td>\n      <td>Z789</td>\n      <td>[Z789, K5660, K5669, K566, R4789, R0989, Z712, K084, Z7689, N971, Q922, Z9119, H332, E230, F6589...</td>\n      <td>[partial response to treatment [Other specified health status], partial obstruction of small bow...</td>\n      <td>[0.1588, 0.2428, 0.2428, 0.2366, 0.2361, 0.2366, 0.2396, 0.2418, 0.2456, 0.2631, 0.2611, 0.2572,...</td>\n      <td>[1, 0, 0, 0, 1, 1, 1, 0, 1, 1, 1, 1, 0, 1, 1, 1]</td>\n      <td>[0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0]</td>\n      <td>[0, 33, 33, 0, 0, 0, 0, 0, 0, 0, nan, 0, 0, 23, 0, 0]</td>\n      <td>0.4619</td>\n    </tr>\n    <tr>\n      <th>16</th>\n      <td>PRs</td>\n      <td>TEST</td>\n      <td>921</td>\n      <td>923</td>\n      <td>Z30431</td>\n      <td>[Z30431, R198, X19XXXD, X19XX, W301X, W301XXD, L282, X19XXXA, Z8774, F902, T796XXA, F909, L200, ...</td>\n      <td>[iud, surveillance [Encounter for routine checking of intrauterine contraceptive device], psoas ...</td>\n      <td>[0.3105, 0.3207, 0.3489, 0.3489, 0.3531, 0.3531, 0.3442, 0.3482, 0.3481, 0.3229, 0.3467, 0.3290,...</td>\n      <td>[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, nan, 0, nan, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>0.1158</td>\n    </tr>\n    <tr>\n      <th>17</th>\n      <td>MR</td>\n      <td>TEST</td>\n      <td>932</td>\n      <td>933</td>\n      <td>H360</td>\n      <td>[H360, N469, N46, Z7689, Y610, N468, D475, Q251, N460, R198, L604, E291, R222, L298, Q983, R4189...</td>\n      <td>[dr [Retinal disorders in diseases classified elsewhere], primary male infertility [Male inferti...</td>\n      <td>[0.3007, 0.3549, 0.3540, 0.4256, 0.4195, 0.4072, 0.4223, 0.4138, 0.4311, 0.4438, 0.4297, 0.4306,...</td>\n      <td>[1, 1, 0, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 52]</td>\n      <td>0.3767</td>\n    </tr>\n    <tr>\n      <th>18</th>\n      <td>NCs out</td>\n      <td>TEST</td>\n      <td>940</td>\n      <td>946</td>\n      <td>Z789</td>\n      <td>[Z789, Z9289, Z7689, X52XXXD, X52XX, H54511, H542X2, Q959, H542X1, O4210, H33051, O4700]</td>\n      <td>[patient in remission [Other specified health status], treatment completed (procedure) [Personal...</td>\n      <td>[0.3253, 0.3490, 0.3728, 0.3878, 0.3878, 0.3867, 0.3760, 0.3632, 0.3783, 0.3846, 0.3700, 0.3879]</td>\n      <td>[1, 1, 1, 1, 1, 0, 0, 1, 0, 1, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>0.1554</td>\n    </tr>\n    <tr>\n      <th>19</th>\n      <td>TheKaplan-Meier estimate</td>\n      <td>TEST</td>\n      <td>956</td>\n      <td>979</td>\n      <td>Z7689</td>\n      <td>[Z7689, D720, R700]</td>\n      <td>[seen by endocrinology service (finding) [Persons encountering health services in other specifie...</td>\n      <td>[0.2599, 0.3172, 0.3300]</td>\n      <td>[1, 1, 1]</td>\n      <td>[0, 1, 0]</td>\n      <td>[0, 47, 0]</td>\n      <td>0.5512</td>\n    </tr>\n    <tr>\n      <th>20</th>\n      <td>The response rate in the visceral organs</td>\n      <td>TEST</td>\n      <td>1037</td>\n      <td>1076</td>\n      <td>S278</td>\n      <td>[S278, N992, R840, D4989, N9489, S2789, S27898, S27893S, M9912, H35011, M9914, Q335, I715, H3501...</td>\n      <td>[injury of other specified intrathoracic organs [Injury of other specified intrathoracic organs]...</td>\n      <td>[0.1780, 0.1772, 0.1780, 0.1939, 0.1855, 0.1923, 0.1923, 0.1961, 0.1916, 0.1926, 0.1957, 0.1891,...</td>\n      <td>[0, 1, 1, 1, 1, 0, 0, 1, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 107, 0, 0, 0, 0, 0, 107]</td>\n      <td>0.0751</td>\n    </tr>\n    <tr>\n      <th>21</th>\n      <td>Themajor toxicity</td>\n      <td>PROBLEM</td>\n      <td>1110</td>\n      <td>1126</td>\n      <td>T460X1A</td>\n      <td>[T460X1A, T604X, T603X, X49, X48, D8989, T5291, T531X4D, T531X, X46, T600, T594X, T594X4A, T590X...</td>\n      <td>[digoxin toxicity [Poisoning by cardiac-stimulant glycosides and drugs of similar action, accide...</td>\n      <td>[0.1514, 0.1835, 0.2043, 0.2205, 0.2274, 0.2309, 0.2354, 0.2519, 0.2519, 0.2504, 0.2386, 0.2663,...</td>\n      <td>[1, 0, 0, 1, 1, 1, 0, 1, 0, 1, 0, 0, 1, 0, 1, 1, 0, 0, 1, 1, 1, 1, 1, 1]</td>\n      <td>[0, 1, 1, 0, 0, 1, 0, 0, 1, 0, 0, 1, 0, 1, 0, 0, 1, 0, 0, 0, 1, 0, 0, 0]</td>\n      <td>[0, 59, 59, 0, 0, 47, 0, 0, 59, 0, 0, 59, 0, 59, 0, 0, 59, 0, 0, 0, 55, 0, 0, 0]</td>\n      <td>0.3070</td>\n    </tr>\n    <tr>\n      <th>22</th>\n      <td>myelosuppression</td>\n      <td>PROBLEM</td>\n      <td>1132</td>\n      <td>1147</td>\n      <td>D759</td>\n      <td>[D759, D7589, N9489, Q059, C900, Z8579, C9001, D471, Z807, C9000, T441X, T441X6S, A804, R631, Q0...</td>\n      <td>[myelosuppression [Disease of blood and blood-forming organs, unspecified], myelosuppression [Ot...</td>\n      <td>[0.0000, 0.0000, 0.2969, 0.2885, 0.2985, 0.3011, 0.3153, 0.3476, 0.3276, 0.3330, 0.3438, 0.3438,...</td>\n      <td>[1, 1, 1, 1, 0, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1, 0, 1, 1]</td>\n      <td>[0, 0, 0, 1, 0, 0, 1, 1, 0, 1, 1, 0, 0, 0, 1, 1, 0, 1]</td>\n      <td>[0, 0, 0, 72, 0, 0, 9, 48, 0, 9, 59, 0, 0, 0, 72, 59, 0, 23]</td>\n      <td>0.5000</td>\n    </tr>\n    <tr>\n      <th>23</th>\n      <td>requirediscontinuation</td>\n      <td>TREATMENT</td>\n      <td>1183</td>\n      <td>1204</td>\n      <td>N3949</td>\n      <td>[N3949, N39498, M2653, J349, J3489, R159, R15, T698XXD, T698X, T698XXA, Q6211, R3981, T7589, T75...</td>\n      <td>[other specified urinary incontinence [Other specified urinary incontinence], other specified ur...</td>\n      <td>[0.2526, 0.2526, 0.2601, 0.2745, 0.2745, 0.2617, 0.2680, 0.2918, 0.2918, 0.3024, 0.3012, 0.2721,...</td>\n      <td>[0, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1, 1, 0, 1, 0, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>0.0802</td>\n    </tr>\n    <tr>\n      <th>24</th>\n      <td>treatment</td>\n      <td>TREATMENT</td>\n      <td>1209</td>\n      <td>1217</td>\n      <td>Z9289</td>\n      <td>[Z9289, Z7689, T66XXXA, Z789, T829XXA, T859XXA, T8181XA, T8579XA, T814, Z7189, T86829, T8181, F4...</td>\n      <td>[treatment given (regime/therapy) [Personal history of other medical treatment], response to tre...</td>\n      <td>[0.1914, 0.2055, 0.2419, 0.2329, 0.2402, 0.2438, 0.2450, 0.2431, 0.2467, 0.2518, 0.2501, 0.2607,...</td>\n      <td>[1, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 0, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>0.2374</td>\n    </tr>\n    <tr>\n      <th>25</th>\n      <td>this study</td>\n      <td>TEST</td>\n      <td>1247</td>\n      <td>1256</td>\n      <td>Z7689</td>\n      <td>[Z7689, Z30431, R2689, H5232, Q131, Z331, Z33, Z3141, Z139, N3582, O2685, O26859, R4589]</td>\n      <td>[patient in local study [Persons encountering health services in other specified circumstances],...</td>\n      <td>[0.2919, 0.3441, 0.3495, 0.3460, 0.3460, 0.3286, 0.3286, 0.3369, 0.3274, 0.3588, 0.3348, 0.3348,...</td>\n      <td>[1, 1, 1, 1, 1, 1, 0, 1, 1, 1, 0, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]</td>\n      <td>0.1741</td>\n    </tr>\n    <tr>\n      <th>26</th>\n      <td>thatvinorelbine monotherapy</td>\n      <td>TREATMENT</td>\n      <td>1263</td>\n      <td>1289</td>\n      <td>Z7689</td>\n      <td>[Z7689, I7389, T45626, T4562, T477X6S, T477X, Y721, Z7189, T45626S, T448X1S, T415X6S, Z3183, N46...</td>\n      <td>[incretin mimetic therapy started (situation) [Persons encountering health services in other spe...</td>\n      <td>[0.2691, 0.2901, 0.2826, 0.2826, 0.2809, 0.2809, 0.2971, 0.2756, 0.2905, 0.2984, 0.2837, 0.2892,...</td>\n      <td>[1, 1, 0, 0, 1, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 0, 1]</td>\n      <td>[0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0]</td>\n      <td>[0, 108, 0, 59, 0, 59, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 59, 0, 55, 59, 0]</td>\n      <td>0.0824</td>\n    </tr>\n    <tr>\n      <th>27</th>\n      <td>recurrent breastcancer</td>\n      <td>TREATMENT</td>\n      <td>1330</td>\n      <td>1351</td>\n      <td>I830</td>\n      <td>[I830, K269, E11622, L98499, E10622, K263, K265, E1162, K260, I87031, I8703, I87032, K261, K633,...</td>\n      <td>[recurrent venous leg ulcer [Varicose veins of lower extremities with ulcer], duodenal ulcer dis...</td>\n      <td>[0.0932, 0.1144, 0.1191, 0.1191, 0.1222, 0.1190, 0.1218, 0.1246, 0.1240, 0.1350, 0.1350, 0.1356,...</td>\n      <td>[0, 1, 1, 1, 1, 1, 1, 0, 1, 1, 0, 1, 1, 1, 1, 1, 1, 0, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 33, 18/161, 0, 0, 107, 0, 33, 0, 0, 0, 0, 0, 0]</td>\n      <td>0.1577</td>\n    </tr>\n    <tr>\n      <th>28</th>\n      <td>anthracyclines</td>\n      <td>TREATMENT</td>\n      <td>1380</td>\n      <td>1393</td>\n      <td>A220</td>\n      <td>[A220, A229, A22, A222, L940, Z1629, B999, D239, A599, A227, Q821, A5272, H5054, L998, N897, A22...</td>\n      <td>[skin anthrax [Cutaneous anthrax], anthrax infection [Anthrax, unspecified], anthrax [Anthrax], ...</td>\n      <td>[0.2478, 0.2633, 0.2688, 0.2688, 0.2868, 0.2857, 0.2857, 0.2944, 0.2948, 0.2823, 0.2905, 0.2970,...</td>\n      <td>[1, 1, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 115, 6, 0, 0, 0, 0, 0]</td>\n      <td>0.0817</td>\n    </tr>\n    <tr>\n      <th>29</th>\n      <td>taxanes</td>\n      <td>TREATMENT</td>\n      <td>1399</td>\n      <td>1405</td>\n      <td>H1511</td>\n      <td>[H1511, H15119, D4989, C7220, Q103, C781, L293, L291, I722, P2810, I714, R198, Q702, Q7649, L812...</td>\n      <td>[episcleritis periodica fugax [Episcleritis periodica fugax], episcleritis periodica fugax [Epis...</td>\n      <td>[0.3039, 0.3039, 0.2873, 0.2735, 0.2948, 0.3006, 0.2971, 0.2971, 0.2937, 0.3039, 0.3005, 0.2809,...</td>\n      <td>[0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1, 1, 1, 1, 0, 1, 1, 1, 1]</td>\n      <td>[0, 0, 0, 1, 0, 1, 0, 0, 1, 0, 1, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 1, 1, 1]</td>\n      <td>[0, 0, 0, 10, 0, 8, 0, 0, 108, 0, 108, 0, 0, 0, 0, 108, nan, 111, 11, 11, 0, 0, 11, 108, 107]</td>\n      <td>0.0579</td>\n    </tr>\n  </tbody>\n</table>\n</div>"]}}],"execution_count":0},{"cell_type":"markdown","source":["**Lets check the confidence level > 0.5 results**"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"6fdd5e08-ac14-4a35-a239-32f2adeb80dd"}}},{"cell_type":"code","source":["df[df.confidence.astype(float) > 0.5]"],"metadata":{"scrolled":true,"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"f518c8cd-3d4a-44c5-8318-869c68d0b3c6"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div class=\"ansiout\">Out[61]: </div>","removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"html","arguments":{}}},"output_type":"display_data","data":{"text/html":["<style scoped>\n  .ansiout {\n    display: block;\n    unicode-bidi: embed;\n    white-space: pre-wrap;\n    word-wrap: break-word;\n    word-break: break-all;\n    font-family: \"Source Code Pro\", \"Menlo\", monospace;;\n    font-size: 13px;\n    color: #555;\n    margin-left: 4px;\n    line-height: 19px;\n  }\n</style>\n<div class=\"ansiout\">Out[61]: </div>"]}},{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>chunks</th>\n      <th>entity</th>\n      <th>begin</th>\n      <th>end</th>\n      <th>code</th>\n      <th>all_codes</th>\n      <th>resolutions</th>\n      <th>all_distances</th>\n      <th>billable</th>\n      <th>hcc_status</th>\n      <th>hcc_score</th>\n      <th>confidence</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>1</th>\n      <td>breast cancer</td>\n      <td>PROBLEM</td>\n      <td>84</td>\n      <td>96</td>\n      <td>C50919</td>\n      <td>[C50919, Z1239, C50911, C4452, D0590, D493, C61, C44501, Z853, C50819, C50111, C50929, C50921, C...</td>\n      <td>[breast cancer [Malignant neoplasm of unspecified site of unspecified female breast], screening ...</td>\n      <td>[0.0000, 0.1055, 0.1108, 0.1151, 0.1247, 0.1303, 0.1323, 0.1391, 0.1372, 0.1420, 0.1439, 0.1440,...</td>\n      <td>[1, 1, 1, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 12, 0, 0, 0, 0, 0, 0, 12, 0, 0, 0, 9, 12]</td>\n      <td>0.9984</td>\n    </tr>\n    <tr>\n      <th>19</th>\n      <td>TheKaplan-Meier estimate</td>\n      <td>TEST</td>\n      <td>956</td>\n      <td>979</td>\n      <td>Z7689</td>\n      <td>[Z7689, D720, R700]</td>\n      <td>[seen by endocrinology service (finding) [Persons encountering health services in other specifie...</td>\n      <td>[0.2599, 0.3172, 0.3300]</td>\n      <td>[1, 1, 1]</td>\n      <td>[0, 1, 0]</td>\n      <td>[0, 47, 0]</td>\n      <td>0.5512</td>\n    </tr>\n  </tbody>\n</table>\n</div>","textData":null,"removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"htmlSandbox","arguments":{}}},"output_type":"display_data","data":{"text/html":["<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>chunks</th>\n      <th>entity</th>\n      <th>begin</th>\n      <th>end</th>\n      <th>code</th>\n      <th>all_codes</th>\n      <th>resolutions</th>\n      <th>all_distances</th>\n      <th>billable</th>\n      <th>hcc_status</th>\n      <th>hcc_score</th>\n      <th>confidence</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>1</th>\n      <td>breast cancer</td>\n      <td>PROBLEM</td>\n      <td>84</td>\n      <td>96</td>\n      <td>C50919</td>\n      <td>[C50919, Z1239, C50911, C4452, D0590, D493, C61, C44501, Z853, C50819, C50111, C50929, C50921, C...</td>\n      <td>[breast cancer [Malignant neoplasm of unspecified site of unspecified female breast], screening ...</td>\n      <td>[0.0000, 0.1055, 0.1108, 0.1151, 0.1247, 0.1303, 0.1323, 0.1391, 0.1372, 0.1420, 0.1439, 0.1440,...</td>\n      <td>[1, 1, 1, 0, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0]</td>\n      <td>[0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1, 1]</td>\n      <td>[0, 0, 0, 0, 0, 0, 12, 0, 0, 0, 0, 0, 0, 12, 0, 0, 0, 9, 12]</td>\n      <td>0.9984</td>\n    </tr>\n    <tr>\n      <th>19</th>\n      <td>TheKaplan-Meier estimate</td>\n      <td>TEST</td>\n      <td>956</td>\n      <td>979</td>\n      <td>Z7689</td>\n      <td>[Z7689, D720, R700]</td>\n      <td>[seen by endocrinology service (finding) [Persons encountering health services in other specifie...</td>\n      <td>[0.2599, 0.3172, 0.3300]</td>\n      <td>[1, 1, 1]</td>\n      <td>[0, 1, 0]</td>\n      <td>[0, 47, 0]</td>\n      <td>0.5512</td>\n    </tr>\n  </tbody>\n</table>\n</div>"]}}],"execution_count":0},{"cell_type":"markdown","source":["### Entity Resolution Visualization"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"4563495b-7d09-470e-9afd-5f637cc93dc4"}}},{"cell_type":"code","source":["from sparknlp_display import EntityResolverVisualizer\n\ner_vis = EntityResolverVisualizer()\n\n\n## To set custom label colors:\ner_vis.set_label_colors({'TREATMENT':'#800080', 'PROBLEM':'#77b5fe'}) #set label colors by specifying hex codes\n\nvis = er_vis.display(resolver_res, \n                     label_col='ner_chunk', \n                     resolution_col = 'icd10_code',\n                     document_col='document',\n                     return_html=True)\n\ndisplayHTML(vis)"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"60ddf626-76ea-4a4a-a8c7-3d76b8a6998d"}},"outputs":[{"output_type":"display_data","metadata":{"application/vnd.databricks.v1+output":{"datasetInfos":[],"data":"\n<style>\n    @import url('https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;500;600;700&display=swap');\n    @import url('https://fonts.googleapis.com/css2?family=Vistol Regular:wght@300;400;500;600;700&display=swap');\n    \n    .spark-nlp-display-scroll-entities {\n        border: 1px solid #E7EDF0;\n        border-radius: 3px;\n        text-align: justify;\n        \n    }\n    .spark-nlp-display-scroll-entities span {  \n        font-size: 14px;\n        line-height: 24px;\n        color: #536B76;\n        font-family: 'Montserrat', sans-serif !important;\n    }\n    \n    .spark-nlp-display-entity-wrapper{\n    \n        display: inline-grid;\n        text-align: center;\n        border-radius: 4px;\n        margin: 0 2px 5px 2px;\n        padding: 1px\n    }\n    .spark-nlp-display-entity-name{\n        font-size: 14px;\n        line-height: 24px;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        background: #f1f2f3;\n        border-width: medium;\n        text-align: center;\n        \n        font-weight: 400;\n        \n        border-radius: 5px;\n        padding: 2px 5px;\n        display: block;\n        margin: 3px 2px;\n    \n    }\n    .spark-nlp-display-entity-type{\n        font-size: 14px;\n        line-height: 24px;\n        color: #ffffff;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        text-transform: uppercase;\n        \n        font-weight: 500;\n\n        display: block;\n        padding: 3px 5px;\n    }\n    \n    .spark-nlp-display-entity-resolution{\n        font-size: 14px;\n        line-height: 24px;\n        color: #ffffff;\n        font-family: 'Vistol Regular', sans-serif !important;\n        \n        text-transform: uppercase;\n        \n        font-weight: 500;\n\n        display: block;\n        padding: 3px 5px;\n    }\n    \n    .spark-nlp-display-others{\n        font-size: 14px;\n        line-height: 24px;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        font-weight: 400;\n    }\n\n</style>\n <span class=\"spark-nlp-display-others\" style=\"background-color: white\">BACKGROUND: At present, it is one of the most important issues for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">the treatment </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">Z7689 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">response to treatment [Persons encountering health services in other specified circumstances]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">breast cancer </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">C50919 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">breast cancer [Malignant neoplasm of unspecified site of unspecified female breast]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> to develop </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">the standard therapy </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">Z789 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">complete therapeutic response [Other specified health status]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> for patients previously treated with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">anthracyclines </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">A220 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">skin anthrax [Cutaneous anthrax]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">taxanes </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">H1511 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">episcleritis periodica fugax [Episcleritis periodica fugax]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. With the objective of determining </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">the usefulnessof vinorelbine monotherapy </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">Z7189 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">accutane treatment counseling [Other specified counseling]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in patients with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">advanced or recurrent breast cancerafter standard therapy </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">Z1239 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">screening exam for breast cancer [Encounter for other screening for malignant neoplasm of breast]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, we evaluated the efficacy and safety of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">vinorelbine </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">E7201 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">cystinuria, type 1 [Cystinuria]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> inpatients previously treated with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">anthracyclines </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">A220 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">skin anthrax [Cutaneous anthrax]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">taxanes </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">H1511 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">episcleritis periodica fugax [Episcleritis periodica fugax]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. METHODS: </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">Vinorelbinewas </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">Z7689 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">under care of cmhn [Persons encountering health services in other specified circumstances]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> administered at a dose level of 25 mg/m(2) intravenously on days 1 and 8 of a3 week cycle. Patients were given three or more cycles in the absence of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">tumorprogression </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">R3989 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">pseudoemission [Other symptoms and signs involving the genitourinary system]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. A maximum of nine cycles were administered. RESULTS: The responserate in 50 evaluable patients was 20.0% (10 out of 50; 95% confidence interval,10.0-33.7%). Responders plus those who had minor response (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">MR) </span><span class=\"spark-nlp-display-entity-type\">TEST</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">N469 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">primary male infertility [Male infertility, unspecified]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> or no </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">change </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">F6089 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">personality change [Other specific personality disorders]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">NC) </span><span class=\"spark-nlp-display-entity-type\">TEST</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">Z30431 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">iud, surveillance [Encounter for routine checking of intrauterine contraceptive device]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> accounted for 58.0% [10 </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">partial responses </span><span class=\"spark-nlp-display-entity-type\">TEST</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">Z789 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">partial response to treatment [Other specified health status]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">PRs </span><span class=\"spark-nlp-display-entity-type\">TEST</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">Z30431 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">iud, surveillance [Encounter for routine checking of intrauterine contraceptive device]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) + one </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">MR </span><span class=\"spark-nlp-display-entity-type\">TEST</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">H360 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">dr [Retinal disorders in diseases classified elsewhere]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> + 18 </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">NCs out </span><span class=\"spark-nlp-display-entity-type\">TEST</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">Z789 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">patient in remission [Other specified health status]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of 50]. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">TheKaplan-Meier estimate </span><span class=\"spark-nlp-display-entity-type\">TEST</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">Z7689 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">seen by endocrinology service (finding) [Persons encountering health services in other specified circumstances]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (50% point) of time to progression (TTP) was 115.0 days.</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">The response rate in the visceral organs </span><span class=\"spark-nlp-display-entity-type\">TEST</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">S278 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">injury of other specified intrathoracic organs [Injury of other specified intrathoracic organs]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was 17.3% (nine PRs out of 52). </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">Themajor toxicity </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">T460X1A </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">digoxin toxicity [Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">myelosuppression </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">D759 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">myelosuppression [Disease of blood and blood-forming organs, unspecified]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, which was reversible and did not </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">requirediscontinuation </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">N3949 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">other specified urinary incontinence [Other specified urinary incontinence]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">treatment </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">Z9289 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">treatment given (regime/therapy) [Personal history of other medical treatment]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. CONCLUSION: The results of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">this study </span><span class=\"spark-nlp-display-entity-type\">TEST</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">Z7689 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">patient in local study [Persons encountering health services in other specified circumstances]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> show </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">thatvinorelbine monotherapy </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">Z7689 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">incretin mimetic therapy started (situation) [Persons encountering health services in other specified circumstances]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> is useful in patients with advanced or </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">recurrent breastcancer </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">I830 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">recurrent venous leg ulcer [Varicose veins of lower extremities with ulcer]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> previously exposed to both </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">anthracyclines </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">A220 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">skin anthrax [Cutaneous anthrax]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">taxanes </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">H1511 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">episcleritis periodica fugax [Episcleritis periodica fugax]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">.</span></div>","textData":null,"removedWidgets":[],"addedWidgets":{},"metadata":{},"type":"htmlSandbox","arguments":{}}},"output_type":"display_data","data":{"text/html":["\n<style>\n    @import url('https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;500;600;700&display=swap');\n    @import url('https://fonts.googleapis.com/css2?family=Vistol Regular:wght@300;400;500;600;700&display=swap');\n    \n    .spark-nlp-display-scroll-entities {\n        border: 1px solid #E7EDF0;\n        border-radius: 3px;\n        text-align: justify;\n        \n    }\n    .spark-nlp-display-scroll-entities span {  \n        font-size: 14px;\n        line-height: 24px;\n        color: #536B76;\n        font-family: 'Montserrat', sans-serif !important;\n    }\n    \n    .spark-nlp-display-entity-wrapper{\n    \n        display: inline-grid;\n        text-align: center;\n        border-radius: 4px;\n        margin: 0 2px 5px 2px;\n        padding: 1px\n    }\n    .spark-nlp-display-entity-name{\n        font-size: 14px;\n        line-height: 24px;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        background: #f1f2f3;\n        border-width: medium;\n        text-align: center;\n        \n        font-weight: 400;\n        \n        border-radius: 5px;\n        padding: 2px 5px;\n        display: block;\n        margin: 3px 2px;\n    \n    }\n    .spark-nlp-display-entity-type{\n        font-size: 14px;\n        line-height: 24px;\n        color: #ffffff;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        text-transform: uppercase;\n        \n        font-weight: 500;\n\n        display: block;\n        padding: 3px 5px;\n    }\n    \n    .spark-nlp-display-entity-resolution{\n        font-size: 14px;\n        line-height: 24px;\n        color: #ffffff;\n        font-family: 'Vistol Regular', sans-serif !important;\n        \n        text-transform: uppercase;\n        \n        font-weight: 500;\n\n        display: block;\n        padding: 3px 5px;\n    }\n    \n    .spark-nlp-display-others{\n        font-size: 14px;\n        line-height: 24px;\n        font-family: 'Montserrat', sans-serif !important;\n        \n        font-weight: 400;\n    }\n\n</style>\n <span class=\"spark-nlp-display-others\" style=\"background-color: white\">BACKGROUND: At present, it is one of the most important issues for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">the treatment </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">Z7689 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">response to treatment [Persons encountering health services in other specified circumstances]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">breast cancer </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">C50919 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">breast cancer [Malignant neoplasm of unspecified site of unspecified female breast]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> to develop </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">the standard therapy </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">Z789 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">complete therapeutic response [Other specified health status]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> for patients previously treated with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">anthracyclines </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">A220 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">skin anthrax [Cutaneous anthrax]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">taxanes </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">H1511 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">episcleritis periodica fugax [Episcleritis periodica fugax]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. With the objective of determining </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">the usefulnessof vinorelbine monotherapy </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">Z7189 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">accutane treatment counseling [Other specified counseling]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in patients with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">advanced or recurrent breast cancerafter standard therapy </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">Z1239 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">screening exam for breast cancer [Encounter for other screening for malignant neoplasm of breast]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, we evaluated the efficacy and safety of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">vinorelbine </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">E7201 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">cystinuria, type 1 [Cystinuria]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> inpatients previously treated with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">anthracyclines </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">A220 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">skin anthrax [Cutaneous anthrax]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">taxanes </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">H1511 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">episcleritis periodica fugax [Episcleritis periodica fugax]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. METHODS: </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">Vinorelbinewas </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">Z7689 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">under care of cmhn [Persons encountering health services in other specified circumstances]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> administered at a dose level of 25 mg/m(2) intravenously on days 1 and 8 of a3 week cycle. Patients were given three or more cycles in the absence of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">tumorprogression </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">R3989 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">pseudoemission [Other symptoms and signs involving the genitourinary system]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. A maximum of nine cycles were administered. RESULTS: The responserate in 50 evaluable patients was 20.0% (10 out of 50; 95% confidence interval,10.0-33.7%). Responders plus those who had minor response (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">MR) </span><span class=\"spark-nlp-display-entity-type\">TEST</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">N469 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">primary male infertility [Male infertility, unspecified]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> or no </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">change </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">F6089 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">personality change [Other specific personality disorders]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">NC) </span><span class=\"spark-nlp-display-entity-type\">TEST</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">Z30431 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">iud, surveillance [Encounter for routine checking of intrauterine contraceptive device]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> accounted for 58.0% [10 </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">partial responses </span><span class=\"spark-nlp-display-entity-type\">TEST</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">Z789 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">partial response to treatment [Other specified health status]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">PRs </span><span class=\"spark-nlp-display-entity-type\">TEST</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">Z30431 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">iud, surveillance [Encounter for routine checking of intrauterine contraceptive device]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">) + one </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">MR </span><span class=\"spark-nlp-display-entity-type\">TEST</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">H360 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">dr [Retinal disorders in diseases classified elsewhere]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> + 18 </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">NCs out </span><span class=\"spark-nlp-display-entity-type\">TEST</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">Z789 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">patient in remission [Other specified health status]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of 50]. </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">TheKaplan-Meier estimate </span><span class=\"spark-nlp-display-entity-type\">TEST</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">Z7689 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">seen by endocrinology service (finding) [Persons encountering health services in other specified circumstances]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> (50% point) of time to progression (TTP) was 115.0 days.</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">The response rate in the visceral organs </span><span class=\"spark-nlp-display-entity-type\">TEST</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">S278 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">injury of other specified intrathoracic organs [Injury of other specified intrathoracic organs]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was 17.3% (nine PRs out of 52). </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">Themajor toxicity </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">T460X1A </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">digoxin toxicity [Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">myelosuppression </span><span class=\"spark-nlp-display-entity-type\">PROBLEM</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">D759 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">myelosuppression [Disease of blood and blood-forming organs, unspecified]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, which was reversible and did not </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">requirediscontinuation </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">N3949 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">other specified urinary incontinence [Other specified urinary incontinence]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">treatment </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">Z9289 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">treatment given (regime/therapy) [Personal history of other medical treatment]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. CONCLUSION: The results of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #77b5feB3\"><span class=\"spark-nlp-display-entity-name\">this study </span><span class=\"spark-nlp-display-entity-type\">TEST</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feFF\">Z7689 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #77b5feCC\">patient in local study [Persons encountering health services in other specified circumstances]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> show </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">thatvinorelbine monotherapy </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">Z7689 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">incretin mimetic therapy started (situation) [Persons encountering health services in other specified circumstances]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> is useful in patients with advanced or </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">recurrent breastcancer </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">I830 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">recurrent venous leg ulcer [Varicose veins of lower extremities with ulcer]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> previously exposed to both </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">anthracyclines </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">A220 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">skin anthrax [Cutaneous anthrax]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #800080B3\"><span class=\"spark-nlp-display-entity-name\">taxanes </span><span class=\"spark-nlp-display-entity-type\">TREATMENT</span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080FF\">H1511 </span><span class=\"spark-nlp-display-entity-resolution\" style=\"background-color: #800080CC\">episcleritis periodica fugax [Episcleritis periodica fugax]</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">.</span></div>"]}}],"execution_count":0},{"cell_type":"markdown","source":["**If you want to go more over about entity resolution model examples, you can check this comprehensive notebooks :**\n\nhttps://github.com/JohnSnowLabs/spark-nlp-workshop/blob/master/tutorials/Certification_Trainings/Healthcare/24.Improved_Entity_Resolvers_in_SparkNLP_with_sBert.ipynb\nhttps://github.com/JohnSnowLabs/spark-nlp-workshop/blob/master/tutorials/Certification_Trainings/Healthcare/3.Clinical_Entity_Resolvers.ipynb"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"6d3f4e3d-be1c-4360-af9e-e4cfa14c64c5"}}},{"cell_type":"markdown","source":["### End of Notebook"],"metadata":{"application/vnd.databricks.v1+cell":{"title":"","showTitle":false,"inputWidgets":{},"nuid":"8c2ebd31-bfae-449a-8869-689f4400dd59"}}}],"metadata":{"kernelspec":{"display_name":"Environment (conda_tensorflow_p36)","language":"python","name":"conda_tensorflow_p36"},"language_info":{"mimetype":"text/x-python","name":"python","pygments_lexer":"ipython3","codemirror_mode":{"name":"ipython","version":3},"version":"3.6.10","nbconvert_exporter":"python","file_extension":".py"},"application/vnd.databricks.v1+notebook":{"notebookName":"Get_Started_Spark_NLP_for_Healthcare","dashboards":[],"notebookMetadata":{"pythonIndentUnit":2},"language":"python","widgets":{},"notebookOrigID":1887236546067831}},"nbformat":4,"nbformat_minor":0}
